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Abstract
RNA Methylation and Ythdf Readers in Posttranscriptional Regulation and Development
Cassandra Kontur
2021
Development in animals requires precise and coordinated changes in gene expression. This
genetic remodeling is achieved through extensive regulatory networks of proteins and RNAs that
function together to specify new cell fates and patterns. One developmental event heavily reliant
on these regulatory networks is the maternal-to-zygotic transition (MZT), a universal step in
metazoan embryogenesis in which a fertilized oocyte is reprogrammed into a pluripotent embryo.
The earliest stages of the MZT are governed by maternally inherited gene products, which are
required for cellular functions in the initially transcriptionally silent embryo. To shift
developmental control to the zygote, these maternal mRNAs are massively degraded through
multiple posttranscriptional mechanisms. The RNA modification, N6-methyladenosine (m6A) has
been proposed as a master regulator of mRNA decay during developmental transitions, but the
direct effects of this pathway on maternal transcript clearance remain unclear. To determine
whether m6A facilitates gene expression changes during the MZT, I employed zebrafish embryos
as a model system to dissect the contributions of RNA methylation and its reader proteins to
maternal transcript fate.
Through transcriptome analysis and reporter assays, I found that m6A controls maternal
mRNA degradation by promoting deadenylation. To understand how RNA methylation fits into
the framework of known decay pathways, I compared transcripts co-targeted by m6A and miR430, a microRNA that controls mRNA clearance in zebrafish. This revealed that these mechanisms

function independently but additively to promote mRNA degradation, reflecting that methylation
modulates transcript abundance in concert with known regulators.
To disentangle the roles of the Ythdf proteins that mediate the effects of m6A on mRNA, I
generated zebrafish genetic mutants of Ythdf1, Ythdf2, and Ythdf3. Through transcriptomic and
phenotypic analysis of these mutants, I determined that global maternal mRNA clearance, zygotic
genome activation, and development proceed normally in the absence of any one reader. This
revealed that individual Ythdf proteins have limited effects on the removal of methylated maternal
mRNAs during the MZT. To test if this limited impact of single Ythdf loss stems from functional
redundancy between the readers, I produced double mutants of Ythdf2 and Ythdf3. Double Ythdf
deletion prevents female gonad development, indicating that these factors exert overlapping
activities during oogenesis. Finally, to fully establish functionally redundancy, I created triple
Ythdf mutants, which are larval lethal. I observed this same phenotype in zebrafish lacking the
methylases that add m6A to mRNA, indicating that RNA methylation is essential for
developmental viability.
Together, this work provides insight into the contributions of the m6A modification and its
Ythdf effectors to maternal mRNA clearance, and establishes how these key regulators coordinate
the gene expression changes that underlie embryonic reprogramming.
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CHAPTER 1: RNA methylation regulates
gene expression during development
Global changes in gene expression underlie all cellular transitions. To ensure that this
massive genetic remodeling is executed precisely and efficiently, a complex web of regulatory
mechanisms coordinate their functions to specify new cell fates and patterns. While transcription
is integral to the modulation of gene expression, multiple posttranscriptional maneuvers also
contribute to reprogramming. By finetuning the genetic output from already synthesized mRNAs,
these posttranscriptional mechanisms offer rapid and responsive transcriptome manipulations
without necessitating largescale transcriptional adjustments.
One transition heavily reliant on posttranscriptional regulation is the maternal-to-zygotic
transition (MZT), a process universal to all metazoans. The MZT is the hallmark first step in
embryogenesis, in which a fertilized oocyte undergoes developmental reprogramming into a
pluripotent embryo. This transition is an ideal situation to study the effects of posttranscriptional
processes, as the zygote is initially transcriptionally silent and development is sustained by
maternally inherited gene products. This means that posttranscriptional pathways dominate the
early MZT, and a vast network of regulatory factors remodels the maternal transcriptome and
proteome to facilitate proper developmental progression.
The posttranscriptional mechanisms controlling gene expression changes during the MZT
are extensive, interwoven, and often universal across organisms. The embryo employs multiple
regulatory pathways simultaneously, including those involving RNA-binding proteins (RBPs) and
microRNAs, which rely on sequence elements embedded in target mRNAs for their activity. Other
pathways engage features inherent to the mRNA transcript, such as RNA secondary structures or
codon identity. Ubiquitous RNA modifications such as the 5’end cap and the 3’end poly(A) tail

1

also play a crucial regulatory role, through interactions with translation and decay machinery.
Recently, internal mRNA modifications have been identified as mediators of mRNA fate, where
deposition of chemical groups on the canonical A, C, G, and U nucleotides confers an additional
layer of regulatory information. As the most abundant internal mRNA modification, N6methyladenosine (m6A, also termed methylation) has the capacity to mark thousands of transcripts
for simultaneous, specific changes in RNA regulation, making it an especially promising
mechanism to control maternal transcriptome remodeling.
RNA methylation has already been implicated in numerous developmental transitions that
require extensive genetic reprogramming, suggesting that it may be a global mechanism to control
development. m6A has been linked to stem cell differentiation, gametogenesis, and embryogenesis,
where the function of m6A as a posttranscriptional regulator is central to its facilitation of these
transitions (Fig. 1.1.). To direct cell state switching, RNA methylation tags transcripts encoding
developmental regulators and relies on its effectors to mediate their degradation or translation. The
enzymes responsible for m6A metabolism are often essential to development across organisms,
reflecting that this pathway plays a critical role in reprogramming. Given that m6A is a master
mediator of posttranscriptional remodeling during developmental transitions, its impact on the
maternal transcriptome during the MZT is likely to be significant.
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Figure 1.1. m6A facilitates developmental transitions by modulating mRNA decay
RNA methylation contributes to the transition from a pluripotent to a differentiated state in multiple
developmental contexts, including in stem cells, oogenesis, and zebrafish embryogenesis. Transcripts
marked by m6A are more rapidly degraded than unmarked mRNAs, allowing for global changes in
gene expression. These effects of m6A on mRNA fate are frequently mediated by the YTHDF readers
(green).
In this dissertation, I aim to address how the m6A modification serves as a central
determinant of gene expression changes during key developmental transitions. First, I review
foundational literature in the field of maternal mRNA clearance during the maternal-to-zygotic
transition (Chapter 1.1.). I then focus on the posttranscriptional mechanisms through which m6A
controls mRNA decay and translation, with an emphasis on the factors involved in adding and
interpreting the modification (Chapter 1.2.). I address how RNA methylation contributes to both
embryogenesis and parallel transcriptome reprogramming events, including in stem cells and
gametogenesis (Chapter 1.3.)
I then explore whether these roles of RNA methylation on mRNA decay and translation
extend into control of gene expression during the maternal-to-zygotic transition in zebrafish. In
Chapter 2, I investigate the behavior of endogenously methylated maternal mRNAs to gain insight
into how this mark specifies maternal transcript fate. I combine mRNA-sequencing and poly(A)
tail analysis to reveal that m6A modification is associated with enhanced deadenylation, clarifying
the mechanistic underpinnings of m6A regulation of maternal mRNA clearance (Chapter 2.1). I
validate the impact of m6A on poly(A) tail shortening through methylated reporters, and
demonstrate the reliance of this pathway on zygotic transcription (Chapter 2.2.). I explore the
interplay between methylation and microRNAs, revealing that these pathways coordinate their
functions to co-target specific mRNAs for enhanced clearance (Chapter 2.3.), and that the
microRNA miR-430 controls Ythdf3 downregulation at the mRNA level. Finally, I analyze
ribosome profiling data to show that m6A also promotes maternal mRNA translation (Chapter

3

2.4.). Together, these analyses demonstrate how RNA methylation contributes to the
posttranscriptional regulatory landscape guiding transcriptome turnover during the MZT.
To understand which m6A writers and readers impart the significance of methylation onto
maternal transcripts, I analyze their expression during the MZT (Chapter 3.1.) To dissect the
contributions of each YTHDF reader to maternal mRNA clearance, I generate single mutants of
YTHDF1, YTHDF2, and YTHDF3, and use RNA-sequencing analysis to establish the
consequences of reader deletion on the maternal transcriptome. I reveal that loss of any one reader
is not sufficient to fully stabilize methylated maternal messages, suggesting that these factors
redundantly control degradation (Chapter 3.2.). Further, I carefully address the role of YTHDF2
on maternal mRNA clearance versus zygotic genome activation, uncovering that YTHDF2 is not
required for progression of either event, thus overturning the view that YTHDF2 alone dictates
timing of decay and transcription during the MZT (Chapter 3.2., Chapter 3.3.).
Finally, I examine the possibility of redundancy of YTHDF function through single,
double, and triple zebrafish mutants. I demonstrate that deletion of any single YTHDF or even
double YTHDFs does not impact embryogenesis (Chapter 4.1.). Yet, I discover that the YTHDFs
exhibit dosage dependency to control oogenesis and larval viability, as double mutants cannot
establish ovaries, and triple mutants are lethal (Chapter 4.2., Chapter 4.3.). Together, this reveals
that the YTHDFs exert overlapping functions to control gene expression changes, and that these
m6A readers are essential for multiple stages of development.
Lastly, I summarize the results obtained and explain their implications relative to the field
of RNA methylation as a whole in Chapter 5. I suggest routes of further exploration, and explore
outstanding questions (Chapter 5). Finally, I describe the methodologies employed (Chapter 6).
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1.1. Posttranscriptional control of maternal mRNA clearance
Early embryonic development is initially sustained by maternal mRNAs and proteins preloaded into the oocyte (Vastenhouw et al., 2019). As developmental control shifts towards the
zygote, these maternally inherited products are systematically degraded through multiple,
interconnected clearance pathways (Despic and Neugebauer, 2018; Tadros and Lipshitz, 2009;
Vastenhouw et al., 2019; Yartseva and Giraldez, 2015). While the extent and timing of maternal
clearance vary across eukaryotes, several core posttranscriptional mechanisms are found to
contribute to mRNA removal in most species (Fig. 1.2.) (Vastenhouw et al., 2019). These factors
and elements can be both maternally derived or zygotically produced, and frequently target the
same mRNAs simultaneously (Yartseva and Giraldez, 2015).

Figure 1.2. Mechanisms of maternal mRNA clearance
Multiple pathways and features contribute to maternal mRNA degradation in zebrafish embryos, and
thus enable changes in gene expression. These mechanisms include RNA secondary structure, codon
optimality, RNA modifications, sequence elements, RNA-binding proteins (RBPs), and microRNAs.
The first major mechanism facilitating maternal mRNA clearance is RNA binding proteins
(RBPs), which bind to sequence elements in transcripts and recruit effectors to enable
deadenylation and decay. For example, in Drosophila, binding of the Smaug RBP to specific
hairpin structures results in transcript deadenylation or translational repression, through
interactions with downstream factors (Chen et al., 2014a; Newton et al., 2015; Semotok et al.,
2005; Tadros et al., 2007; Temme et al., 2010). Pumilio and BRAT also function in flies, and
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recognize unique motifs to promote deadenylation (Gerber et al., 2006; Laver et al., 2015;
Thomsen et al., 2010; Weidmann et al., 2014), thus ensuring specific sets of mRNAs are cleared
by different trans-acting factors. Similarly, AU-rich-element binding proteins help degrade
transcripts in zebrafish (Despic et al., 2017; Rabani et al., 2017; Vejnar et al., 2019), C. elegans
(D’Agostino et al., 2006; Gallo et al., 2008; Schubert et al., 2000), and Xenopus laevis (Graindorge
et al., 2008; Moraes et al., 2006; Paillard et al., 1998; Voeltz and Steitz, 1998), and the factor
BTG4 in mice mediates deadenylation (Yu et al., 2016).
A second major player degrading maternal transcripts is small non-coding RNA, which
includes microRNAs (miRNAs), PIWI-interacting RNAs (piRNAs), and endogenous small
interfering RNAs (endo-siRNAs) (Vastenhouw et al., 2019). For instance, the miRNA miR-430 in
zebrafish induces translational repression and deadenylation of hundreds of maternal transcripts
(Bazzini et al., 2012; Giraldez et al., 2006), and miR-427 in Xenopus (Lund et al., 2009) and miR309 in Drosophila (Bushati et al., 2008) function similarly. In Drosophila, maternal transcripts are
also cleared by piRNAs (Barckmann et al., 2015; Dufourt et al., 2017; Rouget et al., 2010), and in
C. elegans, endo-siRNAs are required for transcript elimination (Stoeckius et al., 2014). Both
RBPs and these non-coding RNAs rely on cis elements embedded in the transcript for their
function, such as specific sequences or structures (Rabani et al., 2017; Vejnar et al., 2019).
A third recently uncovered pathway is codon optimality, in which the ratio of stabilizing
to destabilizing codons influences maternal mRNA translation and half-life in zebrafish,
Drosophila, Xenopus, and mouse (Bazzini et al., 2016; Medina-Muñoz et al., 2021; Mishima and
Tomari, 2016). Codon optimality relies on the abundance of cognate tRNAs for each codon, where
the search for scarce tRNAs slows ribosome decoding, enabling interactions with deadenylase
machinery (Boël et al., 2016; Presnyak et al., 2015; Wu et al., 2019a). Several factors have been
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proposed to sense codon-dependent slowing and modulate downstream decay, including the RNA
helicase Dhh1p (Radhakrishnan et al., 2016), the RBP FMRP (Shu et al., 2020), and CCR4-NOT
itself (Buschauer et al., 2020), although which of these are required for codon-mediated mRNA
degradation in the MZT remains unclear.
Finally, chemical modifications of the mRNA have emerged as another regulatory layer in
maternal mRNA clearance. For example, the m6A reader YTHDF2 controls maternal transcript
abundance in early mouse oocytes and in zebrafish embryos (Ivanova et al., 2017; Zhao et al.,
2017). Similarly, the reader of 5-methylcytosine, Ybx1 promotes mRNA stabilization and
translational repression in zebrafish, potentially via interaction with poly(A) tail binding proteins
((Sun et al., 2018; Yang et al., 2019). Terminal uridylation of maternal transcripts in mice,
zebrafish, and Xenopus helps rapidly degrade transcripts with short poly(A) tails during the MZT
and oocyte-to-embryo transition (Chang et al., 2018; Morgan et al., 2017). Finally, loss of the
deadenylase component CNOT6L in mice reduces inosine modifications in maternal mRNAs,
although whether this accounts for defective translation and decay in these mutants is unclear
(Brachova et al., 2021). While these examples illustrate the importance of these marks in specific
contexts, the universality, extent of activity, and mechanisms employed by RNA modifications to
remove messages during the MZT are yet to be defined.
Together, this multitude of pathways orchestrates maternal mRNA clearance across
organisms. These pathways frequently intersect, with the fate of a single transcript simultaneously
dictated by multiple modes of clearance, potentially to ensure robust and timely degradation. Yet,
as known mechanisms cannot account for the full breadth of clearance (Yartseva and Giraldez,
2015), additional pathways or interactions governing maternal mRNA decay are likely to be
revealed through future research.
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1.2. RNA methylation and posttranscriptional control of gene
expression
1.2.1. Characteristics of the m6A modification
m6A was initially discovered through several landmark studies in the 1970s, which
revealed not only the presence of this modification on mRNA molecules, but also its function in
transcript destabilization (Adams and Cory, 1975; Camper et al., 1984; Desrosiers et al., 1974;
Dubin and Taylor, 1975; Perry and Kelley, 1974; Perry et al., 1975; Sommer et al., 1978). The
m6A modification is conserved across eukaryotes, from plants to yeast to vertebrates, and can also
be found in bacteria and viruses (Beemon and Keith, 1977; Bodi et al., 2010; Canaani et al., 1979;
Deng et al., 2015; Furuichi et al., 1975; Garcias Morales and Reyes, 2021; Horowitz et al., 1984;
Nichols, 1979; Sommer et al., 1978; Zhong et al., 2008). Although m6A on mRNA is the focus
here, this mark is also found in other classes of RNA, including tRNAs, rRNAs, lncRNAs,
snRNAs, and microRNAs, each with unique processing machinery (Lence et al., 2019). Since the
early demonstrations that m6A is functionally significant to the cell (Camper et al., 1984; Sommer
et al., 1978), RNA methylation is now understood to contribute to almost every aspect of the
mRNA lifestyle, including processing, splicing, polyadenylation, nuclear export, localization,
stability, and translation (Heck and Wilusz, 2019; Roundtree et al., 2017a; Zaccara et al., 2019).
The mark itself appears to be regulatorily neutral, and its functional outcome is instead dictated by
its context and interactors. Characterization of the enzymes and proteins that control m6A
homeostasis, termed the writers, readers, and erasers, have demonstrated that the modification is
highly regulated and required for specific cellular and developmental processes (Heck and Wilusz,
2019). Similarly, high throughput m6A-sequencing (Dominissini et al., 2012; Meyer et al., 2012)
uncovered specific features of m6A topology throughout the transcriptome that suggest its
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incorporation is intentional and meant to confer specific instructions for gene expression (Zaccara
et al., 2019). These mapping studies also uncovered the abundance of m6A throughout the
transcriptome, where 25% of transcripts are estimated to harbor at least one modification in
mammals (Balacco and Soller, 2019; Dominissini et al., 2012; Meyer et al., 2012; Wei et al., 1975,
1976), further strengthening the view that methylation functionally regulates mRNA and cell fates.

1.2.2. Transcriptome topography of the m6A modification
While m6A is highly abundant, its presence is also selective, and only some transcripts are
enriched in the modification (Linder et al., 2015; Schwartz et al., 2014). Precisely how this
specificity is achieved remains unclear, but it likely stems from the selectivity of its writer proteins
and their cofactors, as well as the underlying structural and sequence contexts of the mRNA (Lence
et al., 2019). Several specific features are known to define the m6A modification landscape, many
of which were established through early high-throughput sequencing studies of methylated
mRNAs (Dominissini et al., 2012; Meyer et al., 2012).
First, the methyltransferase complex that deposits m6A scrupulously installs the mark in
the DRACH consensus sequence (D = A,G,U; R= A,G; H = A,C,U) (Dominissini et al., 2012;
Harper et al., 1990; Meyer et al., 2012). Yet thousands of DRACH motifs are not methylated,
suggesting that the writers have additional means to control where methylation occurs (Zaccara et
al., 2019).
Second, m6A exhibits a specific pattern along the transcript body, with enrichment in the
5’UTR, CDS, and 3’UTR, and most highly around the stop codon (the last being linked to the
terminal exon-exon junction likely for regulation of alternative polyadenylation and 3’UTRs (Ke
et al., 2017)) (Bodi et al., 2012; Dominissini et al., 2012; Linder et al., 2015; Meyer et al., 2012;
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Schwartz et al., 2014). This topography is conserved across cell types, where m6A tags in the
3’UTR and near stop codons are largely constitutive, suggesting tight regulation of these sites,
while those in the 5’UTR or CDS are less conserved, implying more dynamic control in these
regions (An et al., 2020; Schwartz et al., 2014; Zhang et al., 2020a).
Third, substantial evidence indicates that methylation is introduced co-transcriptionally
onto nascent transcripts (Barbieri et al., 2017; Bertero et al., 2018; Haussmann et al., 2016; Huang
et al., 2019a; Ke et al., 2017; Knuckles et al., 2017; Lence et al., 2016; Slobodin et al., 2017).
Incorporation likely occurs during RNA PolII elongation, as METTL3 and RNA PolII interact in
plants (Bhat et al., 2020), and prior to splicing, as m6A can be detected in introns and splice
junctions (Louloupi et al., 2018). Deposition of m6A to nascent transcripts suggests that the act of
transcription likely influences writer specificity or guides the m6A enrichment pattern (Slobodin
et al., 2017; Zaccara et al., 2019).
Fourth, the selectivity of m6A addition is determined by both the main components of the
writer complex and its cofactors (Schwartz et al., 2014). The catalytic core, METTL3 and
METTL14, are suggested to dictate broad m6A deposition in canonical regions, while the cofactors
modulate m6A at more context specific sites (Wang et al., 2021). Subunit proteins may recognize
their own binding motifs and thus recruit the writer to neighboring m6A sequences, thereby
controlling where the transcript is methylated (Patil et al., 2016; Zhang et al., 2020c). Modulation
in the expression and activity of the methyltransferase complex may explain differential m6A
modifications across cell and developmental states.
Together, these features of m6A deposition demonstrate that the methylation landscape is
highly specific and can be attenuated to diverse physiological contexts. Understanding the pattern
of m6A can provide key insight into how this mark controls gene expression. Yet, current
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knowledge of where m6A is located is limited by its mapping techniques (McIntyre et al., 2020).
These approaches traditionally rely on antibody capture coupled with high throughput sequencing,
which preclude determination of site specific stoichiometries and are associated with
immunoprecipitation biases (McIntyre et al., 2020). Additionally, many of these mapping
techniques cannot distinguish m6A from another modification, N6,2’-O-dimethyladenosine
(m6Am), which also influences transcript stability (Linder et al., 2015; Mauer et al., 2017).
Numerous new approaches are being developed to overcome these limitations, which often rely
instead on fusion proteins, restriction endonucleases, and single-molecule direct RNA sequencing
(Anreiter et al., 2021; Linder and Jaffrey, 2019). As the identification of m6A becomes more
quantitative, capable of capturing fractional abundance, and site specific, our understanding of the
function importance of this epitranscriptomic mark will greatly improve.

1.2.3. The m6A writer complex
METTL3 and METTL14
Discovery of the “writer” proteins that catalyze m6A addition to mRNA greatly advanced
the field of epitranscriptomics. Methyltransferase identification enabled mutagenesis studies that
revealed how loss of methylation impacts gene expression, and showed that these enzymes are
essential for numerous cellular and developmental processes (Clancy et al., 2002; Zhong et al.,
2008). The m6A methyltransferase complex is comprised of METTL3 and METTL14, which form
a heterodimer to serve as the catalytic core (Bokar et al., 1997; Liu et al., 2014; Schöller et al.,
2018; Śledź and Jinek, 2016; Wang et al., 2016a, 2016b, 2014b) (Fig. 1.3.). Several auxiliary
cofactors facilitate m6A deposition by interacting with the core to guide methylase localization,
specificity, binding, and activity (Fig. 1.2.). These cofactors are still being identified, but are

11

known to include WTAP, VIRMA, RBM15, ZC3H13, and CBLL1/HAKAI (Garcias Morales and
Reyes, 2021; Lence et al., 2019). Although both METTL3 and METTL14 contain a
methyltransferase domain, crystal structure analysis has shown that only METTL3 has catalytic
activity, while METTL14 functions as an allosteric adapter to stabilize interaction with the RNA
and improve methylation efficiency (Huang et al., 2019b; Schöller et al., 2018; Śledź and Jinek,
2016; Wang et al., 2016a, 2016b). Notably the functions of METTL3 extend beyond its role as a
methyltransferase, as this enzyme has also been found to promote translation in the cytoplasm
(Choe et al., 2018; Lin et al., 2016; Sorci et al., 2018).
Proper function of METTL3 and METTL14 is vital to development, as loss of these writers
disrupts the methylome and subsequently impairs cellular reprogramming across organisms.
For instance, METTL3 and METTL14 are required for early embryogenesis in mice, as genetic
knockouts are lethal and depletion in mESCs inhibits differentiation (Aguilo et al., 2015; Batista
et al., 2014; Chen et al., 2015; Geula et al., 2015; Meng et al., 2019; Wang et al., 2014b). Similarly,
the homolog, MTA, is essential for embryogenesis and growth in Arabidopsis thaliana (Bodi et
al., 2012; Shen et al., 2016; Zhong et al., 2008), and inactivation of core methyltransferase
components Ime4 and Mum2 in yeast prevents meiosis and sporulation (Agarwala et al., 2012;
Bodi et al., 2010; Clancy et al., 2002; Schwartz et al., 2013). The methylases are also crucial for
spermatogenesis and oogenesis in zebrafish and mice, where they regulate gene expression at
multiple stages of maturation, including in the germ cells (Lin et al., 2017; Sui et al., 2020; Xia et
al., 2018; Xu et al., 2017). In Drosophila, they are necessary for sex determination (Haussmann et
al., 2016; Lence et al., 2016). This extensive range of developmental functions across organisms
demonstrate the importance of m6A and its writers in modulating gene expression during key
developmental milestones and transcriptome turnover.
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Figure 1.3. The methyltransferase complex adds m6A to mRNAs co-transcriptionally
The m6A modification is added to mRNA by the methyltransferase complex, which is comprised of
two core components, METTL3 and METTL14, as well as several cofactors that help determine the
activity, localization, and specificity of the complex, including WTAP, VIRMA, HAKAI, RBM15, and
ZC3H13. The methyltransferase interacts with RNA polymerase II to install the modification cotranscriptionally, and methylation on transcripts leads to their downstream regulation. Other unknown
or cellular context specific factors may also contribute to methyltransferase activity and specificity.
WTAP
WTAP, also called Fl(2)d in flies, is a central adapter of the methyltransferase complex,
and its interaction with METTL3 is required for m6A formation in yeast and mammals (Agarwala
et al., 2012; Horiuchi et al., 2013; Ping et al., 2014; Schwartz et al., 2014). WTAP helps recruit
and anchor the methylases to target RNAs, and thereby guide the levels and specificity of
methylation (Liu et al., 2014; Ping et al., 2014; Schöller et al., 2018). In Drosophila, WTAP is
involved in sex determination and dosage compensation through regulation of Sxl alternative
splicing (Granadino et al., 1990; Penn et al., 2008), although the extent to which this relies on its
function in the methyltransferase complex is unclear. WTAP is also essential for proper m6A levels
on transcripts encoding stem cell fate regulators during plant development (Shen et al., 2016).
Similarly, conditional deletion of WTAP in mouse Sertoli cells impairs sperm stem cell selfrenewal and differentiation, again reflecting the central function of m6A in stem cell fate decisions
and spermatogenesis (Jia et al., 2020).
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VIRMA
VIRMA, also called Virilizer or KIAA1429, is another methyltransferase subunit that helps
establish the pattern of m6A through recruitment of the methylases (Hu et al., 2020; Liu et al.,
2018a; Schwartz et al., 2014). VIRMA’s function as an alternative splicing regulator is critical
during female development. In Drosophila, VIRMA works with WTAP to regulate Sxl splicing
and control sex determination (Hilfikert et al., 1995; Ortega et al., 2003). In mice, KIAA1429 is
essential for oocyte competence, likely by promoting localization of SRSF3 and YTHDC1 to
nuclear speckles, where they assist with splicing (Hu et al., 2020).

RBM15
RBM15 and its paralog RBM15b are RBPs responsible for METTL3 and WTAP
recruitment to mRNA and the lncRNA, Xist, where RBM15 binds to U-rich sequences near
DRACH motifs, thus helping to specify m6A target sites (Knuckles et al., 2018; Lee et al., 2020;
Moindrot et al., 2015; Patil et al., 2016). Like other subunits in the methyltransferases complex,
the RBM15 homolog in Drosophila (called Spenito) contributes to sex determination via
regulation of alternative splicing of Sxl (Kan et al., 2017; Lence et al., 2016; Yan and Perrimon,
2015). Loss of RBM15 is lethal in Drosophila and mice (Lence et al., 2016; Patil et al., 2016),
suggesting that its functions in m6A regulation are essential for viability.

ZC3H13
Three concurrent studies revealed that ZC3H13 (also called Flacc in flies) is another
component of the methyltransferase, functioning as an adapter protein between WTAP and
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RBM15 in Drosophila and mice, and controlling complex nuclear localization (Guo et al., 2018;
Knuckles et al., 2018; Wen et al., 2018). ZC3H13 regulates mESC self-renewal by promoting
methylation of genes involved in pluripotency and differentiation, and deletion of its homolog,
Xio in Drosophila results in female specific lethality, defects in wing development, and nervous
system impairment (Knuckles et al., 2018; Wen et al., 2018). Unsurprisingly, absence of Xio
phenocopies loss of other central writer complex components in Drosophila, obstructing Sxl
alternative splicing and sex determination (Guo et al., 2018; Knuckles et al., 2018).

CBLL1/HAKAI
Known as both CBLL1 and HAKAI, this conserved E3 ubiquitin ligase is found in the
WTAP interactome (Horiuchi et al., 2013) and its deletion reduces m6A levels in Arabidopsis,
suggesting it is another factor involved in m6A deposition (Růžička et al., 2017). Yet, while
HAKAI deletion causes embryonic defects, mutants are viable, unlike knockouts of METTL3,
METTL14, VIRMA, and WTAP in Arabidopsis, indicating it may be an auxiliary factor
controlling methyltransferase specificity (Růžička et al., 2017). Indeed, confirmation of HAKAI
as a component of the writer complex awaits study of its impact on Sxl splicing in Drosophila.

These many methyltransferase cofactors are essential to both m6A distribution and gene
regulation. Yet, it remains unclear which subunits are necessary for all sites versus a select subset
of modifications. Knockdowns of Fl(2)d, Nito, Flacc, and Vir in Drosophila lead to differential
expression of both shared and unique mRNAs (Knuckles et al., 2018), suggesting that methylation
patterns can be attuned by altering the composition of the writer complex. Even inactivation of
METTL3 and METTL14 does not always abolition all modifications (Batista et al., 2014; Lin et
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al., 2017), potentially due to other compensatory methyltransferases. Alternatively, incomplete
loss of m6A upon methylase mutagenesis may reflect a hypomorphic phenotype, as partial loss of
core writer components is frequently observed when complete knockouts are lethal (Sharpe and
Cooper, 2017; Zaccara et al., 2019).
While these many proteins guide and specify m6A installation, it is likely that other, yet
unidentified cofactors also help recognize candidate methylation sites. Additionally, METTL3 and
METTL14 may interact with indirect regulators, like TRA2A and CAPRIN1 (An et al., 2020;
Horiuchi et al., 2013; Zhang et al., 2020b). These recently identified factors control m6A catalysis
on specific transcripts and in select cell types, suggesting they are not constitutive subunits but
rather transient interactors of the methylases (An et al., 2020). Because trans-factors like these can
modulate writer activity and selectivity without being integral for methylation, the topology of
m6A can be temporally and spatially tailored to distinct biological contexts.
Finally, it is possible that these proteins have functions beyond their roles in the
methyltransferase complex. For example, Fl(2)d and Nito localize outside of the complex in flies
(Kan et al., 2017), and their depletion can result in stronger phenotypes than knockouts of
METTL3 and METTL14 (Knuckles et al., 2018). It is often unclear if these transcriptomic and
developmental phenotypes stem from global or transcript specific elimination of m6A, or from
activities unrelated to RNA methylation. Further, many mutagenesis studies of the methylases rely
on full gene knockouts and transcript dysregulation is observed for both methylated and nonmethylated transcripts. Discerning the direct versus indirect consequences of m6A absence will
require the use of catalytically dead METTL3 and METTL14 mutants, to preserve non-methylase
dependent functions. Regardless, it is clear that the many factors responsible for writing the m6A
modification are crucial for gene expression regulation and developmental progressions.
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1.2.4. Erasers of RNA methylation
The demethylases ALKBH5 and FTO are m6A erasers that catalytically remove the
modification from specific transcripts (Rajecka et al., 2019). Discovery of the erasers initially led
to the view that m6A is dynamically regulated, where it is added and removed to rapidly control
gene expression in a manner akin to epigenetic marks (Zhao et al., 2016). Yet, the scope of
demethylase activity now appears to be limited to specific tissues, diseases, or stress responses
(Darnell et al., 2018). Indeed, unlike m6A writers and readers, the erasers are not highly conserved
and function only in vertebrates (Robbens et al., 2008; Zheng et al., 2013), suggesting that
demethylation is a specific rather than universal mechanism of gene expression control (Heck and
Wilusz, 2019).

FTO
Initially believed to be a major remover of RNA methylation, the relevance of FTO as an
m6A demethylase is now highly debated (Jia et al., 2011; Mauer et al., 2019; Rajecka et al., 2019).
FTO can demethylate a broad spectrum of substrates and targets m6Am with much higher affinity
than m6A (Mauer et al., 2019; Meyer et al., 2015; Wei et al., 2018). Yet, some transcripts do exhibit
reduced m6A levels upon FTO depletion, although FTO majorly prefers small nucleolar and
nuclear RNAs (Koh et al., 2019; Su et al., 2018; Wei et al., 2018; Yu et al., 2018). As FTO activity
and specificity can be modulated by protein partners, such as TRMT10A and SFPQ, RNA
structure, subcellular distribution, and cell lineage (Ontiveros et al., 2020; Song et al., 2020a; Wei
et al., 2018; Zhang et al., 2019b; Zou et al., 2016), it is likely that the function of FTO as an m6A
demethylase is context dependent.
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FTO expression is largely nuclear (Gerken et al., 2007; Jia et al., 2011), indicating that any
demethylation will occur prior to mRNA export (Mauer and Jaffrey, 2018), and even suggesting
that FTO prohibits m6A addition rather than actively erasing the mark (Koh et al., 2019). Yet some
instances of FTO demethylation have been observed in the cytoplasm during heat shock, DNA
damage responses, and cancerous states, (Cui et al., 2017; Li et al., 2017d; Xiang et al., 2017;
Zhang et al., 2016), reflecting that this may be a highly specialized pathway.
Disruption of FTO is linked to increased mRNA levels, potentially due to loss of
destabilizing m6A modifications, or to defects in pre-mRNA processing and alternative splicing,
which are likely the main FTO functions (Bartosovic et al., 2017; Louloupi et al., 2018; Mauer et
al., 2019; Su et al., 2018; Wei et al., 2018; Zhao et al., 2014). FTO can also modulate translation
upon cellular stress (Meyer et al., 2015; Zhou et al., 2015).
Loss of FTO in mice is linked to reduced postnatal growth and viability (Boissel et al.,
2009; Fischer et al., 2009), disrupted neuronal development (Engel et al., 2018; Gao et al., 2010;
Ho et al., 2010; Li et al., 2017c), impaired adipogenesis (Church et al., 2010; Gulati et al., 2013;
Merkestein et al., 2015; Tung et al., 2015; Wang et al., 2015a; Zhang et al., 2015; Zhao et al.,
2014), and repressed sperm proliferation (Huang et al., 2019c). Thus FTO is essential for
adipogenesis, neurogenesis, and spermatogenesis (Rajecka et al., 2019). Intriguingly, mouse
mutant phenotypes of the m6Am methylase PCIF1 often mirror those of FTO depletion, suggesting
that FTO function in these developmental contexts may be dependent on m6Am rather than m6A
(Pandey et al., 2020). Yet, given that FTO targets multiple modifications as well as multiple RNA
types (Gulati et al., 2013; Wei et al., 2018), future work is required to address whether FTO
influences methylated RNA metabolism during development.
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ALKBH5
The second known demethylase ALKBH5 is more likely to serve as a specific eraser of
m6A, as its expression consistently correlates with reduced methylation in mice and human tissues
(Liu et al., 2020a; Zheng et al., 2013). Further, crystal structure analysis has revealed that
ALKBH5 has an m6A-specific binding pocket and uses a distinct demethylation mechanism from
FTO that lend it greater selectivity (Aik et al., 2014; Chen et al., 2014b; Feng et al., 2014; Toh et
al., 2020; Xu et al., 2014a; Zhang et al., 2019b). These structural and mechanistic differences
between FTO and ALKBH5 likely reflect unique substrate preferences, which in turn increase the
breadth of spatiotemporal dynamics through which m6A is removed from RNAs. Similar to FTO,
ALKBH5 exhibits nuclear localization, indicating that cytoplasmic demethylation is largely
nonexistent (Thalhammer et al., 2011; Zheng et al., 2013).
Yet, while ALKBH5 is more specific for m6A than FTO, methylation increases by only
about 10% upon its knockdown in mice, indicating that it is not a global regulator of methylated
mRNAs (Zheng et al., 2013). Depletion of murine ALKBH5 results in misregulated mRNA
processing and export (Zheng et al., 2013), and in spermatocytes, aberrant splicing and 3’UTR
usage, as well as accelerated transcript degradation due to higher m6A levels (Tang et al., 2017).
These molecular defects in ALKBH5 mouse mutants manifest as smaller testes, abnormal
spermatozoa, and sterility, indicating that this eraser is essential for spermatogenesis, although the
mice are viable (Tang et al., 2017; Zheng et al., 2013). ALKBH5 also functions during the
development of many cancers, in which it frequently contributes to hypoxia response (Chen et al.,
2019; Ma et al., 2018; Shen et al., 2020; Wang et al., 2020a; Zhang et al., 2016, 2017b). Given the
lack of overt phenotypes for most tissues upon loss of ALKBH5, this demethylase may have a
narrow regulatory focus for select cellular and physiologically processes. Ultimately, future
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research is needed to determine the extent to which the m6A erasers contribute to gene expression
changes during development.

1.2.5. Shared and unique features of the YTH m6A readers
While m6A does not disrupt the coding capacity of mRNA, its presence dramatically
expands the functional diversity of RNA, allowing for dynamic regulation of gene expression
(Lence et al., 2019). The operational significance of m6A is dictated by the reader proteins, which
recognize and bind to the mark, and subsequently employ effectors to specify transcript splicing,
processing, stability, translation, and localization (Patil et al., 2018). While many proteins mediate
methylated transcript regulation, only a few are bona fide readers, with the capacity for direct
binding (Patil et al., 2018; Zaccara et al., 2019). These include the YTH-domain containing family,
which rely on specific residues and conformations of their YTH domain to interact with the methyl
moiety on the RNA molecule, as demonstrated through crystal structure studies (Li et al., 2014,
2021; Luo and Tong, 2014; Theler et al., 2014; Xu et al., 2014b, 2015; Zhu et al., 2014). Other
m6A regulators act indirectly, either through weak binding to m6A (as well as non-methylated
mRNAs) as is the case for FMRP (Edupuganti et al., 2017; Worpenberg et al., 2021; Zhang et al.,
2018), or via m6A-structural switches, where presence of the mark induces conformational changes
favorable to protein binding, as observed for IGF2BPs (Edupuganti et al., 2017; Huang et al., 2018)
and HNRNPs (Alarcón et al., 2015a; Liu et al., 2015, 2017; Roost et al., 2015; Wu et al., 2018).
Regardless of the mechanism by which m6A interpreters engage with the transcript, these factors
are known to play pivotal roles in transcriptome remodeling.
The YTH family of readers contain five central factors, YTHDF1, YTHDF2, YTHDF3,
YTHDC1, and YTHDC2. These factors are highly conserved, with YTHDF and YTHDC1-like
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proteins found in organisms ranging from plants to humans (Patil et al., 2018), although YTHDC2
is largely limited to mammals (Jain et al., 2018). In vertebrates, amino acid sequence homology is
high within the YTH domains for all five readers, but YTHDC1 and YTHDC2 also exhibit distinct
sequences and domain organization, suggesting they may have additional unique roles (Patil et al.,
2016). Lower organisms, like Drosophila express only one YTHDF protein (and one DC1), instead
of three separate paralogs as in vertebrates (Kan et al., 2017), suggesting that the DFs share a single
conserved function. Indeed, the sequence homology of the YTHDFs is extensive both within the
YTH domains and within their low complexity regions (Patil et al., 2018), indicating that
differences in m6A-recognition may stem from distinctive expression patterns rather than
individual binding profiles. Transcriptome-wide binding analyses by CLIP-sequencing
demonstrate that all YTHs bind to the m6A motif (Hsu et al., 2017; Li et al., 2017a; Patil et al.,
2016; Wang et al., 2014a, 2015b; Xiao et al., 2016), but whether each reader has additional
sequence preferences is yet to be determined. Across multiple cell types, the YTHDFs consistently
recognize the same sites throughout the transcriptome (Li et al., 2017a; Patil et al., 2016; Shi et
al., 2017), again suggestive of potentially redundant functions. YTHDC1 largely binds to nuclear
methylated mRNAs, including lncRNAs, while YTHDC2 has a unique binding profile that
includes some non-modified transcripts (Patil et al., 2016; Xiao et al., 2016). It is possible that the
unique regions of the YTHDCs confer their specificity for certain RNAs, in addition to differences
in subcellular localization or interacting partners (Kasowitz et al., 2018; Li et al., 2014; Wojtas et
al., 2017; Xu et al., 2014b, 2015; Zhu et al., 2014). Indeed, YTHDC1 exhibits nuclear localization
(Xiao et al., 2016), the YTHDFs are largely cytoplasmic (Shi et al., 2017; Wang et al., 2014a,
2015b), and YTHDC2 is found in both the nucleus and cytoplasm (Hsu et al., 2017). Finally, the
DFs and YTHDC1 contain low complexity regions (Patil et al., 2018), which enable the proteins
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to undergo phase separation, allowing them to target methylated transcripts to non-membrane
organelles like P-bodies, stress granules, and other ribonucleoprotein (RNP) complex granules (Fu
and Zhuang, 2020; Gao et al., 2019; Ries et al., 2019; Wang et al., 2020b, 2014a).
Yet, whether the YTHDF readers have shared or independent functions remains debated
(Fig. 1.4.) (Patil et al., 2018; Shi et al., 2019). The extensive overlap in protein sequence and
structure, shared sets of m6A targets, overlapping interactomes, and similar cytoplasmic
distributions, indicate that the YTHDFs have the capacity to regulate methylated mRNAs through
common mechanisms (Zaccara and Jaffrey, 2020). Further, double or triple YTHDF depletion
often results in more severe phenotypes than single mutants, potentially owing to compensation
upon loss of a single reader (Lasman et al., 2020a; Li et al., 2017a; Zaccara and Jaffrey, 2020).
Additionally, the YTHDFs interact within the cell (Jin et al., 2020; Shi et al., 2017), but
whether this reflects overlapping functions, competition, or ordered binding remains unclear. For
instance, all three YTHDFs can induce phase separations (Ries et al., 2019), suggesting that any
combination of readers is acceptable to partition modified mRNAs, as long as they meet the
threshold for phase transition to occur. Alternatively, binding by one reader may recruit a second
reader, allowing them to target a single transcript with multiple regulatory mechanisms (Liu et al.,
2020b; Shi et al., 2017).
Some studies have uncovered specific roles for each reader (Liu et al., 2018b), as well as
different degrees to which each factor is required for development (Lasman et al., 2020a). This
may indicate that the cell type or physiological state determines the reader activity (Shi et al.,
2019). Alternatively, these differences may reflect distinct expression patterns between the readers
(Lasman et al., 2020a). Moreover, many studies limit their assessment to a single reader, and thus
common functions may be overlooked. Ultimately, a thorough analysis of all three YTHDF
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proteins and their interactions is essential to test if their roles converge or diverge to control m6Amediated cell fate decisions.

Figure 1.4. The two predominant models of YTHDF reader function
The degree to which the YTHDF m6A readers share common functions can be explained by two main
models: (A) the YTHDFs exert unique functions to regulate methylated mRNAs, with YTHDF1
promoting translation, YTHDF2 facilitating decay, and YTHDF3 contributing to both enhanced
translation and degradation, or (B) the YTHDFs functional redundantly, as observed in their
regulation of mRNA destabilization through localization to decay granules or interaction with
deadenylases.
1.2.6. YTHDF reader function in mRNA decay
Upon its discovery, RNA methylation was quickly linked to transcript instability (Sommer
et al., 1978). Now, m6A is cemented as a central regulator of decay, with numerous studies showing
that mRNA half-lives increase upon loss of methyltransferase function (Batista et al., 2014; Ke et
al., 2017; Liu et al., 2014; Schwartz et al., 2014). YTHDF2 was the first identified mediator of
methylated transcript degradation (Wang, et al., 2014a), but all three YTHDFs and YTHDC2 are
now known regulators of mRNA decay (Patil et al., 2018). In some contexts, the YTHDFs exert
redundant functions on methylated transcript elimination (Kennedy et al., 2016; Lasman et al.,
2020a; Lu et al., 2018; Tirumuru et al., 2016; Zaccara and Jaffrey, 2020), although YTHDF2 is
the dominant or sole regulator in others (Park et al., 2019; Wang et al., 2014a; Zhao et al., 2017).
Mechanistically, the YTHDFs can promote transcript elimination through three main pathways:
deadenylation, endoribonucleolytic cleavage, and localization to P-bodies (Du et al., 2016; Lee et
al., 2020; Park et al., 2019; Wang et al., 2014a). This YTHDF triggered decay is especially
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important during developmental transitions (Huang et al., 2020; Paris et al., 2019; Zhang et al.,
2017a; Zhao et al., 2017), where recognition of m6A enables rapid changes in mRNA fate and gene
expression.

Localization to phase separated granules
The first mechanism used by the YTHDF readers to ensure short mRNA half-lives is
sequestration of methylated transcripts into phase-separated compartments (Fu and Zhuang, 2020;
Gao et al., 2019; Ries et al., 2019; Wang et al., 2020b, 2014a). In human cells, YTHDF2 induces
modified mRNA degradation through targeting to P-bodies (Wang et al., 2014a), which are
enriched in decapping and decay machinery (Luo et al., 2018). Similarly, YTHDF1, 2, and 3 drive
methylated transcript localization to stress granules upon heat shock, where their translation is
inhibited (Ries et al., 2019). Notably, transcripts with multiple, clustered m6A residues exhibit the
greatest decay, potentially because they attract more YTHDF readers and thus enhance their own
entrapment to repressive, phase-separated compartments (Zaccara et al., 2019). Because all three
YTHDF readers share the capacity to partition methylated transcripts into RNA-protein droplets
(Ries et al., 2019), it is likely to be a universal mechanism for clearance.

Deadenylation
The second mechanism of the YTHDFs is recruitment of deadenylation machinery to
promote poly(A) tail removal (Du et al., 2016). All three YTHDFs interact with the CCR4-NOT
deadenylase complex (Zaccara and Jaffrey, 2020), and tethering of each reader accelerates reporter
deadenylation in human cells (Du et al., 2016). Yet, in somatic reprogramming of mouse
embryonic fibroblasts (MEFs), YTHDF2 and YTHDF3 function by independent deadenylation
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mechanisms, with YTHDF2 again interacting with CCR4-NOT and YTHDF3 exclusively
recruiting the PAN2-PAN3 deadenylase complex (Liu et al., 2020b). Given that these
deadenylases exhibit distinct tail length substrates and rates of tail removal (Wahle and Winkler,
2013), these unique YTHDF interactions may help target multiple machineries to shared
methylated targets and ensure their complete deadenylation. Future work should address how the
YTHDFs achieve specificity in deadenylation machinery recruitment, especially given the high
degree of protein homology and common m6A targets (Zaccara et al., 2019).

Other decay pathways
Third, the YTH readers can facilitate cleavage of target transcripts. For instance, YTHDF2
promotes endoribonucleolytic cleavage of m6A-containing mRNAs and circRNAs through
recruitment of the adapter protein HRSP12 and subsequent binding of the endoribonuclease RNase
P/MRP in human cells (Park et al., 2019). YTHDF1 and YTHDF3 can also interact with HRSP12,
suggesting this may be a common mechanism (Park et al., 2019). The extent to which this program
is employed is unclear, but HRSP12 binds preferentially to specific motifs (Park et al., 2019),
suggesting that m6A sequence context helps determine how degradation will proceed. YTHDC2
also expedites cleavage, by recruiting the cytoplasmic 5’-3’ exoribonuclease XRN1 (Kretschmer
et al., 2018; Wojtas et al., 2017), which was also recovered in the YTHDFs’ interactomes (Zaccara
and Jaffrey, 2020)
Finally, although initially believed to be inconsequential for mRNA abundance, (Wang et
al., 2015b), YTHDF1 also promotes destabilization in some contexts. In human cancer cells,
YTHDF1 facilitates m6A-dependent Epstein-Barr viral RNA decay through recruitment of
degradation machinery DCP2, DDX17, and ZAP, demonstrating that this factor has the capacity
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to downregulate transcript expression (Xia et al., 2021). Whether other readers also encourage
decapping is unknown, although some m6A marked transcripts are dependent on Dcp2 activity for
their destabilization (Luo et al., 2020b). Additionally, some factors, like HuR, TRA2A, ZFP217,
and SMAD2/3 modulate methylated mRNA stability by manipulating methyltransferase activity,
thereby increasing or decreasing m6A levels on specific transcripts to flag them for downstream
regulation (Aguilo et al., 2015; An et al., 2020; Bertero et al., 2018; Panneerdoss et al., 2018).
The extent to which these clearance pathways are used by the m6A readers is unknown, as
is how specific mRNAs are selected for each mode of regulation, and how the YTHDFs coordinate
message removal. It is likely that the YTHDFs share redundant roles in transcript destabilization,
especially considering that triple depletion is often necessary to inhibit methylated mRNA
clearance to the same degree as METTL3 mutation (Lasman et al., 2020a; Zaccara and Jaffrey,
2020). Further, precisely how stability is influenced by methylation sequence and structural
context, cooperation with other decay pathways, and physiological state remains undefined.

mRNA Stability
Rather than promoting transcript clearance, several readers have been identified as
methylated mRNA stabilizers. The IGF2BP family helps maintain modified transcript abundance
(Huang et al., 2018), and are known to shield mRNAs from decay in cytoplasmic granules,
although it is unknown if this particular function is m6A-dependent (Bell et al., 2013). IGF2BPs
act during numerous developmental transitions, including embryogenesis in mice and flies (Boylan
et al., 2008; Geng and Macdonald, 2006; Munro et al., 2006; Nielsen et al., 1999), as well as
zebrafish, where IGF2BP3 is proposed to promote maternal mRNA stability during the MZT (Ren
et al., 2020). Yet, whether the IGF2BPs are true “readers” of methylation is debated. IGF2BP3
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was initially proposed to directly recognize m6A (Huang et al., 2018), but other work finds that
IGF2BP3 binds nonspecifically to regions of high mRNA accessibility (Sun et al., 2019), such as
those as induced by m6A (Liu et al., 2015; Roost et al., 2015). Because IGF2BPs can also bind in
the absence of methylation (Huang et al., 2018; Müller et al., 2019), it is likely that these factors
are indirect modulators of methylated mRNAs rather than specific readers.
FMRP is another indirect m6A regulator, as its sequence preference overlaps the DRACH
motif, but the factor itself does not require m6A for binding (Worpenberg et al., 2021; Zhang et
al., 2018). In Drosophila, YTHDF recruits the FMRP homolog FMR1 to methylated transcripts,
where it represses translation to restrict axonal growth (Worpenberg et al., 2021). FMRP also cobinds with YTHDF2 in the mouse cerebral cortex, although here it competes promote stability
while YTHDF2 engenders decay (Zhang et al., 2018). Additionally, PRRC2A stabilizes
methylated mRNAs in mouse oligodendrocytes (Wu et al., 2019b), although it too binds
unmethylated transcripts. Another indirect regulator is the mRNA-stabilizing stress granule
protein G3BP1, which is repelled by m6A, and thus absence of its stabilizing effect results in
enhanced degradation (Edupuganti et al., 2017). ELAVL1, or HuR, functions through a similar
mechanism; when it binds to its AU-rich recognition elements near m6A sites, transcript stability
increases likely because interaction with decay inducing readers is blocked (Wang et al., 2014b).
While these indirect effectors promote stability, it remains unclear how opposite
consequences can be incurred on the same methylated transcripts, especially in conditions where
readers with contrasting functions are simultaneously expressed, such as early embryogenesis (Ren
et al., 2020; Zhao et al., 2017). It is possible that stabilizing factors occupy unique localities within
the cell, antagonize the YTHDFs, or recognize distinct m6A sequences, as suggested for the
IGF2BPs versus YTHDF2 (Huang et al., 2018). Careful comparison of each reader’s methylome
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preferences and cellular activities is required to better dissect the roles of m6A effectors on
transcript clearance.

1.2.7. m6A and YTHDF regulation of translation
RNA methylation is capable of both stimulating and inhibiting global mRNA translation
across organisms and cellular contexts (Meyer, 2019). The cellular conditions, location of the
methylation within the transcript, local secondary structure, codon identity, ribosomal interactions,
and association with different trans factors all shape how m6A will modulate translation. These
regulatory functions of m6A on translation and protein synthesis have a developmental impact,
including on embryogenesis, oogenesis, spermatogenesis, cancer cells, and neurons.

m6A in the 5’UTR
The position of m6A within the transcript dictates its role in translation. Methylation in the
5’UTR represents only about 10% of the total m6A along the transcript body (Mao et al., 2019).
Yet these 5’UTR residues enable ribosome loading and promote non-canonical translation in the
absence of cap-binding proteins, especially in response to stressors like heat shock (Meyer et al.,
2015; Zhou et al., 2015). This mechanism appears specific to 5’UTR methylation (Zhou et al.,
2015), and may impact only a select handful of mRNAs (Luo et al., 2020a), but it represents a
unique means by which m6A ensures protein synthesis from transcripts when traditional
translational pathways are impaired. m6A in the 5’UTR can also downregulate translation. In
human cancer cells, methylation in the 5’UTR of transcripts lengthens ribosomal dwell time
around the start codon, delaying initiation and restricting translational output (Dong et al., 2021).
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As YTH reader binding was not detected around these 5’UTR m6A sites, it remains unclear which
factor mediates these inhibitory effects on translation.

m6A in the CDS
An estimated 36% to 52% of m6A residues are located within the CDS in human cells,
which impact translation in multiple ways (Louloupi et al., 2018; Mao et al., 2019). First, higher
m6A levels in the CDS correlate with decreased translation efficiency in MEF cells (Mao et al.,
2019), and with lower protein production from reporters in human cells (Slobodin et al., 2017).
Indeed, clustered or multiple marks have even greater inhibitory effects (Hoernes et al., 2019; Luo
et al., 2020a; Slobodin et al., 2017). Inactive translation of these transcripts may be explained by
the observation that coding region m6A delays tRNA accommodation and thus slows translational
elongation, as determined from single molecule measurements in vitro (Choi et al., 2016) and
transcriptomic analysis in cell culture (Mao et al., 2019).
Conversely, m6A in the CDS also correlates with enhanced translation. Loss of coding
region m6A through METTL3 knockdown reduces translation efficiency in mouse and human cells
(Mao et al., 2019). This discrepancy may reflect the effect of the RNA structure underlying the
modification (Mao et al., 2019). When methylation helps resolve highly structured CDSs,
ribosome pausing is alleviated and translation efficiency increases. Alternatively, m6A in
unstructured transcripts slows tRNA accommodation and impedes translation. RNA unfolding is
mediated by YTHDC2, indicating that the presence of specific readers also helps modulate
translation (Mao et al., 2019). The codon identity and position of m6A within codons also
influences translation, with different codons exhibiting different degrees of ribosome pausing and
occupancy, and evolutionary conservation patterns, indicating that m6A-codon interactions may
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affect ribosomal decoding (Barbieri et al., 2017; Choi et al., 2016; Hoernes et al., 2019; Liu et al.,
2018c; Mao et al., 2019). Thus, the effects of CDS m6A on translation appear to be context
dependent, where the codon identity, local structure, recruited factors, and ribosomal interactions
dictate the translational output for each transcript.

m6A in the 3’UTR
Up to 55% of methylated residues are harbored in the 3’UTR, and these modifications are
largely linked to enhanced translation (Meyer, 2019). Loss of 3’UTR methylation through
METTL3 depletion decreases mRNA translation efficiency (Mao et al., 2019), and YTHDF1 and
YTHDF3 are thought to promote cap-dependent translation via marks in this region (Shi et al.,
2017; Wang et al., 2015b). How these factors facilitate translation through the 3’UTR is unclear,
though a looping mechanism dependent on the eukaryotic translation initiation factor eIF3 has
been proposed.
It is possible that the effects of m6A on translation are linked to its role in mRNA
degradation. Indeed, m6A in the 3’UTR is associated with transcript decay (Wang et al., 2014a),
meaning m6A can attenuate the levels of transcript availabile for translation (Meyer, 2019).
Further, some readers like YTHDC2 enhance both mRNA clearance and translation (Mao et al.,
2019; Wojtas et al., 2017), and can thus coordinate these processes to fine tune gene expression
control. Together, these studies reveal that the consequences of methylation on mRNA translation
are diverse and dependent on many trans factors and transcript features.

YTHDFs and translation
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As the consequences of methylation on mRNA translation vary extensively, the interacting
reader proteins help determine the regulatory outcome. The first identified effector of m6Adependent translation is YTHDF1, whose depletion in human cells decreases translation efficiency
(Wang et al., 2015b). Since then, YTHDF1 is found to upregulate translation of specific
methylated mRNAs across cellular contexts, including in stem cells, cancer, immune response,
and neural development, suggesting this regulatory function is conserved (Han et al., 2020, 2019a;
Huang et al., 2018; Liu et al., 2020c; Weng et al., 2018; Wu et al., 2019c; Zhuang et al., 2019).
YTHDF1 may regulate translation by binding to 3’UTR m6A, and looping the mRNA
through recruitment of eIF3, to facilitate ribosome loading near the 5’end (Han et al., 2019a; Wang
et al., 2015b). Yet, other work suggests that interactions between the YTHDFs and eIF3 are nonspecific (Zaccara and Jaffrey, 2020). YTHDF1 can also promote translation via CDS methylation,
potentially by engaging with elongation factors, as seen in cancer cells (Lin et al., 2019).
YTHDF1 also downregulates translation. Up to a third of YTHDF1 m6A targets increase
in translational efficiency upon DF1 depletion (Zhang et al., 2020c), and DF1 recruits the
translational suppressor FMR1 to methylated transcripts in Drosophila cells (Worpenberg et al.,
2021). Thus, multiple mechanisms and factors likely influence the impact of YTHDF1 on
translation simultaneously.
YTHDF3 is another translation regulator (Chang et al., 2020; Li et al., 2017a; Shi et al.,
2017; Wu et al., 2021; Zhang et al., 2019c), and is proposed to cooperate with YTHDF1 to enhance
target translation (Li et al., 2017a; Shi et al., 2017). Yet, YTHDF3 may also function
independently, as loss of DF3 alone is sufficient to drive down translation of specific transcripts
(Chang et al., 2020; Wu et al., 2021). YTHDF3 also promotes cap-independent translation of
methylated circRNAs (Yang et al., 2017a), and may even control protein synthesis in the absence
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of m6A, as observed during the innate immune response (Zhang et al., 2019c), although m6Aindependent DF functions are rare.
Yet, it is possible that the YTHDFs do not universally influence translation, as conclusions
from major studies of DF1 and DF3 were recently challenged (Zaccara and Jaffrey, 2020). In this
work, neither individual nor triple YTHDF knockdowns affected translation efficiency, and
reanalysis of ribosome profiling data from Wang et al., 2015 and Shi et al., 2017 uncovered no
consequences of DF1 or DF3 depletion on translation (Zaccara and Jaffrey, 2020). Yet, the
YTHDFs mediate translational output in other systems, and thus may serve as transcript specific
if not global regulators. Future work is required to conclusively establish the impact of the
YTHDFs in translation across unique biological contexts.

YTHDC2 and translation
The reader YTHDC2 also promotes translation, and employs its helicase domains to
directly unwind methylated mRNA structures in the CDS, thereby relieving ribosomal stalling
(Mao et al., 2019). This remodeling activity of YTHDC2 is not limited to the CDS, as DC2 also
unwinds highly structured 5’UTRs to promotes translation initiation in human cells under hypoxia
(Tanabe et al., 2016). Further, YTHDC2 binds directly to the 40S small ribosomal subunit
(Kretschmer et al., 2018), together suggesting a mechanism by which YTHDC2 recognizes m6A,
unwinds RNA structures, and favorably interact with the ribosome to enhance target translation.
Yet, how many mRNAs are subject to translational upregulation by YTHDC2 remains unclear
(Tanabe et al., 2016), and future study is warranted to establish the prevalence of this m6Amediated regulatory mechanism.
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METTL3 as a “reader” of m6A in translational control
In addition to its function as an m6A writer, cytoplasmic METTL3 can associate with
ribosomes to promote translation of specific mRNAs in human cancer cells (Choe et al., 2018; Lin
et al., 2016). In this context, catalytically dead METTL3 promotes reporter translation without
impacting mRNA abundance, indicating that METTL3 exclusively regulates translation, and does
so independently of its methylase activity (Choe et al., 2018; Lin et al., 2016). Mechanistically,
METTL3 facilitates translation by interacting with the cap-binding complex and eIF3, although
how this occurs with METTL3 binding in the 3’UTR is unclear (Choe et al., 2018). This translation
promoting function of METTL3 contributes to human lung cancer cell growth (Choe et al., 2018;
Lin et al., 2016), but it remains to be determined if METTL3 serves as an m6A “reader” in other
physiological states. Because METTL3 does not bind to most m6A sites, but METTL3 depletion
does globally repress translation, downstream loss of methylation likely accounts for the majority
of misregulation (Meyer, 2019).
Indeed, METTL3 also promotes translation through m6A deposition. In acute myeloid
leukemia cells, METTL3 association with transcript promoters is linked to enhanced CDS
methylation of the corresponding mRNAs (Barbieri et al., 2017). These higher m6A levels
correlate with greater translation, suggesting that promoter-bound METTL3 boosts protein
synthesis by increasing methylation (Barbieri et al., 2017). The precise mechanisms underlying
this connection between DNA binding, m6A deposition, and translation efficiency remain unclear.

eif3 and non-canonical m6A translation
eIF3 is another regulator of translation via m6A. eIF3 can directly bind methylation in the
5’UTR and recruit translational machinery independent of cap binding proteins (Meyer et al.,
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2015). This pathway is employed in response to cell stressors, like heat shock, during which m6A
is highly redistributed to the 5’UTR (Meyer et al., 2015; Zhou et al., 2015). The ATP-binding
cassette protein, ABCF1 functions similarly, and recruits translation initiation machinery to
methylated transcripts in stress conditions (Coots et al., 2017). Although eIF3 and ABCF1
regulation is often limited to a select subset of mRNAs, m6A-dependent cap-independent
translation is likely a universal means to control protein output when canonical pathways are
restricted. Indeed, numerous other examples of m6A promoting non-canonical translation in
response to cell stress are documented, although the reader responsible may vary by each case.
(Fry et al., 2017; Miao et al., 2019; Shen et al., 2019; Xiang et al., 2017; Zhou et al., 2018).

1.2.8. m6A and microRNA biogenesis and function
RNA methylation and microRNAs interact in multiple ways. These pathways can integrate
their functions to decay the same transcripts or indirectly control gene expression by regulating
one another’s activities (Chen et al., 2020b; Fazi and Fatica, 2019). Thus, crosstalk between m6A
and miRNAs can be divided into three main types: m6A controlling miRNA biogenesis and
activity, miRNAs modulating m6A deposition and function, and miRNAs and m6A coordinately
degrading shared targets.
First, RNA methylation is known to modify miRNAs to regulate their maturation and
expression (Alarcón et al., 2015b; Berulava et al., 2015; Bhat et al., 2020). Loss of m6A through
depletion of METTL, or its homolog MTA, impairs miRNA biogenesis in human cells and
Arabidopsis, respectively (Alarcón et al., 2015b; Bhat et al., 2020). This most likely arises from
improper miRNA processing, as m6A stabilizes the pri-miRNA stem loop structure, and thus is
crucial for recognition by microprocessor components (Alarcón et al., 2015b; Bhat et al., 2020).
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Additionally, METTL3, METTL14, and the reader HNRNPA2B1 can regulate miRNA biogenesis
directly by recruiting and interacting with the processing enzymes (Alarcón et al., 2015a, 2015b;
Knuckles et al., 2017; Ma et al., 2017). Methylation may also modulate miRNA activity by altering
expression of transcripts encoding other miRNA regulatory factors, like AGO2 and DROSHA
(Min et al., 2018). It remains unclear if m6A-dependent miRNA processing is universal, as
biogenesis of some miRNAs is unaffected by METTL3 or HNRNPA2B1 knockdown (Alarcón et
al., 2015a, 2015b), although it appears to be a central mechanism mediating carcinogenesis (Chen
et al., 2020a; Han et al., 2019b; Ma et al., 2017; Peng et al., 2019; Zhang et al., 2019a).
Second, miRNAs can influence m6A deposition and function. Dicer or miRNAs may
facilitate cellular m6A installation by promoting METTL3 binding (Chen et al., 2015), although
how this is achieved is unclear. miRNAs also target m6A regulatory proteins to directly control
their expression. For example, miR-33a downregulates METTL3 mRNA in non-small-cell lung
carcinoma cells, (Du et al., 2017) and the same strategy is employed by miR-4429 in gastric cancer
cells (He et al., 2019) and miRNA let-7g in breast cancer cells (Cai et al., 2018). Similarly, miR145 targets the 3’UTR of YTHDF2 in cancer cells, thereby increasing overall m6A-modified
mRNA stability (Li et al., 2020; Yang et al., 2017b). miRNA control over m6A interpreters also
helps regulate key developmental events, as when miR-670 targets Igf2bp1 to facilitate mouse
embryogenesis (Hao et al., 2020). This mechanism may represent a means by which miRNAs can
rapidly expand the pool of transcripts under their regulatory umbrella without necessitating a
binding sequence.
Finally, m6A and miRNAs can combinatorially regulate transcripts. Transcriptome wide
analysis in humans and mice reveals that m6A peaks are enriched at miRNA target sites (Chen et
al., 2015; Liu et al., 2020a). Similarly, ~60-80% of m6A-modified mRNAs are estimated to harbor
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at least one miRNA binding site (Liu et al., 2020a; Meyer et al., 2012). miRNAs are also known
to pair with mRNA at methylated residues, with the consensus motif inversely complementary to
the seed of hundreds of miRNAs (Chen et al., 2015; Liu et al., 2020a). The outcome of this pairing
is unclear, as m6A within 3’UTRs can both destabilize miRNA duplex formation (Briand et al.,
2020; Konno et al., 2019), and promote favorably interactions with miRNAs (Cheng et al., 2020).
Thus, the nature of interaction between m6A and miRNAs on the same transcript may depend on
the cellular context and mRNA identity.
Together, these examples demonstrate extensive crosstalk between m6A and miRNAs to
control gene expression at the posttranscriptional level. These collaborative interactions and cross
regulatory pathways may help exert precise control over mRNA levels and timing of decay. The
precise nature of m6A and miRNA regulation is likely determine by the expression and localization
of each pathways components, and the specific cell state.
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1.3. RNA methylation regulates developmental transitions
RNA methylation is a regulator of message metabolism in numerous physiological
transitions, with functions in stem cell differentiation, neuronal development, hematopoiesis,
gametogenesis, cancer development, and immunity. These reprogramming events often rely on
methylation to promote transcriptome turnover, where m6A helps balance expression of mRNAs
between the old and new programs of gene expression. While the specific targets of methylation,
and the activities of its writers and readers vary by developmental context, the universal
importance of m6A on cell fate specification is clear, as loss of m6A writers or readers frequently
disrupts both pluripotency and differentiation (Heck and Wilusz, 2019). Here, I will discuss the
diverse cell state changes mediated by RNA methylation, with an emphasis on how m6A reshapes
the posttranscriptional landscape to establish new patterns of gene expression and facilitate
development.

1.3.1. RNA methylation in stem cells
Embryonic stem cells have the capacity to self-renew and maintain their pluripotent
capacities, or to differentiate into the unique cell lineages that give rise to all embryonic tissues.
The establishment, maintenance, and transition of stem cells from a pluripotent to differentiated
state requires coordinated changes in gene expression, which are executed by transcriptional,
epigenetic, and posttranscriptional pathways. m6A appears to contribute to stem cell fate by
modulating the balance between self-renewal and differentiation, where it regulates expression of
genes encoding the existing cell state. For instance, in mouse and human embryonic stem cells
(ESCs), m6A marks mRNAs encoding core pluripotency transcription factors like Nanog, Klf4,
and Myc for decay (Batista et al., 2014). Loss of methylation on these transcripts through genetic
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inactivation of METTL3 in mouse or human ESCs prolongs their expression and blocks the exit
from self-renewal toward differentiation (Batista et al., 2014). Alternatively, a second study finds
that reduction of m6A upon METTL3 knockdown causes mESCs to lose their capacity for selfrenewal, likely through repressed decay of developmental regulators and continued expression of
pluripotency factors like Nanog and Sox2 (Wang et al., 2014b). While these studies agree that m6A
marks and regulates determinants of both self-renewal and lineage-commitment, their findings
regarding the role of methylation in the maintenance of pluripotency appear contradictory. This
conflict is resolved by the discovery that the timing of m6A depletion determines the consequences
on development, where absence of METTL3 in naïve ESCs traps cells in pluripotency, while in
primed cells, METTL3 depletion blocks self-renewal and accelerates differentiation (Geula et al.,
2015). Because m6A controls the half-life of transcripts governing both the naïve and primed state,
loss of METTL3 prolongs expression of whichever genes dominant the current cell state, thus
locking cells in an either hyper differentiated or pluripotent state (Fig. 1.5.) (Geula et al., 2015).

Figure 1.5. m6A regulates the balance between stem cell self-renewal and differentiation.
RNA methylation and METTL3 control the balance between pluripotency and differentiation in stem
cells by promoting degradation of transcripts maintaining the current cell state. When METTL3 is
removed from pluripotent stem cells in the naïve state, mRNAs encoding pluripotency regulators fail
to degrade, causing the cells to assume a hyper-pluripotent state. When METTL3 is lost in primed
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pluripotent stem cells, transcripts for lineage determinants are stabilized, resulting in differentiation
and cell death.
These effects are not limited to core writer components, as loss of ZC3H13 also impairs
self-renewal and triggers mESC differentiation, and knockdown of WTAP, KIAA1429, or HAKAI
likewise alters expression of transcripts controlling pluripotency and differentiation (Wen et al.,
2018). This suggests that any misregulation of m6A deposition disrupts developmental
determination. Similarly, in porcine iPSCs, loss of METTL3 debilitates self-renewal and enhances
differentiation, by reducing m6A levels on JAK2 and SOCS3 mRNAs and inhibiting subsequent
YTHDF1-dependent translation, and YTHDF2-dependent degradation, respectively (Wu et al.,
2019c). Because proper levels of these factors in the JAK-STAT pathway are needed to
transcriptionally activate KLF4 and SOX2 for prolonged self-renewal, maintenance of iPSCs
pluripotency is deterred (Wu et al., 2019c). This same mechanism of m6A and YTHDFs facilitating
multipotency by regulating the JAK-STAT cascade is also observed in porcine bone marrow stem
cells, prior to their differentiation into adipose tissue (Yao et al., 2019), in mouse neural
stem/progenitor cells developing into neurites (Li et al., 2018), and in T cell homeostasis and
differentiation (Li et al., 2017b), suggesting a conserved function across organisms and tissues.
Further, loss of m6A interpretation hinders lineage determination, as triple YTHDF knockouts in
mice are unable to differentiate due to protracted expression of pluripotency markers, closely
paralleling the METTL3 hyperpluripotency phenotype (Lasman et al., 2020a). Yet, single YTHDF
knockouts in mESCs differentiate properly, and m6A mRNA half-lives increase only upon triple
reader ablation, indicating that all three readers share common roles in transcript decay during
stem cell development (Lasman et al., 2020a).
Additionally, some factors manipulate methyltransferase activity to control methylation
levels and thereby transcript stability. For example, in mESCs, ZFP217 interacts with METTL3 to
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decrease modification of pluripotency factors, enabling their persisted expression and fostering
self-renewal (Aguilo et al., 2015). In human ESCs, SMAD2/3 interacts with METTL3-METTL14WTAP to upregulate methylation on pluripotency regulators, enhancing their degradation and
facilitating differentiation in response to changes in activin/TGFb signaling (Bertero et al., 2018).
RNA methylation also regulates efficient somatic cell reprogramming into pluripotent stem
cells through transcriptome remodeling. In MEFs, early METTL3 knockout inhibits
reprogramming (Geula et al., 2015), while higher m6A levels promote reprogramming (Chen et
al., 2015). The YTHDF readers appear to be responsible for modulating these effects of m6A on
somatic cells (Liu et al., 2020b). YTHDF2 and YTHDF3 are required to transform MEFs into
iPSCs, by enhancing deadenylation of somatic-specific transcripts to accelerate the mesenchymalto-epithelial transition, a process required to initiate reprogramming (Liu et al., 2020b). YTHDF2
has also been linked to m6A-mediated destabilization of neural-specific factors to promote
pluripotency during neural differentiation of iPSCs (Heck et al., 2020). This indicates that the
YTHDFs may globally regulate clearance of lineage determinants, although how they target only
a subset of methylated transcripts to prime cells for reprogramming remains unclear.
The impact of m6A on cell fate transitions extends into numerous other systems, including
hematopoiesis (Vu et al., 2019; Weng et al., 2019), neural development (Livneh et al., 2020;
Vissers et al., 2020), adipogenesis (Song et al., 2020b; Wu and Wang, 2021), muscle development
(Zhang et al., 2020b), and cancer progression (Delaunay and Frye, 2019; Liang et al., 2020),
reflecting the universality of this modification in balancing pluripotency and differentiation. To
facilitate these transitions, RNA methylation primarily promotes clearance of transcripts
establishing the current state, thus priming cells for rapid shifts in gene expression. Given that the
timing and stage of the transition dictate which mRNAs are regulated by m6A (Geula et al., 2015),
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understanding how the YTHDFs distinguish transcripts for degradation will be essential. Future
research is needed to fully illuminate how RNA methylation and the YTHDFs
posttranscriptionally regulate gene expression to potentiate stem cell fate decisions.

1.3.2. RNA methylation functions in gametogenesis
RNA methylation, its writers, and its readers play critical roles at multiple stages of
gametogenesis, from the germ cells to fully functional oocytes and sperm (Lasman et al., 2020b).
Similar to other cellular contexts, m6A primarily promotes gametogenesis by regulating transcript
stability and translation (Qi et al., 2016). RNA methylation is pivotal for gametogenesis across
organisms, as evidenced by the frequent enrichment of m6A-associated factors in reproductive
organs, and the copious studies showing that loss of writer or reader function causes infertility
(Hongay and Orr-Weaver, 2011; Hu et al., 2020; Jia et al., 2020; Kan et al., 2017; Lin et al., 2017;
Pan et al., 2005; Xia et al., 2018; Xu et al., 2017; Zhong et al., 2008). For instance, almost all
components of the methyltransferase complex are required for female development, fertility, and
sex determination in Drosophila (Granadino et al., 1990; Guo et al., 2018; Haussmann et al., 2016;
Hilfikert et al., 1995; Hongay and Orr-Weaver, 2011; Kan et al., 2017; Knuckles et al., 2018;
Lence et al., 2016; Yan and Perrimon, 2015). Examples like these demonstrate that m6A is a master
mediator of the gene expression changes required for successful reproductive development.

Spermatogenesis
Spermatogenesis is the process of producing mature sperm from the primordial germ cells,
and it occurs continuously in the seminiferous tubules of the testes. Spermatogenesis begins with
the spermatogonial stem cells (SSCs), which balance self-renewal with lineage commitment into
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sperm progenitors, and undergo mitosis to form primary spermatocytes (Griswold, 2016; Holstein
et al., 2003). The primary spermatocytes next undergo meiosis I to generate secondary
spermatocytes, which then undergo meiosis II to form haploid spermatids. Finally, the spermatids
transition into mature haploid spermatozoa through the process of spermiogenesis (Griswold,
2016; Holstein et al., 2003). The methylation pathway regulates spermatogenesis in multiple
organisms, through various effects of the m6A writers METTL3 and METTL14, the erasers,
ALKBH5 and FTO, and the readers YTHDC1, YTHDC2, and YTHDF2 (Lasman et al., 2020b).
In mice, the methyltransferase complex is required in both early and late spermatogenesis.
Early primordial germ cell knockouts of METTL3 or METTL14 reduce methylation on genes
required for SSC proliferation and differentiation, disrupting their translation and causing sterility
(Lin et al., 2017). Similarly, testes specific METTL3 deletion leads to infertility, reduces the
number of germ cells, impairs spermatogonial differentiation, and disrupts meiosis initiation in
mice, potentially through dysregulation of alternative splicing and transcript expression (Lasman
et al., 2020a; Xu et al., 2017). Loss of Mettl3 in zebrafish also impairs sperm maturation and
reduces motility (Xia et al., 2018). In this case, neither the germ cells nor meiosis are affected, and
fertility decreases but is not fully compromised (Xia et al., 2018), suggesting either that Mettl3 is
nonessential for zebrafish spermatogenesis, or that this mutant is a hypomorph, as other instances
of Mettl3 deletion are larval lethal (see Section 4.4). Other writer components are also required for
spermatogenesis. Like METTL3 and METTL14, WTAP in mice is necessary for SSC
maintenance, spermatogonial differentiation, and fertility, likely through the influence of m6A on
splicing, stability, and translation (Jia et al., 2020). Indeed, even in humans, higher m6A, METTL3,
and METTL14 levels are associated with reduced sperm motility (Yang et al., 2016). Intriguingly,
the writers are not required for spermiogenesis or mature sperm function, as spermatid specific
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loss of METTL3 has no impact on fertility in mice (Lasman et al., 2020a). This is likely because
spermatids are transcriptionally inactive and the methylases largely function co-transcriptionally.
Together, these studies demonstrate that the m6A writers are crucial for spermatogenesis across
organisms.
The eraser ALKBH5 also functions in spermatogenesis, and is required for fertility and
testes development in mice (Tang et al., 2017; Zheng et al., 2013). Loss of ALKBH5 disturbs
mRNA export, processing, splicing, and transcript stability, and thus inhibits spermatocyte
progression (Tang et al., 2017; Zheng et al., 2013). ALKBH5 may also influence circular RNA
biogenesis and translation in male germ cells in mice, suggesting that demethylation controls
spermatogenesis through multiple pathways (Tang et al., 2020). Finally, inhibition of the other
demethylase, FTO, via meclofenamic acid treatment increases m6A modification, and thus
enhances degradation of cyclin dependent kinases required for sperm cell proliferation during
meiosis (Huang et al., 2019d).
The most famous m6A-mediator in spermatogenesis is YTHDC2, which facilitates meiosis
in both male and female mice (Bailey et al., 2017; Hsu et al., 2017; Jain et al., 2018; Wojtas et al.,
2017). Knockout of YTHDC2 causes infertility, reduces testes size, impairs differentiation of male
germ cells, and halts the transition from mitosis to meiosis, likely through downregulation of
meiotic genes and upregulation of mitotic genes (Bailey et al., 2017; Jain et al., 2018; Wojtas et
al., 2017). YTHDC2 also controls transcript abundance and translation in sperm, (Hsu et al., 2017),
interacts with the exoribonuclease Xrn1 (Wojtas et al., 2017), and localizes to RNA granules in
the testes (Bailey et al., 2017). Whether these posttranscriptional roles of YTHDC2 in
spermatogenesis are m6A-dependent remains unclear.
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Other readers also guide male reproductive development. YTHDC1 deletion reduces
mature sperm levels, and causes loss of germ cells and male sterility, potentially through its
function as a splicing regulator (Kasowitz et al., 2018). Mouse knockouts of YTHDF2 exhibit
disrupted sperm cell morphology, migration, and proliferation, stemming from stabilization of
transcripts involved in sperm cell adhesion (Huang et al., 2020). Further, YTHDF2 mouse mutants
have seminiferous tubule degeneration, loss of sperm, and hypofertility, again due to dysregulated
transcript decay (Lasman et al., 2020a). The main functions of YTHDF2 are likely late in
spermatogenesis, as YTHDF2 is highly expressed in spermatocytes, while YTHDF1 and YTHDF3
expression is limited to spermatogonia (Lasman et al., 2020a). These differences in expression
may account for differences in their activity during sperm maturation, although the role of
YTHDF1 and YTHDF3 in male reproductive development is yet to be explored. Taken together,
these studies demonstrate that the writers, eraser, and readers of RNA methylation are essential for
spermatogenesis, where loss of any one factor dramatically disrupts male fertility.

Oogenesis
Generation of the mature egg, or ovum, is achieved through oogenesis. Oogenesis begins
with mitosis of a diploid germ cell into a primary oocyte, which subsequently enters meiosis I
(Marlow, 2018; Sánchez and Smitz, 2012). Here, the primary oocyte arrests in the germinal vesicle
(GV) stage, until hormones trigger its re-entry into meiosis I. The oocyte then divides
asymmetrically, forming the secondary oocyte and the first polar body. The secondary oocyte
matures in the ovary until it begins meiosis II, where it arrests in metaphase II until fertilization
(Marlow, 2018; Sánchez and Smitz, 2012). Because early embryogenic success depends on proper
oocyte development and maternally supplied RNAs and proteins, the maternal transcriptome must
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be faithfully assembled during this process (Marlow, 2018). Further, because there is no
transcription past the GV stage, posttranscriptional regulation controls gene expression during late
oogenesis and early zygotic development (Ivanova et al., 2017). RNA methylation greatly
contributes to this posttranscriptional regulatory landscape, and both m6A readers and writers are
critical to ensure production of healthy oocytes (Lasman et al., 2020b).
The writers of m6A, METTL3 and KIAA1429, are both essential for oocyte maturation and
competence. In zebrafish, loss of METTL3 stalls oogenesis and greatly reduces the number of
mature oocytes produced (Xia et al., 2018). In mice, loss of METTL3 early in murine oogenesis
results in complete sterility and abnormal ovary morphology, while later absence of METTL3
causes failure of meiosis I and stalls oocyte maturation in the GV stage, again leading to sterility
(Lasman et al., 2020a). Deletion of METTL3 specifically at the GV stage causes major
transcriptomic defects, and interferes with both translational efficiency and maternal transcript
degradation (Lasman et al., 2020a; Sui et al., 2020). In Drosophila, hypomorphs of the METTL3
homolog IME4 exhibit oogenesis defects, which cannot be rescued by a catalytic dead IME4,
indicating that the methylase activity is required for oogenesis (Hongay and Orr-Weaver, 2011).
KIAA1429 is also required for oocyte competence in mice, where oocyte specific deficiency
disrupts maturation of the ovarian follicle, a shell of somatic cells surrounding the immature oocyte
(Hu et al., 2020). These defects may stem from abnormal RNA processing and splicing, as colocalization between YTHDC1, SRSF3, and KIAA1429 to nuclear speckles is impaired in the
mutants (Hu et al., 2020). YTHDC1 is also required for oogenesis, and absence of this reader
blocks oocyte growth at the primary follicle stage (Kasowitz et al., 2018). This is likely due to
disruptions of alternative polyadenylation and splicing, which cannot be rescued by an m6A-
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binding-deficient YTHDC1 (Kasowitz et al., 2018). These studies demonstrate that RNA
methylation is essential to regulate maternal transcriptome assembly and secure oogenic success.
Other m6A readers are also key mediators of oogenesis. In mice, YTHDF2 is required for
oocyte maturation and the wave of maternal RNA degradation that establishes the meiosis II
transcriptome (Ivanova et al., 2017). Loss of YTHDF2-dependent changes in transcript abundance
causes oocyte incompetence, female specific infertility, and failure of early zygotic development
(Ivanova et al., 2017; Lasman et al., 2020a). Similarly, the MZT stalls in zebrafish YTHDF2
mutants, potentially due to delayed maternal mRNA clearance, although the extent to which this
relies on methylation remains unclear (Kontur and Giraldez, 2017; Zhao et al., 2017). YTHDF1
and YTHDF3 knockouts have no impact on murine oogenesis, likely because they are not highly
expressed in the developing oocytes (Lasman et al., 2020a), although YTHDF1 is required for
female germline stem cell self-renewal in mice (Zhao et al., 2021). The IGF2BPs are also enriched
in mouse and zebrafish ovaries, where they are important for germline development and
embryogenesis, although dependence on m6A for these IGF2BP functions has not been
demonstrated (Liu et al., 2019; Ren et al., 2020; Vong et al., 2020).
YTHDC2 is also pivotal for oogenesis in mice, and knockouts have smaller ovaries, loss
of germinal vesicles, and infertility, likely due to transcriptome misregulation (Bailey et al., 2017;
Hsu et al., 2017; Wojtas et al., 2017). Thus, the timing of reader mutant phenotypes in oogenesis
correlates with the readers molecular activities. The YTHDFs impact late oocyte maturation when
transcription has ceased and posttranscriptional regulation dominants. Alternatively, the YTHDCs
phenocopy loss of the writers, reflecting an earlier role in oogenesis when transcription and m6A
addition are still ongoing. Together, these studies uncover significant contributions of RNA
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methylation, its writer, and its readers in ensuring proper maternal transcriptome establishment
and successful oocyte generation across organisms.

1.3.3. RNA methylation and embryogenesis
Embryogenesis is the process through which multiple cell fate decisions guide an embryo
to differentiate and create the complex tissues and organs required for life. Because embryogenesis
parallels stem cell differentiation, development of the zygote relies on many of the same regulatory
pathways to control transcript fate. Thus, it is unsurprising that RNA methylation is an essential
mediator of embryogenesis.
Across organisms, loss of the methyltransferase is embryonic lethal, including in mice
(Geula et al., 2015; Meng et al., 2019), flies (Granadino et al., 1990; Hilfikert et al., 1995; Kan et
al., 2017; Knuckles et al., 2018), zebrafish (Zhang et al., 2017a), pig (Cao et al., 2021), and plants
(Bodi et al., 2012; Shen et al., 2016; Zhong et al., 2008). These dramatic phenotypes demonstrate
that m6A is required to regulate the intricate genetic programs driving embryogenesis. For
example, blastocysts from mice lacking METTL3 develop normally through preimplantation, after
which they exhibit developmental defects (Batista et al., 2014; Geula et al., 2015; Wang et al.,
2014b). Transcriptome analyses of these mutant embryos show that pluripotency factors, like
Nanog, Sox2, and Klf4 lose methylation and have sustained expression, preventing the blastocyst
from exiting pluripotency and differentiating (Batista et al., 2014; Geula et al., 2015). Similarly,
ablation of METTL14 traps mouse embryos in naïve pluripotency and leads to embryonic arrest,
again due to transcriptome dysregulation (Meng et al., 2019; Wang et al., 2018). Also is mice,
ZC3H13 is required for embryonic stem cell self-renewal (Wen et al., 2018), RBM15 knockouts
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are lethal (Raffel et al., 2009), and WTAP is required for mesoderm and endoderm differentiation,
although this last phenotype is not yet linked specifically to methylation (Fukusumi et al., 2008).
Readers of methylation are also important in embryogenesis, though the degree of their
impact varies for each reader and across organisms. For instance, in mice, YTHDC2 is dispensable
for viability (Bailey et al., 2017; Hsu et al., 2017; Wojtas et al., 2017), but YTHDC1 deletion is
embryonic lethal, likely because DC1 influences transcript splicing and export (Kasowitz et al.,
2018). hnRNPA2/B1 is also required for early embryonic development in mice, as its knockdown
arrests post-implantation embryo growth, likely due to decreased expression of pluripotency
markers (Kwon et al., 2019).
Other readers, like YTHDF2, have a more mild impact on embryogenesis, potentially
reflecting overlapping functions of the YTHDFs during embryogenesis. For example, in mice,
maternal YTHDF2 is required for development past the 2-cell stage, but zygotic-only mutants are
viable (Ivanova et al., 2017), although recovered at lower rates (Lasman et al., 2020a; Li et al.,
2018). These YTHDF2 mutant mice exhibit defects in cortical development, arising from impaired
neural stem/progenitor cell differentiation, indicating that DF2 reader function is necessary to
properly execute neurogenesis (Li et al., 2018). In zebrafish, maternal-zygotic YTHDF2 mutants
fully progress through embryogenesis into adulthood, indicating that this reader is not absolutely
required for their development (Zhang et al., 2017a; Zhao et al., 2017).
Yet, triple YTHDF loss of function recapitulates METTL3 deletion phenotypes, and fully
arrests embryonic growth (Lasman et al., 2020a). The YTHDF readers seem to control
embryogenesis via a dosage dependent mechanism, as lack of YTHDF1 or YTHDF3 can be
compensated by the remaining two readers (Lasman et al., 2020a). YTHDF2 may play a central
role in maintaining viability, as its absence cannot be fully compensated, likely owing to its higher

48

expression level (Lasman et al., 2020a) Together, this suggests that the YTHDF readers exert
overlapping activities during early development, and a specific threshold of their function must be
met for embryogenesis to proceed.
Finally, the IGF2BPs have been proposed as critical regulators of maternal transcript
stability in early embryogenesis (Hansen et al., 2004; Huang et al., 2018; Ren et al., 2020).
IGF2BP1 knockdown reduces global methylation levels and hinders embryogenesis in
parthenogenically activated mouse embryos (Hao et al., 2020). Similarly, IGF2BP2 knockout
mouse embryos arrest at the 2-cell stage, but whether these phenotypes are linked to regulation of
m6A is unclear (Liu et al., 2019). In zebrafish, IGF2BP3 mutants are non-viable and have ectopic
and reduced primordial germ cell development, suggesting that IGF2BPs are mandatory for
embryogenesis across vertebrates (Vong et al., 2020). Together, these studies of RNA methylation
and its regulatory factors demonstrate the importance of m6A in controlling transcriptome changes
during embryonic differentiation.

1.3.4. RNA methylation and the YTHDF readers role in the maternal-to-zygotic transition
The maternal-to-zygotic transition (MZT) is an essential first step in embryogenesis, in
which developmental control is passed from the mother to the zygote through activation of the
zygotic genome and clearance of the established maternal transcriptome (Vastenhouw et al., 2019).
RNA methylation, its writers, and its readers are key contributors to posttranscriptional gene
expression changes during the MZT. For instance, METTL3 depletion in parthenogenically
activated mouse embryos impedes transcriptional activation and maternal mRNA degradation, and
deters embryogenesis in the 2-cell stage (Sui et al., 2020).
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The IGF2BPs are also proposed regulators of the MZT, through transcript upregulation in
both mice and zebrafish (Liu et al., 2019; Ren et al., 2020). In mice, loss of IGF2BP2 reduces
transcription of factors involved in developmental competence, and arrests embryos around the
onset of ZGA (Liu et al., 2019). In zebrafish, IGF2BP3 is suggested to promote maternal transcript
stability (Ren et al., 2020). Loss of IGF2BP3 impairs development as early as the 8-cell stage,
potentially due to premature maternal clearance (Ren et al., 2020). It remains unclear how the
IGF2BPs distinguish select methylated mRNAs for stabilization while the decay-inducing YTHDF
readers are simultaneously active.
Finally, the reader YTHDF2 facilitates the MZT. In mice, YTHDF2 ablation blocks MZT
progression, likely because of improper maternal transcript dosage (Ivanova et al., 2017). In goat,
YTHDF2 mutants cannot develop past the 2-cell stage, exhibit abnormal abundances of maternal
and zygotic transcripts, and have reduced expression of deadenylase and decapping machinery
needed for clearance (Deng et al., 2020). In the zebrafish MZT, maternal mutants of YTHDF2
exhibit a lag in development, which was posited to result from a corresponding delay in maternal
mRNA clearance and inhibition of zygotic genome activation (Zhao et al., 2017). Together, these
studies illustrate the importance of RNA methylation and its effectors in transcriptome switching
during the MZT. Yet, this work also raises several major questions regarding the roles of each
factor and the mechanisms underlying m6A-dependent gene expression changes.
First, as many of these factors are also required in oocyte maturation (Ivanova et al., 2017;
Liu et al., 2019; Sui et al., 2020), it is unknown if impaired MZT in these m6A mutants arises from
failure to establish the maternal transcriptome versus an inability to clear maternal mRNAs.
Further, absence of these proteins often results in both increased and decreased mRNA expression,
convoluting the direct impact of these methylation effectors on transcript fate during the MZT.
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Carefully controlled analyses are required to better dissect the origins of transcriptome changes
upon loss of m6A function.
Second, the extent to which writer or reader phenotypes depends on methylation is
unknown. Most studies present the broad impact of methylation mutants on the maternal or zygotic
transcriptome without assessing consequences on the pool of endogenously modified mRNAs.
Indeed, misregulated mRNAs in zebrafish and mouse YTHDF2 mutants are both methylated and
unmethylated (Ivanova et al., 2017; Zhao et al., 2017), suggesting that either disrupted gene
expression resulted indirectly from loss of YTHDF2, or that YTHDF2 exerts a regulatory function
independent of m6A. The consequences of m6A-mediator absence on methylated transcripts must
be specifically and separately addressed.
Third, it is unclear if m6A-dependent defects in maternal mRNA clearance subsequently
impede ZGA, if disrupted clearance is a consequence of delayed transcriptional activation, or if
methylation independently impacts both processes. For instance, although m6A predominantly
drives decay, it is known to globally promote translation (Wang et al., 2015b). In the context of
the MZT, m6A could boost translation of key activators of zygotic transcription. In the case of
zebrafish YTHDF2 mutants, it is noted that many transcripts dependent on DF2 are also targets of
the zygotically supplied microRNA, miR-430 (Zhao et al., 2017). Delayed ZGA would reduce
miR-430 abundance, thus causing a lag in maternal clearance that could be misattributed to loss of
YTHDF2 (Kontur and Giraldez, 2017). The role of methylation in maternal mRNA clearance
versus zygotic genome awakening must be carefully dissected.
Fourth, while many studies revolve around YTHDF2, the impact of the other YTHDF
proteins is frequently ignored. Given that these factors can function redundantly (Lasman et al.,
2020a; Zaccara and Jaffrey, 2020), a thorough assessment of reader function is necessary to

51

comprehensively understand how methylation guides transcriptome turnover during the MZT. For
instance, in goat, YTHDF1 and YTHDF3 exhibit dramatically higher expression than YTHDF2,
but are neglected for mutagenesis (Deng et al., 2020). In zebrafish, 2,653 methylated transcripts
are unaffected by loss of DF2, suggesting that other factors compensate to clear these maternal
messages (Kontur and Giraldez, 2017). Characterizing how all of the YTHDF factors contribute
to maternal mRNA decay during the MZT is essential to fully comprehend m6A-dependent control
of gene expression during this foundational developmental event.
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CHAPTER 2: RNA methylation regulates
maternal mRNAs in early embryogenesis
In early embryogenesis, animal development is initially dictated by maternally inherited
gene products (Laver et al., 2015; Wagner et al., 2004). During the maternal-to-zygotic transition
(MZT), developmental control shifts to the zygote through massive remodeling of the mRNA
landscape, characterized by the awakening of the zygotic genome and clearance of maternal
mRNAs and proteins (Lee et al., 2014; Tadros and Lipshitz, 2009; Vastenhouw et al., 2019;
Yartseva and Giraldez, 2015). Removal of these maternal mRNAs is essential for transcriptome
reprogramming during the MZT and thus a host of posttranscriptional decay mechanisms
contribute to maternal clearance (DeRenzo and Seydoux, 2004; Despic and Neugebauer, 2018;
Stitzel and Seydoux, 2007; Tadros and Lipshitz, 2009; Yartseva and Giraldez, 2015). Yet, the
impact of RNA m6A methylation, a known regulator of decay, on the degradation of maternal
transcripts remains undefined.
Herein, I explored the role of the RNA modification m6A on maternal mRNA clearance
during the MZT. Using zebrafish embryos as a model organism, I characterized m6A as a facilitator
of maternal transcript deadenylation, decay, and translation. I identified m6A-mediated clearance
as a component of the zygotic mode of decay, and uncovered combinatorial regulation between
m6A and the microRNA miR-430, revealing interplay between these distinct pathways of transcript
turnover.

ATTRIBUTIONS
This chapter is modified from my first author paper published in December, 2020 in Cell Reports
(Kontur et al., 2020), which I wrote with input from Antonio Giraldez. Data for the zebrafish
developmental time course mRNA-sequencing was from Vejnar et al., 2019, Beaudoin et al., 2018,
and Bazzini et al., 2016. m6A-sequencing data, used to distinguish methylated and non-methylated
mRNAs, was from Zhao et al., 2017 and Aanes et al., 2019, and polyadenylation data was from
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Chang et al., 2018 and Subtelny et al., 2014. mRNA-sequencing in the MZdicer and LNA
conditions was performed by Minsun Jeong, and mRNA-sequencing in the dominant negative Caf1
and Dcp2 conditions (unpublished data) was done by Carter Takacs.

2.1. RNA methylation promotes maternal mRNA deadenylation during
the zebrafish MZT

2.1.1. m6A-containing maternal mRNAs are differentially deadenylated
Maternally deposited transcripts in the early embryo are known to contain m6A
modifications, suggesting that this mark may tag specific mRNAs for tailored regulation during
the MZT (Aanes et al., 2019; Ivanova et al., 2017; Zhao et al., 2017). Yet, whether methylation
dictates changes in maternal mRNA abundance has not been thoroughly addressed. Thus, I sought
to establish the effects of m6A on transcript stability directly, by examining how endogenously
methylated mRNAs behave in vivo during the zebrafish MZT. To determine if m6A primarily
impacts maternal mRNA decay or deadenylation, I compared the stability and polyadenylation
status of maternal mRNAs that were found to contain m6A to a control set of mRNAs found to be
unmodified, as detected by previously reported m6A-sequencing in zebrafish embryos (Zhao et al.,
2017). I observed that methylated transcripts were significantly more deadenylated than
unmethylated ones when I analyzed the poly(A) tail lengths, which were determined from two
previously published datasets in zebrafish embryos, PAL-seq (Subtelny et al., 2014) and TAILseq (Chang et al., 2018) (Fig. 2.1.a) (P = 4.2e-08; P = 3.5e-03, respectively, Mann-Whitney U test
6 hours post fertilization (hpf)). Differential deadenylation was observed for methylated mRNAs
even upon controlling for transcript co-regulation by miR-430 (Fig. 2.1.b), which is also known
to promote deadenylation (Bazzini et al., 2012; Giraldez et al., 2006). This data suggests that
modification by m6A drives poly(A) tail shortening during the MZT.
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Figure 2.1. m6A methylation correlates with shorter poly(A) tails
(A) Correlation between m6A RNA methylation and shorter average poly(A) tail length at 6 hpf for
maternal m6A-modified transcripts (m6A, n = 675, pink) and non-modified transcripts (non, n = 841,
grey) for both PAL-seq and TAIL-seq datasets. P-values were computed using a Mann-Whitney U
test. Box, first to last quartiles; whiskers, 1.5x interquartile range; center line, median; diamonds,
outliers.
(B) Average poly(A) tail lengths at 6 hpf for maternal mRNAs that were m6A methylated (m6A, n =
418, pink), contain a miR-430 seed (miR-430, n = 207, blue), have both methylation and a miR-430
seed (both, n = 229, purple), or contain neither (none, n = 519, grey) for both PAL-seq and TAIL-seq
datasets. P-values were computed using a Mann-Whitney U test. * P < 0.05; ** P < 0.01; *** P <
0.001. Box, first to last quartiles; whiskers, 1.5x interquartile range; center line, median; diamonds,
outliers.
2.1.2. m6A is associated with greater initial adenylation and greater deadenylation
Next, I analyzed changes in mRNA abundance from an mRNA-sequencing time course of
zebrafish embryos (Vejnar et al., 2019), to determine if the shorter poly(A) tails observed for
methylated mRNAs coincide with changes in transcript levels. I found that the abundance of
endogenous methylated mRNAs was significantly decreased over time relative to controls in the
poly(A)-selected (poly(A)) mRNA-sequencing (P = 7.7e-21, Mann-Whitney U test, 6 vs. 2 hpf)
(Fig. 2.2.a). The differential effect of m6A on transcript levels was less pronounced on mRNA
decay than on deadenylation, as changes in total mRNA abundance were more similar for
methylated and unmethylated transcripts in rRNA-depleted (ribo0) mRNA-sequencing (P = 9.6e04, Mann-Whitney U test, 6 vs. 2 hpf) (Fig. 2.2.b).
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To further assess the relative impact of methylation on maternal mRNA deadenylation and
decay, I compared the ratio of poly(A) to ribo0 (p(A)/r0) mRNA abundances for methylated and
non-methylated transcripts (Fig 2.2.c). The p(A)/r0 ratio was initially high for m6A-modified
mRNAs, but dramatically decreased over the course of the MZT, until the p(A)/r0 ratio of
methylated transcripts fell below that of non-methylated transcripts at 6 hpf. This dynamic of m6Amodified mRNAs suggests that methylated transcripts were initially more adenylated, but were
also more actively deadenylated by 6 hpf than non-modified mRNAs. Conversely, the nonmethylated transcripts exhibited a much lower p(A)/r0 ratio over time, reflecting a lower overall
expression, less initial adenylation, and a less rapid rate of deadenylation relative to methylated
transcripts.

Figure 2.2. m6A-containing maternal mRNAs start more adenylated but become less
adenylated during the MZT
(A and B) Cumulative distributions of fold change in maternal mRNA abundance (log2 RPKM)
between 6 and 2 hpf in wild-type embryos, displaying decreased levels of m6A-modified (red, n = 708)
relative to non-modified transcripts (black, n = 841), from poly(A) (A) or ribo0 (B) mRNAsequencing. P-values were computed using a Mann-Whitney U test.
(C) The ratio of poly(A) to ribo0 mRNA abundance (log2 RPKM) at multiple time points (hpf)
throughout the MZT for m6A-modified (red, n = 708), non-modified (blue, n = 841), and all strictly
maternal transcripts (grey, n = 3847).
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(D and E) Average poly(A) tail length of individual maternal transcripts for m6A-modified transcripts
(m6A, n = 675, maroon) and non-methylated mRNAs (non-m6A, n = 841, green) from either TAILseq (D) or PAL-seq (E) datasets. Solid lines represent mean value for all transcripts in each group.
m6A-modified transcripts were significantly more adenylated at early time points, TAIL-seq (D): 0 hpf,
P = 1.6e-15; 1 hpf, P = 1.1e-11; 2 hpf, P = 2.7e-06; PAL-seq (E): 2 hpf, P = 2.3e-17. At later time
points, m6A-modified transcripts were significantly less adenylated than non-modified mRNAs; TAILseq (D): 4 hpf, P = 2.3e-03; 6 hpf, P = 4.2e-08. PAL-seq (E); 4 hpf, P = 0.11; 6 hpf, P = 3.5e-03.
Differences between m6A-modified and non-modified transcripts were computed by Mann-Whitney
U test.
I reasoned that this differential deadenylation of methylated mRNAs could arise from
either stronger deadenylation by 6 hpf or from longer initial poly(A) tails, following the major
wave of cytoplasmic polyadenylation that occurs in early embryogenesis (Chang et al., 2018;
Subtelny et al., 2014; Ulitsky et al., 2012). To address this, I compared polyadenylation (Chang et
al., 2018; Subtelny et al., 2014) at multiple time points throughout the MZT, which revealed that
methylated mRNAs were more adenylated early at 0 and 2 hpf (P = 1.6e-15; P = 2.7e-06,
respectively, from TAIL-seq, Mann-Whitney U test), and had significantly shorter tails at 6 hpf
(average tail length of 21 vs. 25 nucleotides, m6A-modified and unmodified, respectively, P =
4.2e-08, from TAIL-seq, Mann-Whitney U test) (Fig. 2.2.d-e). This indicates that methylation is
associated with greater initial adenylation, in accordance with previous findings (Aanes et al.,
2019), and that it enhances later mRNA deadenylation, relative to unmodified mRNAs.
Collectively, these analyses suggest that m6A promotes maternal mRNA deadenylation of its
endogenous target transcripts during the MZT.

2.1.3. m6A-methylation promotes deadenylation and decay of reporter mRNA
To definitively determine if RNA methylation induces transcript deadenylation, I
generated an mRNA reporter, made with or without m6A-modified nucleotides, but otherwise
identical in sequence (Fig. 2.3.a). The reporter was designed without adenosines in the CDS, to
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specifically test the effects of m6A in the 3’UTR, because this region is highly linked to regulation
of transcript stability (Charlesworth et al., 2013; Rabani et al., 2017; Semotok et al., 2005; Vejnar
et al., 2019; Voeltz and Steitz, 1998) and is known to harbor m6A modifications (Dominissini et
al., 2012; Meyer et al., 2012). To test whether m6A specifically drives tail shortening, I
polyadenylated the reporters in vitro. Prior to injection, the incorporation of m6A modification and
poly(A) tail addition were validated using dot blot analysis and an RNase H assay with gel
electrophoresis, respectively (Fig. 2.3.b-c). Reverse transcription followed by Sanger sequencing
of the methylated reporter mRNA confirmed proper incorporation of m6A only as specified by the
plasmid sequence.
Upon injection of reporter mRNA into wild-type zebrafish embryos, I first observed
enhanced deadenylation of the m6A-modified reporter between 0 and 4 hpf relative to the
unmodified mRNA. Second, I noted that the m6A reporter exhibited greater degradation by 6 hpf
than the unmethylated one (Fig. 2.3.d). Thus, m6A both accelerated deadenylation and enhanced
subsequent reporter mRNA degradation. This supports the finding that methylation contributes to
maternal mRNA clearance by promoting maternal transcript deadenylation, and reveals that m6A
may also regulate mRNA decay.
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Figure 2.3. Validation and Northern blot analysis of methylated reporter mRNA
(A) Schematic of the methylated mRNA reporter assay. The capped mRNA reporter has a 5’UTR
without adenines, AUG start codon, CDS without adenines, UAG stop codon, and 3’UTR with 12x
repeats of the m6A motif (GGACT). The reporter was in vitro transcribed either with or without m6Amodified adenines, and then polyadenylated in vitro by the poly(A) tailing enzyme. Reporter mRNA
was injected into embryos and mRNA abundance and polyadenylation were visualized by Northern
blotting.
(B) Dot blot for m6A demonstrates that methylated adenines were incorporated into the m6A reporter
but not the non-methylated reporter, for both polyadenylated and non-adenylated mRNAs.
Unincorporated m6-ATP nucleotides were included as a positive control and unmethylated dsRed
mRNA was included as a negative control.
(C) RNase H assay and polyacrylamide gel electrophoresis validation of reporter (~660 nt) generation.
The reporter, with (+) or without (-) methylation, and the adenylated reporter (+ poly(A)) were
subjected to digestion with RNase H and run on a polyacrylamide gel to confirm that they were the
expected size. To test for successful polyadenylation, one sample included oligo dT, to specifically
digest away the poly(A) tail.
(D) Northern blot (left) showing rapid deadenylation and subsequent decay of m6A-modified (+ m6A)
versus unmodified (- m6A) reporter at respective timepoints (hpf) in untreated wild-type embryos.
Internal 18S rRNA loading control (~1900 nt) shown along bottom. Ratio of methylated versus nonmethylated reporter mRNA abundance (normalized to 18S rRNA) quantified from five replicates is
shown on right. A0, reporter injected without poly(A) tail.
To determine if the impact of m6A extends to both deadenylation and decay, as indicated
by the reporter assay, I assessed the abundance of methylated transcripts in two dominant negative
(DM) conditions, where the catalytically inactive form a decay or deadenylation enzyme was
overexpressed. These two enzymes are central components of key degradation pathways: Dcp2 is
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part of the decapping machinery and Caf1 (also called Cnot7) is an exonuclease subunit of the
Ccr4-Not deadenylase complex (Makino et al., 2015; Mishima and Tomari, 2016, 2017). To focus
specifically on the consequences of m6A modification, only transcripts that are not targets of miR430 were included, as microRNAs often rely on the function of these enzymes to clear maternal
transcripts (Bazzini et al., 2012; Giraldez et al., 2006). While abundance of almost all maternal
transcripts increased in the a-amanitin, Dcp2-DM, and Caf1-DM conditions, methylated mRNAs
were significantly, differentially more stabilized than non-methylated transcripts (Fig. 2.4.). This
suggests that the m6A modification may indeed rely on both decay and deadenylation pathways
for its degradation. Together, these analyses indicate that m6A methylation enhances maternal
mRNA deadenylation and may also regulate mRNA decay, providing critical mechanistic insight
into how m6A specifies transcript life-times during the MZT.

Figure 2.4. Methylated mRNA abundances in Caf1 and Dcp2 dominant-negative conditions
Fold change (log2 RPKM) of transcript abundance for maternal mRNAs that were either m6Amodified (pink, n = 400) or not modified (blue, n = 537) from poly(A) (p(A)) or ribo0 (r0) mRNAsequencing. Fold change in the wild-type condition (far left) represents 6 versus 2 hpf. Fold changes
for treated embryos represent condition versus wild-type at 6 hpf. Wild-type p(A), P = 4.1e-14; wildtype r0, P = 1.1e-01; a-amanitin p(A), P = 3.8e-11; a-amanitin r0, P = 1.0e-07; Dcp2-DM p(A), P =
4.8e-06; Dcp2-DM r0, P = 1.0e-09; Caf1-DM p(A), P = 5.6e-11; Caf1-DM r0, P = 1.6e-09. P-values
were computed using Mann-Whitney U test.
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2.2. m6A-mediated maternal mRNA clearance depends on the zygotic
program
It is unknown if elements of the RNA methylation pathway are part of the maternal or
zygotic modes of gene expression. Considering the dramatic effect of methylation on maternal
mRNA deadenylation, I sought to uncover whether this effect is mediated by maternally or
zygotically encoded programs (Vejnar et al., 2019; Yartseva and Giraldez, 2015). I distinguished
between these programs by blocking zygotic transcription with the RNA polymerase II inhibitor,
⍺-amanitin (Kane et al., 1996; Lindell et al., 1970; Vejnar et al., 2019), which revealed that m6Amodified maternal mRNAs were differentially stabilized relative to unmethylated (P = 3.2e-17; P
= 1.7e-05; Mann-Whitney U test, untreated vs. ⍺-amanitin at 6 hpf, poly(A) and ribo0 mRNA,
respectively) (Fig. 2.5.a-b).
miR-430 is a zygotically encoded factor that promotes maternal clearance and significantly
overlaps target transcripts with m6A (see Section 2.3, below). It is conceivable that the observed
differential stabilization of methylated transcripts could have arisen from loss of miR-430
expression upon inhibition of ZGA. To control for possible convolution from miR-430 repression,
I divided methylated transcripts into those with a miR-430 seed in their 3’UTR and those without
(Fig. 2.5.c). As anticipated, miR-430 only targets were differentially stabilized in ⍺-amanitin
conditions (P = 1.0e-16; Mann-Whitney U test, untreated vs. ⍺-amanitin at 6 hpf, poly(A) mRNA).
Yet, methylated mRNAs that are not recognized by miR-430 also increased in abundance
compared to controls (P = 9.5e-13; Mann-Whitney U test), indicating that the m6A pathway was
indeed differentially reliant on zygotic transcription for mRNA clearance. Transcripts controlled
by both miR-430 and m6A were the most up-regulated relative to non-targets (P = 1.6e-36; MannWhitney U test), perhaps reflecting the combined dependence of these pathways on the zygotic

61

mode. Collectively, this analysis of endogenous maternal mRNAs in ⍺-amanitin conditions shows
that the zygotic mode contributes to m6A-mediated transcript clearance.
Next, I tested if m6A-based degradation depends on zygotic transcription, by injecting my
methylated reporter into ⍺-amanitin treated embryos. When zygotic transcription was blocked, I
observed that the m6A-modified reporter was no longer decayed at 6 hpf, but unmethylated reporter
decay was unaffected (Fig. 2.5.d). This inhibition of m6A mRNA decay suggests that methylated
transcripts were more dependent on the zygotic program than unmethylated transcripts. Notably,
⍺-amanitin treatment slowed but did not inhibit methylated reporter deadenylation between 0 and
6 hpf, suggesting that both maternal and zygotic pathways control m6A-mediated tail shortening.
Ultimately, these results indicate that a program dependent on zygotic transcription contributes to
the degradation of methylation containing mRNAs, but that their deadenylation is regulated by
both maternal and zygotic programs.

Figure 2.5. m6A maternal mRNA clearance is differentially dependent on zygotic
transcription
(A and B) Cumulative distributions of fold change in maternal mRNA abundance (log2 RPKM)
between a-amanitin treated and wild-type embryos at 6 hpf, displaying increased stabilization for m6A-
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modified (red, n = 708) relative to non-modified transcripts (black, n = 841), from poly(A) (A) or
ribo0 (B) mRNA-sequencing. P-values were computed using a Mann-Whitney U test.
(C) Cumulative distribution of fold changes in maternal mRNA abundance (log2 RPKM) between aamanitin treated and wild-type embryos at 6 hpf for poly(A) mRNA-sequencing. The combination of
both m6A-modification and a miR-430 seed in the 3’UTR (m6A + miR-430, purple, n = 241) caused
the greatest transcript stabilization. Transcripts that are miR-430 targets only (miR-430, blue, n = 207),
or m6A-modified only (m6A, pink, n = 418), were less upregulated than co-target transcripts but were
more stabilized than non-target mRNAs (none, grey, n = 537). Dots indicate which groups were
compared to determine corresponding statistical significance. P-values were computed using a MannWhitney U test.
(D) Northern blot (left) comparing deadenylation and decay of m6A-modified (+ m6A) versus
unmodified (- m6A) reporter at respective timepoints (hpf) in a-amanitin and untreated embryos.
Internal 18S rRNA loading control (~1900 nt) shown along bottom. Ratio of methylated versus nonmethylated reporter mRNA abundance (normalized to 18S rRNA) for a-amanitin treated embryos
quantified from three replicates is shown on right. A0, reporter injected without poly(A) tail.

2.3. Methylation and miR-430 co-regulate maternal mRNAs

2.3.1. miR-430 and m6A act independently and additively to regulate maternal transcript
destabilization
Given that I have demonstrated that the RNA methylation pathway exhibits a dependence
on the zygotic mode for transcript destabilization, I sought to establish whether a prominent
zygotically encoded factor and known regulator of maternal clearance, miR-430 (Bazzini et al.,
2012; Giraldez et al., 2006), is required to destabilize methylated maternal transcripts. Notably, I
observed that more than a third of methylated maternal mRNAs also contain a miR-430 seed in
their 3’UTR (Fig. 2.6.a), consistent with previous reports (Aanes et al., 2019; Zhao et al., 2017),
and indicating that these pathways may attenuate stability of shared targets. Further, I observed a
positive correlation between the strength of mir-430 seeds and the predicted number of m6A
modifications in maternal transcripts (Fig. 2.6.c), again reflecting potential co-regulation. I
hypothesized that miR-430 and m6A could act through several mechanisms to clear transcripts,
functioning either cooperatively, resulting in a synergistic clearance of transcripts, independently,
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wherein each mechanism separately contributes a certain degree of destabilization, or dependently,
in which the activity of one pathway is dependent on the presence of the other (Fig. 2.6.b).

Figure 2.6. miR-430 and m6A pathways share common targets
(A) Venn diagram depicting numbers of maternal transcripts that contain a miR-430 seed in their
3’UTR, were m6A-modified, were stabilized in MZythdf2 mutants (fold change (log2 RPKM) > 0.5) or
have an overlapping set of these features. More transcripts were both methylated and targets of miR430, than were both methylated and stabilized in MZythdf2.
(B) Schematic of potential mechanistic models by which miR-430 and m6A could co-regulate maternal
transcripts, tested in Figure 2.7. These pathways could function cooperatively, causing enhanced decay
of common targets, behave independently, meaning their effects would act additively on common
targets, or m6A could be dependent on miR-430, meaning loss of miR-430 would disrupt m6A-based
mRNA degradation.
(C) Stacked bar plot displaying the proportion of maternal transcripts with a given number of
predicted m6A sites, based on the strength of the miR-430 seed also present in the transcript. 8-mer
corresponds to the strongest miR-430 site, followed by 7-mer, then 6-mer, and no-site denotes
transcripts that are not targets of miR-430. The total number of transcripts with each miR-430 seed
(n) is presented at the top of each bar.
To disentangle these possible roles of m6A and miR-430, I first compared the abundance
of transcripts that contained m6A marks, miR-430 seeds, both, or neither during the MZT. mRNAs
containing both m6A sites and miR-430 seeds were the most degraded, followed sequentially by
miR-430 only targets, methylation-only mRNAs, and non-targets (6 vs. 2 hpf in wild-type
embryos, poly(A) and ribo0 mRNA) (Fig. 2.7.a-b). I noted that the effects of m6A and miR-430
were greater in the poly(A) mRNA-sequencing, as changes in poly(A) mRNA abundance may
reflect enhanced deadenylation driven by m6A and miR-430 (Bazzini et al., 2012; Giraldez et al.,
2006), combined with their effects on transcript destabilization. Further, I found that loss of miR-
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430 affected the abundance only of its cognate mRNAs and did obstruct turnover of methylationonly mRNAs, when I compared wild-type and MZdicer or anti-sense LNA treated embryos (Fig.
2.7.c-d). Together, this suggests that m6A drives mRNA deadenylation independently of miR-430,
as observed in my poly(A) tail analysis (Fig. 2.1.b), and that these mechanisms function additively
to co-regulate a subset of maternal mRNAs for stronger degradation. Thus, while miR-430 is not
required for m6A-mediated mRNA decay, it functions as an independent pathway to regulate their
fate, acting combinatorially alongside methylation to co-regulate a subset of highly degraded
targets.

Figure 2.7. miR-430 and m6A pathways are independent and additively regulate maternal
transcripts for destabilization
(A and B) Cumulative distributions of fold changes in maternal mRNA abundance (log2 RPKM)
between 6 and 2 hpf in wild-type embryos, for poly(A) (A) or ribo0 (B) mRNA-sequencing, the
combination of both m6A-modification and a miR-430 seed in the 3’UTR (m6A + miR-430, purple, n
= 241) caused the greatest transcript destabilization. Transcripts that are miR-430 targets only (miR-
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430 only, blue, n = 207), or m6A-modified only (m6A only, pink, n = 418), were less degraded than cotarget transcripts but were more destabilized than non-target mRNAs (none, grey, n = 537).
(C and D) Cumulative distributions of fold changes in maternal mRNA abundance (log2 RPKM) at 6
hpf between MZdicer (C) or LNA-treated (D) embryos, which both lack functional miR-430, relative
to wild-type, from poly(A) mRNA-sequencing. Only transcripts that are miR-430 targets (purple and
blue) were stabilized in MZdicer or LNA-treated embryos, regardless of m6A-modification, while m6Amodified targets (pink) were unaffected by loss of miR-430, relative to non-targets (grey).
For (A-D): transcripts in each group and corresponding labels are the same, and are presented in the
legend along the bottom. Colored dots indicate which groups were compared to determine
corresponding statistical significance. P-values were computed using a Mann-Whitney U test.
2.3.2. Ythdf3 is regulated by miR-430
miRNAs are known to target the Ythdf m6A readers to modulate their expression, and
consequently, the extent of m6A function (Li et al., 2020; Yang et al., 2017b). I noticed that the
mRNA expression of the reader ythdf3 dramatically decreased around 4 hpf (Fig. 2.8.a, poly(A)
and ribo0 mRNA), by which ZGA is majorly underway, and miR-430 is highly expressed.
Examination of the ythdf3 transcript revealed two miR-430 seed sequences within the 3’UTR (Fig.
2.8.c), suggesting that ythdf3 transcript levels are controlled by miR-430. Indeed, western blot
analysis revealed that Ythdf3 protein expression increased in MZmiR-430 mutant embryos (Liu et
al., 2013) relative to wild-type controls (Fig. 2.8.b). Although the effects of miR-430 inhibition on
ythdf3 mRNA levels remain unclear, this protein analysis suggests that loss of miR-430 function
impaired ythdf3 clearance. miR-430 regulation of Ythdf3 implies a possible feedback mechanism
to control the balance or timing of methylated mRNA decay. Notably, ythdf2 transcription
increases at the same time that ythdf3 levels decrease, revealing potential means through which the
embryo modulates Ythdf reader dosage via miR-430 to ensure the proper degree of m6A-driven
regulation. Future work should address the mechanism through which this miR-430 downregulation of ythdf3 is achieved.
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Figure 2.8. Ythdf3 is a miR-430 target
(A) ythdf3 mRNA expression (log2 RPKM) during the MZT, from poly(A) (dashed line) and ribo0
(solid line) mRNA-sequencing, displaying a dramatic drop in expression around 4 hpf.
(B) ythdf3 mRNA transcript contains two miR-430 seed sequences in the 3’UTR (green bars). The
yellow arrow indicates the end of the CDS, which contains the YTH domain (maroon).
(C) Western blot of Ythdf3 protein expression during the MZT (time, hpf) in MZmiR-430 mutant
embryos and wild-type controls.
(D) Genome tracks at 6 hpf of increased ythdf3 poly(A) mRNA abundance in LNA-treated embryos
(dark purple) relative to untreated embryos (light purple).

2.4. m6A influences maternal mRNA translation
During the MZT, there is a direct correlation between maternal transcript poly(A) tail
length and translation (Vastenhouw et al., 2019). Given that m6A modification correlates with
higher initial polyadenylation and greater deadenylation (section 2.1.), I sought to determine if
methylation also influences maternal mRNA translation. To achieve this, I compared global
differences in translation efficiency between methylated and non-methylated mRNAs. Because the
expression levels of modified and unmodified transcripts varies dramatically (Fig. 2.9.a), and
expression is a major determinant of translation levels, I stratified transcripts by their abundance
(ribo0 mRNA) at 2 hpf. Comparison of global translation revealed that m6A marked maternal
mRNAs were significantly more efficiently translated at 2 hpf than unmarked ones, for all
expression levels (Fig. 2.9.b). Yet, this differential translation largely disappeared by 6 hpf,
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perhaps because the majority of methylated transcripts were being cleared by this time point and
were no longer available for translation (Fig. 2.9.c). Overall, this analysis suggests that m6A
modification promotes maternal transcript translation early in the MZT, although the extent to
which this is linked to poly(A) tail regulation should be further tested.

Figure 2.9. m6A correlates with increased translation efficiency in the early MZT
(A) Kernel density estimate plot of methylated (m6A, green, n = 4832) and non-methylated (non-m6A,
blue, n = 3667) maternal transcripts, displaying relative frequency of transcripts with a given mRNA
expression level from ribo0 mRNA-sequencing. To control for differences in expression in (B-C),
transcripts were binned into quintiles (Q1-Q5), with roughly equal numbers of methylated transcripts
in each bin.
(B-C) Violin plots comparing translation efficiency (RPF / RPKM ribo0 mRNA (log2)) of methylated
(m6A, green) and non-methylated (non-m6A, blue) maternal transcripts at 2 hpf. Transcripts were
binned into quintiles according to mRNA abundance (log2 RPKM) from ribo0 mRNA-sequencing
shown in (A). Expression cutoffs for each bin are shown on the x-axis and the number of transcripts
in each bin (n) is presented along the top. P-values correspond to comparison of m6A-modified (m6A,
green) and non-modified transcripts (non-m6A, blue) for each bin, computed by a Mann-Whitney U
test; *** P < 0.001; * P < 0.05.
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CHAPTER 3: Ythdf reader regulation of the
maternal transcriptome during the MZT
The functional consequences of m6A modification on gene expression are determined by
the “reader” proteins, which interpret the mark and recruit regulatory effectors to the transcript.
The YTH-domain containing family of readers is well characterized, as these proteins have the
capacity to bind the modification directly and induce changes in mRNA splicing, export,
localization, translation, and decay (Boo and Kim, 2020; Heck and Wilusz, 2019; Shi et al., 2019;
Zaccara et al., 2019). All three Ythdfs in zebrafish have been identified as maternal mRNA binders
through interactome capture experiments (Despic et al., 2017), suggesting that all three paralogs
contribute to methylated maternal mRNA decay during the MZT. Yet, precisely how these Ythdfs
impact m6A-modified mRNA fate to promote transcriptome reprogramming remains unclear.
Recently, the Ythdf2 reader was linked to mRNA turnover during the MZT in zebrafish.
In a study by Zhao et al. (2017), Ythdf2 mutants exhibited a developmental delay, which was
posited to result from delayed maternal mRNA clearance and hindered zygotic genome activation.
However, as only the global effect of Ythdf2 on all maternal mRNAs was addressed, how loss of
Ythdf2 specifically impacts endogenously methylated mRNAs is yet to be determined. Further,
both methylated and unmethylated mRNAs were misregulated in the Ythdf2 mutants, suggesting
that either disrupted gene expression resulted indirectly from loss of Ythdf2 or that Ythdf2 exerts
a regulatory function independent of m6A. While work by Zhao et al. (2017) suggests an important
role for Ythdf2 in the MZT, it remains unclear if the Ythdfs specifically guide methylated transcript
decay and whether their activity is required for global transcriptome switching.
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In this chapter, I disentangle the contributions of the Ythdf2 reader to methylated transcript
stability, global maternal mRNA clearance, and zygotic transcription. Through generation and
transcriptome analysis of individual Ythdf mutants I demonstrate that no single reader is required
for m6A-mediated mRNA degradation, although loss of Ythdf2 does minimally stabilize some
modified transcripts. Together, this work demonstrates that the effects of m6A on maternal mRNA
deadenylation do not exclusively depend on Ythdf2, nor any other sole reader, overturning the
model that Ythdf2 has a unique and essential function in maternal transcript clearance during the
zebrafish MZT.
ATTRIBUTIONS
This chapter is modified from my first author paper published in December, 2020 in Cell Reports
(Kontur et al., 2020), which I wrote with input from Antonio Giraldez. Data for the zebrafish
developmental time course mRNA-sequencing was from Vejnar et al., 2019, Beaudoin et al., 2018,
and Bazzini et al., 2016. m6A-sequencing data was from Zhao et al., 2017 and Aanes et al., 2019
and ythdf2D8/D8 mutants were obtained from Zhao et al., 2017.

3.1. m6A writer, eraser, and reader expression during the MZT
To identify which factors play a role in m6A-mediated regulation of the maternal
transcriptome, I first sought to determine which components of the methylation life cycle (Shi et
al., 2019; Zaccara et al., 2019) were expressed during zebrafish embryogenesis. I examined mRNA
abundances of transcripts encoding m6A regulators during the MZT using the mRNA-sequencing
time course (Vejnar et al., 2019, Beaudoin et al., 2018, and Bazzini et al., 2016), which yielded
several intriguing observations regarding expression of m6A writers, readers, and erasers.
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Figure 3.1. mRNA abundances of the m6A writers and erasers during the zebrafish MZT
(A-C) mRNA levels (log2 RPKM) of corresponding transcripts for components of the
methyltransferase complex (A-B) and putative m6A erasers (C) from ribo0 mRNA-sequencing.
First, almost all components of the methyltransferase complex were maternally expressed
(Fig. 3.1.a-b), including both core enzymes and cofactors, which guide writer specificity and
activity (Garcias Morales and Reyes, 2021; Gu et al., 2021). mettl14, one half of the heterodimer
catalyzing m6A addition (Liu et al., 2014; Wang et al., 2014b), exhibited especially high
expression. Given that m6A is deposited co-transcriptionally (Ke et al., 2017), and the embryo is
transcriptionally silent prior to ZGA, it will be exciting to determine the function of the writer
complex prior to the onset of zygotic gene expression. Notably, most methyltransferase
components increased in abundance after ZGA, around 4 hpf, suggesting that they will be required
to methylate newly synthesized transcripts as development proceeds. Based on the observed high
expression of mettl14, and the essential role of METTL3 and METTL14 in methylation and
embryogenesis (Geula et al., 2015; Wang et al., 2014b), these enzymes were selected for
mutagenesis.
Second, expression of both putative m6A erasers, alkbh5 and fto decreased over the course
of the MZT. While the activity of these proteins as demethylases is highly debated (Rajecka et al.,
2019), their early expression pattern poses the intriguing possibility that some maternal transcripts
could be regulated by demethylation prior to ZGA.
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Third, all three ythdf readers and both ythdc readers were maternally expressed (Fig. 3.2.a).
ythdf2 displayed the greatest abundance, and ythdf2, ythdc1, and ythdf1 all increased in abundance
following the onset of ZGA, indicating that they may have continued function in later
development. Indeed, Ythdc1 is a largely nuclear protein, with functions in mRNA splicing and
export (Patil et al., 2016; Roundtree et al., 2017b; Xiao et al., 2016), which may explain why it is
required once zygotic transcription is underway. Conversely, expression of ythdf3 and ythdc2
largely decreased following ZGA, which for ythdf3 can be explained through potential downregulation by miR-430 (see section 2.3.2.). Ythdc2 has been linked to mRNA degradation through
its interaction with the 5’-3’ exoribonuclease Xrn1 (Wojtas et al., 2017) and is also known to
regulate translation (Mao et al., 2019), but is believed to largely function in germ cells and
reproductive organs (Bailey et al., 2017; Hsu et al., 2017; Jain et al., 2018; Wojtas et al., 2017).
Whether Ythdc2 exerts these regulatory functions in this developmental context is unexplored.
Although the expression patterns of all Yth readers implied functionality during early
embryogenesis, I opted to limit my mutagenesis approach to the Ythdf readers, as they are most
strongly linked to cytoplasmic regulation (Patil et al., 2018; Zaccara et al., 2019). To confirm that
the Ythdf proteins were maternally supplied alongside the mRNA, I performed western blot
analysis for the Ythdfs, which revealed that all three proteins were indeed maternally deposited
and expressed throughout the MZT (Fig. 3.2.b). Finally, while many other potential m6A readers
have been identified (An et al., 2020; Arguello et al., 2017; Edupuganti et al., 2017; Huang et al.,
2018; Meyer et al., 2015), their assessment is beyond the scope of the work presented here.
Exploration of these additional m6A effectors will likely yield fruitful insights into the role of
methylation in maternal transcriptome regulation.
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Figure 3.2. mRNA and protein levels of the YTH m6A readers during the zebrafish MZT
(A) ythdf1, ythdf2, ythdf3, ythdc1, and ythdc2 transcripts were all maternally expressed (log2 RPKM) during
the MZT, from ribo0 mRNA-sequencing.
(B) Western blotting shows that Ythdf1, Ythdf2, and Ythdf3 proteins were all maternally deposited
(0 hpf) and expressed throughout the MZT in wild-type embryos. Injection of respective flag-tagged
ythdf mRNAs served as positive controls (+mRNA). Actin levels were measured from
immunoprecipitation inputs as loading controls.

3.2. Role of Ythdf readers in methylated mRNA clearance

3.2.1. Ythdf2 is not mandatory for global maternal mRNA clearance
To determine whether the Ythdf readers control m6A-mediated mRNA clearance during
the zebrafish MZT, I first looked at the role of Ythdf2, as it had the highest maternal expression
(Fig. 3.2.a) and has been extensively linked to the regulation of transcript decay (Du et al., 2016;
Wang et al., 2014a; Yoon et al., 2017; Zhao et al., 2017). To determine if Ythdf2 is sufficient to
drive m6A-mediated maternal mRNA turnover, I performed poly(A) mRNA-sequencing on
maternal-zygotic (MZ) mutant embryos with the same Ythdf2 deletion allele as in Zhao et al. and
on related, genetic background-matched wild-type controls (Fig. 3.3.a). Though Ythdf2 was
reportedly required for maternal mRNA clearance, I found no significant differences in abundance
for the majority of maternal mRNAs upon loss of Ythdf2 relative to controls, regardless of their
methylation status (4 and 6 hpf, Fig. 3.3.b-c). Indeed, of 13642 maternally expressed genes, only
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17 were found to be differentially expressed at either 4 or 6 hpf (determined by DESeq2 (Love et
al., 2014); Table 3.1.), of which only 11 were stabilized and only 2 were predicted to be
methylated. Thus, although Ythdf2 was proposed as a key regulator of maternal clearance, the fact
that maternal transcripts were not majorly stabilized in MZythdf2 mutants demonstrates that
Ythdf2 is not obligatory for global maternal mRNA decay.

Figure 3.3. Loss of Ythdf2 does not disrupt global maternal mRNA levels
(A) Schematic of zebrafish crosses to generate MZythdf2 and background-matched wild-type embryos.
Sibling parents of wild-type or ythdf2-/- homozygous genotype were incrossed to generate control and
mutant embryos with matched backgrounds. Embryos from a cross of TU-AB strain zebrafish were
included as an additional and unrelated wild-type control.
(B-C) Biplots of similar expression levels (log2 RPKM) of maternal (n = 13642) and m6A-modified
maternal mRNAs (n = 2280) between background-matched wild-type and MZythdf2 embryos at 4 hpf
(B) or 6 hpf (C), from poly(A) mRNA. Dashed lines indicate two-fold change.
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Table 3.1. Fold-changes and P-values for 17 differentially expressed maternal transcripts
gene ID

fold-change
4 hpf

P-value
4 hpf

fold-change
6 hpf

P-value
6 hpf

ENSDARG00000002165

-2.8

1.0E-02

-1.96

9.0E-02

ENSDARG00000005479

-1.86

2.0E-02

-0.86

n.s.

ENSDARG00000014498

3.26

5.4E-13

1.23

n.s.

ENSDARG00000017338

2.87

1.0E-02

1.63

n.s.

ENSDARG00000024746

-1.09

n.s.

-2.01

4.0E-03

ENSDARG00000037917

2.03

8.0E-03

1.45

n.s.

ENSDARG00000052894

2.63

4.0E-02

0.47

n.s.

ENSDARG00000054454

5.64

2.0E-03

0.46

n.s.

ENSDARG00000061398

2.49

6.0E-02

0.1

n.s.

ENSDARG00000071087

1.69

4.0E-03

-0.04

n.s.

ENSDARG00000077712

-0.52

n.s.

-1.69

1.0E-03

ENSDARG00000077740

5.59

6.1E-06

6.5

1.0E-03

ENSDARG00000078016

2.99

8.0E-03

0.35

n.s.

ENSDARG00000087937

-2.8

8.0E-03

-0.72

n.s.

ENSDARG00000091111

0.21

n.s.

-1.38

8.0E-03

ENSDARG00000091280

2.15

n.s.

3.79

1.2E-07

ENSDARG00000094210

-2.05

4.0E-03

-0.65

n.s.

methylation
status

m6A
non-m6A

non-m6A

non-m6A

m6A

Differential expression determined between time-matched MZythdf2 and background-matched wildtype embryos at either 4 or 6 hpf in poly(A) mRNA-sequencing by DESeq2 (P-value < 0.05, corrected
for multiple testing). n.s., not significant. No value for methylation status indicates unknown status.
3.2.2. Ythdf2 marginally contributes to m6A-mediated clearance
As maternal transcript decay was largely unaffected in MZythdf2 mutants, I next addressed
how Ythdf2 specifically affects methylated mRNAs. When I compared the abundance of m6Amodified and unmodified transcripts, methylated mRNAs were not differentially expressed at 4
hpf, but were marginally more stabilized in the MZythdf2 mutants at 6 hpf, relative to controls (P
= 0.16, 4 hpf; P = 4.4e-04, 6 hpf; Mann-Whitney U test) (Fig. 3.4.a-b). While this is consistent
with a role for Ythdf2 in methylated mRNA decay, the stabilization of m6A-mRNAs in MZythdf2
mutants was negligible relative to the dramatic stabilization observed in the absence of other key
decay regulators (6 hpf, Fig. 3.4.c). For instance, loss of miR-430 through antisense locked nucleic
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acid (LNA) treatment, lead to an average 0.89-fold increase of target transcript abundance, while
the fold-change in MZythdf2 mutants was only 0.05 for methylated mRNAs at 6 hpf. To further
assess the effects of Ythdf2 on m6A-mRNAs, I quantified abundance of several methylated
transcripts using qRT-PCR and visualized their expression by in situ hybridization. Loss of Ythdf2
did not significantly alter decay of either zgc:162879 or mtus1a, both maternal, m6A-marked
transcripts, as levels were comparable to background-matched controls (Fig. 3.4.d). Conversely,
mtus1a, also a miR-430 target, was clearly stabilized in MZmiR-430 mutants. Together, this data
shows that loss of Ythdf2 only nominally impedes methylated mRNA degradation, and that the
contributions of Ythdf2 to m6A-modified maternal transcript clearance are minimal relative to
established decay pathways.

Figure 3.4. Loss of Ythdf2 marginally stabilizes methylated maternal mRNAs
(A-B) Cumulative distributions of fold change in maternal mRNA abundance (log2 RPKM) between
MZythdf2 and background-matched wild-type embryos at either 4 hpf (A) or 6 hpf (B), depicting slight
stabilization of m6A-modified (red, n = 708) relative to non-modified transcripts (black, n = 841), from
poly(A) mRNA. P-values were computed using a Mann-Whitney U test.
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(G) Fold change (log2 RPKM) of transcript abundance for maternal mRNAs that were either m6Amodified and contain a miR-430 seed (miR-430 + m6A, n = 241) or were not modified nor miR-430
targets (non-target, n = 537). Fold change in wild-type condition represents 6 versus 2 hpf. Fold
change for mutant or treated embryos represents condition versus wild-type (background-matched
for MZythdf2 mutants) at 6 hpf. Wild-type, P = 1.1e-30; a-amanitin, P = 1.6e-36; MZdicer, P = 4.4e-34;
LNA, P = 4.8e-39; MZythdf2, P = 7.3-04; MZythdf2,3 P = 1.1e-05. P-values were computed using
Mann-Whitney U test.
(E) In situ hybridization of methylated maternal transcripts mtus1a (left) and zgc:162879 (right) in wildtype, MZythdf2, and MZmir-430 embryos at 2, 4, or 6 hpf. mtus1a, both a target of miR-430 and m6Amodification, was stabilized in MZmiR-430 but not MZythdf2 embryos. Fold change (log2) in transcript
abundance between 6 and 2 hpf for each genotype, as determined by qRT-PCR, is shown on the far
right (mean ± s.d., n = 3 independent replicates). P-values were computed using a two-sided student’s
t-test. Scale bars, 100 µM.
Given the extensive effects of m6A on mRNA deadenylation (see section 2.1.), the minor
stabilization of maternal transcripts upon loss of Ythdf2 suggests that it is not the sole regulator of
methylated mRNA stability. Indeed, I observed significant stabilization for only 2 of 11 methylated
transcripts that were previously defined as Ythdf2 targets (Zhao et al., 2017), as measured by qRTPCR in MZythdf2 mutants and control embryos (Fig. 3.5.a). To further test if methylated
transcripts can be degraded in the absence of Ythdf2, I injected my methylated reporter into
MZythdf2 mutants. I found no difference in the adenylation or decay dynamics of the m6Amodified reporter between MZythdf2 and background-matched wild-type embryos (Fig. 3.5.b),
illustrating that Ythdf2 is dispensable for methylated reporter degradation. Collectively, these
experiments reveal that Ythdf2 is not mandatory for clearance of all methylated maternal
transcripts, indicating that redundant mechanisms may exist to regulate m6A-mediated decay
during the MZT in zebrafish.

77

Figure 3.5. Loss of Ythdf2 stabilizes few methylated mRNAs
(A) Fold change from qRT-PCR measure of relative abundance of methylated maternal mRNAs
between MZythdf2 and background-matched wild-type embryos was insignificant for most transcripts
at 4 hpf (mean ± s.d., n = 3 independent replicates). Only two transcripts were significantly stabilized,
brca2, P = 5.4e-03; vps26a, P = 6.3e-03.
(B) Northern blot (left) of m6A-modified (+ m6A) versus unmodified (- m6A) reporter at respective
timepoints (hpf) in MZythdf2 embryos. Internal 18S rRNA loading control (~1900 nt) shown on
bottom. Ratio of methylated versus non-methylated reporter mRNA abundance (normalized to 18S
rRNA) quantified from two replicates is shown on right. A0, reporter injected without poly(A) tail.
3.2.3. Ythdf1 and Ythdf3 are not individually required for m6A-mediated clearance
Given that Ythdf2 alone did not control methylated mRNA abundance during the MZT, I
sought to establish whether Ythdf1 or Ythdf3 were dominant regulators of m6A-modified
transcripts. I used CRISPR/Cas9 gene editing to individually disrupt ythdf1, ythdf2, and ythdf3 but
deletion of any one was not sufficient to stabilize the previously defined m6A-containing mRNAs
(Fig. 3.6.). Thus loss of neither ythdf1, ythdf2, nor ythdf3 individually prevented methylated
transcript removal, suggesting that no single reader is required for m6A-mediated maternal mRNA
decay.
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Figure 3.6. Loss of Ythdf1 or Ythdf3 does not stabilize most methylated mRNAs
Fold change from qRT-PCR measure of relative abundance of methylated maternal mRNAs between
MZythdf1 (blue) or MZythdf3 (green) and wild-type embryos was insignificant for most transcripts at 4
hpf (mean ± s.d., n = 3 independent replicates, * P < 0.05). Only one transcript was significantly
stabilized, brca2 in MZythdf3 mutants, P = 4.0e-02.
3.2.4. Ythdf2 and Ythdf3 together are not obligatory for m6A-mediated maternal mRNA
clearance
As absence of individual Ythdf readers was not sufficient to block degradation for the
majority methylated maternal mRNAs, I aimed to determine if double loss of ythdf2 and ythdf3
hindered maternal transcript clearance. When I performed poly(A) mRNA-sequencing on
MZythdf2;MZythdf3 mutants (see section 4.2.2.) and analyzed maternal mRNA expression, I
found that very few transcripts were stabilized in MZythdf2;MZythdf3 mutants relative to wildtype controls (256 of 13642 maternal mRNAs with fold-change > 2.0 at 6 hpf), of which only 20
were found to be methylated (Fig. 3.7.a). Thus, double ythdf2 and ythdf3 deletion did not stabilize
most maternal mRNAs, supporting the possibility that they are not compulsory to regulate global
maternal transcript levels during the MZT.
To test if loss of ythdf2 and ythdf3 specifically affected decay of methylated mRNAs, I
compared changes in maternal transcript abundance between m6A-modified and unmodified
messages. As in MZythdf2 embryos, I found that m6A-modified transcripts were slightly stabilized
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in MZythdf2;MZythdf3 mutants at 6 hpf relative to controls (P = 2.8e-14, Mann-Whitney U test,
Fig. 3.7.b). Further, I did not observe significant stabilization for any of the previously defined
m6A-containing targets in MZythdf2;MZythdf3 mutants relative to background-matched controls,
as measured by qRT-PCR (Fig. 3.7.c). This suggests that m6A-based recognition and
deadenylation of cognate mRNAs was not fully impaired in MZythdf2;MZythdf3 mutants.

Figure 3.7. Methylated maternal mRNA clearance is unaffected by the absence of Ythdf2
and Ythdf3
(A) Biplot comparing similar expression levels (log2 RPKM) of maternal transcripts (blue, n = 13642)
and m6A-modified transcripts (magenta, n = 2280) between background-matched wild-type and
MZythdf2;MZythdf3 mutant embryos at 6 hpf, from poly(A) mRNA.
(B) Cumulative distribution of fold changes in maternal mRNA abundance (log2 RPKM) between
MZythdf2;MZythdf3 mutant and background-matched wild-type embryos, showing m6A-modified
mRNAs (magenta, n = 708) were slightly stabilized relative to non-modified transcripts (black, n =
841) at 6 hpf, from poly(A) mRNA. P-values computed by Mann-Whitney U test.
(C) Fold change from qRT-PCR measure of relative abundance of methylated maternal mRNAs
between MZythdf2;MZythdf3 and background matched wild-type embryos was insignificant for most
transcripts at 4 hpf (mean ± s.d., n = 3 independent replicates, * P < 0.05).

3.3. Role of Ythdf2 in zygotic genome activation
Previous work indicated that loss of Ythdf2 delayed both zygotic genome activation (ZGA)
and gastrulation (Zhao et al., 2017), possibly due to slowed maternal clearance. Though my
analysis shows that loss of Ythdf2 did not prevent methylated or maternal mRNA clearance, I
sought to inspect if zygotic transcription was disrupted in MZythdf2 mutants. To this end, I
compared zygotic gene expression between MZythdf2 mutants and background-matched wild-type
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control embryos. Several lines of evidence suggest that Ythdf2 deletion does not hinder the onset
of ZGA. First, only 5 of 6477 zygotic genes were differentially expressed in MZythdf2 mutants
relative to controls, and only one of these was downregulated (4 and 6 hpf, Fig. 3.8.a) (DESeq2
analysis, P < 0.05, Table 3.2.). Second, when I analyzed the global proportion of intronic reads,
used to detect zygotic transcription, I found that intron expression was unchanged in the MZythdf2
mutants relative to wild-type controls, contrasting the sharp intronic read depletion in embryos
treated with triptolide, an RNA Pol II inhibitor (Fig. 3.8.b). Third, I observed similar RNA levels
for several of the earliest expressed zygotic genes including aplnrb, klf17, and miR-430, between
MZythdf2 mutants and controls (Fig. 3.8.c) (fold-changes of 0.04, -0.21, and -0.32, respectively,
all P < 0.05, 6 hpf). These same genes were dramatically downregulated when zygotic transcription
was blocked with triptolide (fold-changes of -2.67, -3.08, and -3.83, for aplnrb, klf17, and miR430, respectively). Together, these results illustrate that loss of Ythdf2 does not disrupt zygotic
gene expression and thus that Ythdf2 is not essential for the onset nor extent of ZGA.

Figure 3.8. Loss of Ythdf2 does not hinder zygotic genome activation
(A and B) Biplot of similar expression levels (log2 RPKM) of zygotic (magenta, n = 1760) and all
mRNAs (grey, n = 20119) between background-matched wild-type and MZythdf2 embryos at 6 hpf
from poly(A) mRNA. Dashed lines indicate two-fold change.
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(C) Proportion of intronic reads relative to total number of reads for background-matched wild-type
(green), MZythdf2 (blue), and triptolide-treated embryos at 6 hpf from ribo0 mRNA. Triptolide inhibits
zygotic transcription, resulting in decreased count of intronic reads.
(D) Genome tracks at 6 hpf of similar levels of zygotic transcripts between MZythdf2 mutants and
background-matched wild-type compared to reduced mRNA levels in triptolide-treated embryos.
Table 3.2. Fold-changes and P-values for 5 differentially expressed zygotic transcripts
gene ID

fold-change
4 hpf

P-value
4 hpf

fold-change
6 hpf

P-value
6 hpf

methylation
status

ENSDARG00000026236

0.71

n.s.

1.62

2.5E-02

non-m6A

ENSDARG00000036107

2.05

7.8E-03

0.50

n.s.

non-m6A

ENSDARG00000073695

1.53

n.s.

3.75

2.6E-02

ENSDARG00000077618

-1.38

1.1E-03

-1.42

n.s.

ENSDARG00000093131

2.88

n.s.

8.16

1.2E-03

Differential expression determined between time-matched MZythdf2 and background-matched wildtype embryos at either 4 or 6 hpf in poly(A) mRNA-sequencing by DESeq2 (P-value < 0.05, corrected
for multiple testing). n.s., not significant. No value for methylation status indicates unknown status.
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CHAPTER 4: Redundant functions of Ythdf
readers in zebrafish development
m6A methylation and its Ythdf readers are known to modulate mRNA fate to promote key
developmental transitions, including stem cell differentiation, embryogenesis, and gametogenesis
(Heck and Wilusz, 2019; Lasman et al., 2020b). For instance, m6A facilitates decay of pluripotency
promoting mRNAs in mouse embryonic stem cells to enable the shift from self-renewal to
differentiation (Geula et al., 2015). Similarly, YTHDF2, YTHDC1, and YTHDC2 are all found to
be essential for oogenesis and spermatogenesis in mice, (Bailey et al., 2017; Hsu et al., 2017;
Ivanova et al., 2017; Jain et al., 2018; Kasowitz et al., 2018; Wojtas et al., 2017), suggesting several
factors concurrently contribute to these developmental milestones. This multi-layered regulation
by m6A may reflect the fact that redundant mechanisms are needed to ensure robustness in gene
expression changes during cellular reprogramming events.
Indeed, while the three YTHDF readers were initially attributed distinct functional roles
(Wang et al., 2014a, 2015b), new evidence indicates that their cellular activities may instead
overlap. Recent studies have found that the YTHDFs share m6A binding sites and are
simultaneously required for mRNA decay and cellular differentiation, demonstrating that these
proteins function redundantly (Lasman et al., 2020a; Zaccara and Jaffrey, 2020). All three
zebrafish Ythdfs are found to be maternally provided mRNA binders during the MZT (Despic et
al., 2017), suggesting that the three paralogs contribute to transcriptome turnover in concert.
Defining the exact roles of the Ythdfs during development is essential to understand precisely how
methylation and its readers promote key cellular transitions.
Herein, I determined that the Ythdf readers function redundantly at multiple steps in
zebrafish development. I employed single, double, and triple Ythdf mutants to show that individual
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Ythdf readers are not required for embryogenesis, but concurrent loss of two Ythdfs impairs ovary
development, and triple Ythdf deletion results in larval lethality. Through their overlapping
functions, Ythdf1, Ythdf2, and Ythdf3 are likely key mediators of developmental transitions.
ATTRIBUTIONS
This chapter is modified from my first author paper published in December, 2020 in Cell Reports
(Kontur et al., 2020), which I wrote with input from Antonio Giraldez. Daniel Cifuentes, a
contributing author on the paper, generated the ythdf2 and ythdf3 mutant alleles.

4.1. Individual Ythdf readers are not required for embryogenesis
Previous work reported that loss of Ythdf2 delayed gastrulation of zebrafish embryos,
potentially stemming from the corresponding lag in ZGA and maternal clearance (Zhao et al.,
2017). Given that I showed that Ythdf2 deletion did not affect the timing of zygotic transcription
or mRNA transcript removal, I sought to test if loss of Ythdf2 disrupts developmental progression
during the zebrafish MZT. Consistent with a lack of transcriptomic differences between MZythdf2
mutant and control embryos, I observed no difference in the onset of gastrulation in a live imaging
developmental time course (Fig. 4.1.a.).

Figure 4.1. Loss of Ythdf2 does not delay gastrulation of zebrafish embryos
(A) Image of zebrafish embryos where MZythdf2 and background-matched (bkgd-match) wild-type
exhibit similar developmental delay relative to unrelated wild-type at 6 hpf. MZythdf2 embryos were
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from the same clutch and share genetic background with the background-matched wild-type embryo.
n, replicate number of embryos at the same developmental stage. Scale bar, 500 µM.
(B) Quantification of developmental rates of embryos in developmental time course shown in(A). Bars
and dots indicate minutes post fertilization at which embryos reach corresponding developmental
stage. MZythdf2 embryo 2 and 4 correspond to the MZythdf2 embryos second from the left and on the
far right in (E), respectively.
(C) Representative images of MZythdf2 and unrelated TU-AB wild-type embryos that were either
uninjected or injected with ythdf2 rescue mRNA. n, replicate number of embryos from the same clutch
and condition at the same developmental stage. Scale bar, 400 µm.
In this time course, I compared MZythdf2 mutants to both related, genetic backgroundmatched wild-type and to unrelated, TU-AB background wild-type embryos (see Fig. 3.3.a). All
embryos were at the 64-cell stage at approximately 2 hpf. However, both MZythdf2 mutants and
background-matched controls reached 50% epiboly at approximately ~5.9 hpf, while the TU-AB
wild-type reached 50% epiboly about 40 minutes earlier, at ~5.2 hpf (Fig. 4.1.b). This ~40-minute
delay is consistent with that observed by Zhao et al., but because this delay was exhibited by both
MZythdf2 mutants and background-matched wild-type, it is unlikely to be linked to the ythdf2
deletion mutation. Indeed, when I injected ythdf2 mRNA into MZythdf2 mutants, I could not
rescue the delay in gastrulation relative to the TU-AB wild-type embryos (Fig. 4.1.c).
To ensure that Ythdf2 deficiency does not disrupt embryonic development, I employed a
second, independent mutant allele of ythdf2 from CRISPR-Cas9 gene editing (MZythdf2-223/-223). I
found no difference in the onset of gastrulation or developmental timing of MZythdf2-223/-223
mutants relative to background-matched controls (Fig. 4.2.). Thus, loss of Ythdf2 does not disrupt
the timing of gastrulation, supporting the idea of mechanistic redundancy in regulation of m6Amediated changes in gene expression during the MZT.

85

Figure 4.2. Ythdf2 deletion does not disrupt zebrafish embryogenesis
(A) Representative images of similar developmental stages of MZythdf2-223/-223, background-matched
(bkgd-match) wild-type, and unrelated wild-type embryos at 6 hpf. n, replicate number of embryos
from the same clutch at the same developmental stage. Scale bar, 500 µM.
(B) Quantification of normally developing embryos was similar for each genotype. Dots indicate
quantifications from three independent clutches and bars represent mean percentage of normally
developed embryos at each time point (hpf) from all three clutches.
Given that Ythdf2 alone did not control zebrafish embryogenesis, I sought to establish
potentially redundant roles for the Ythdf readers during development. As in humans, zebrafish
have three Ythdfs, which exhibit high protein sequence similarity between themselves and with
their human orthologs (Fig. 4.3.), suggesting conserved and common functions. To determine if
Ythdf1 or Ythdf3 drive zebrafish development, I used CRISPR/Cas9 gene editing to individually
disrupt ythdf1 and ythdf3, but deletion of either reader did not result in developmental phenotypes
(Fig. 4.4.). Together, this analysis demonstrates that individual Ythdf readers are not required for
embryogenesis.

86

Figure 4.3. Zebrafish and human Ythdf homology
(A) Alignment of protein sequences for zebrafish and human Ythdf proteins shows high sequence
similarity between paralogs and homologs of both species, especially in the YTH domain (grey bar).
Sequence alignment was generated by Clustal Omega, where blue shading indicates alignment to the
consensus sequence (top row, bolded) and the consensus threshold was set to > 50%. Colored blocks
along the top indicate percentage of sequence conservation at each residue.
(B) Phylogenetic relationship of zebrafish and human Ythdf proteins generated from the protein
sequence alignment. Branch lengths represent evolutionary distance in number of amino acid
substitutions.
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Figure 4.4. Ythdf1 and Ythdf3 mutant embryos develop normally
Representative images of MZythdf1 (left) and MZythdf3 (right) mutants exhibiting no developmental
differences relative to respective background-matched wild-type controls at ~6.5 hpf. n, replicate
number of embryos from the same clutch at the same developmental stage. Scale bars, 500 µm.

4.2. Ythdf2 and Ythdf3 are together required for ovary development

4.2.1. Double loss of Ythdf2 and Ythdf3 disrupts female gonad development
Because analysis of single ythdf mutants suggested that these proteins could function
redundantly, I generated a double ythdf2 and ythdf3 mutant, as Ythdf3 is also linked to mRNA
decay (Shi et al., 2017). Deletion of both ythdf2 and ythdf3 specifically disrupted female
development, as no double homozygotes (ythdf2-/-;ythdf3-/-) were female, while control siblings
(ythdf2-/+;ythdf3-/-) were an almost equal ratio of males and females (Fig. 4.5.a). This male-only
phenotype was also observed in ythdf1-/-;ythdf2-/- mutants (Fig. 4.5.b), but appears specific to
double ythdf deletion, as single ythdf homozygotes could still become female (Fig. 4.5.c). As sex
determination and gonad development are interdependent in zebrafish (Santos et al., 2017), I
hypothesized that loss of ythdf2 and ythdf3 prevented proper establishment of the ovaries.
Histological staining of gonads from double ythdf2-/-;ythdf3-/- mutants revealed underdeveloped
juvenile ovaries at 27 days post fertilization (dpf) relative to sibling controls (Fig. 4.5.d). By 34
dpf, all homozygous ythdf2-/-;ythdf3-/- mutants had developed testes, the default gonad upon
disruption of ovary development (Nagabhushana and Mishra, 2016), whereas controls exhibited
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both ovaries and testes (Fig. 4.5.d). Loss of ythdf2 and ythdf3 specifically affected ovaries, as male
fish developed healthy testes and were fertile at rates similar to wild-type (Fig. 4.6.). Together,
this phenotype of inhibited female gonad development provides evidence for redundant functions
of ythdf2 and ythdf3 in the establishment of the ovary prior to the MZT.

Figure 4.5. Double loss of Ythdf2 and Ythdf3 disrupts female gonad development
(A-B) Numbers of male and female fish of each genotype, quantifying male-only phenotype of double
ythdf2;ythdf3 (A) and ythdf1;ythdf2 (B) homozygous mutants. Sibling controls and double homozygotes
were offspring from the same crosses, depicted on top.
(C) Numbers of male and female fish of each genotype. Homozygous mutants of ythdf2 (both D8 and
D223 alleles) and ythdf3 (D365) can develop into females.
(D) Gonad histology of ythdf2-/-;ythdf3-/- mutant fish and sibling controls (ythdf2+/-;ythdf3-/-) from same
cross in (A). At 27 dpf, mutants exhibit less developed juvenile ovaries than siblings. At 34 dpf, 6
sibling fish had adult ovaries and 8 had testes, while all 12 ythdf2-/-;ythdf3-/- fish had developed testes. I,
stage I oocytes; II, stage II oocytes; triangle, apoptotic oocyte; sg, spermatogonia; sc, spermatocytes.
n, replicate number of each genotype with similar gonads. Scale bars, 40 µm.
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Figure 4.6. Testes develop normally in ythdf2;ythdf3 double mutants
(A) Embryos from ythdf2;ythdf3 homozygous males and unrelated TU-AB wild-type males were
fertilized at similar rates (mean ± s.d., n = 3 independent biological clutches of each genotype).
(B) Testes histology from ythdf2-/-;ythdf3-/- mutant fish and sibling controls (ythdf2+/-;ythdf3-/-). At 34 dpf,
both sibling and mutant fish exhibited healthy developing testes. triangle, apoptotic oocyte; sg,
spermatogonia; sc, spermatocytes. n, replicate number of each genotype with similar gonads; for
sibling the remaining six were ovaries. Scale bars, 40 µm.
4.2.2. Ythdf2 and Ythdf3 together are not mandatory for embryonic development
Though ythdf2 and ythdf3 function redundantly to establish the ovary, the extent of overlap
in Ythdf reader function during embryogenesis remains unclear. To test the maternal function of
ythdf2 and ythdf3, I first had to overcome the defect in ovarian development. To this end, I treated
growing double ythdf2-/-;ythdf3-/- mutants with 17⍺-ethinylestradiol (EE2), a synthetic estrogen
agonist that promotes ovarian development and subsequently increases the number of female
offspring (Örn et al., 2003). Double homozygous females were recovered following EE2 treatment
(Fig. 4.7.a), enabling study of ythdf2 and ythdf3 during methylated RNA decay and embryonic
development. MZythdf2;MZythdf3 mutants appeared to be phenotypically normal relative to EE2treated background-matched controls, as mutant embryos exhibited normal gastrulation,
morphology, and developmental timing (Fig. 4.7.b).
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Figure 4.7. Embryonic morphology was normal in double ythdf2;ythdf3 mutants
(A) Numbers of male and female fish of each genotype, following rescue of male-only phenotype in
double ythdf2;ythdf3 homozygous mutants by treatment with 17 a-ethinylestradiol (EE2). Sibling
control and homozygous fish were offspring from the same cross as in (Fig. 4.5.a).
(B) MZythdf2;MZythdf3 mutants, background-matched wild-type, and unrelated wild-type zebrafish
embryos develop at similar rates. Parents of mutant or background-matched control embryos were 17
a-ethynylestradiol treated. n, replicate number of embryos of each genotype at the same
developmental stage. Scale bars, 500 µm.

4.3. Triple Ythdf loss of function is lethal to zebrafish
Given that ythdf2 and ythdf3 double deletion did not stabilize methylated mRNAs or disturb
embryogenesis, I generated a triple Ythdf loss of function mutant (Fig. 4.8.a). Triple ythdf
disruption was lethal, as triple homozygous larvae could only survive until 9 dpf, likely due to
maternally contributed Ythdf proteins (Fig. 4.8.b). Triple ythdf mutants were never observed in
adulthood, and I recovered fewer zebrafish double homozygous for two ythdfs and heterozygous
for the remaining ythdf than expected (Fig. 4.8.c). This suggests that the Ythdf proteins act
redundantly to ensure zebrafish viability, likely in a dosage dependent manner, as fewer fish with
only one functional ythdf copy survived. Unfortunately, the lethality phenotype prohibits analysis
of triple Ythdf depletion on methylated mRNA stability and assessment of redundancy during the
MZT. Yet, my double and triple Ythdf mutants demonstrate that dual loss of both Ythdf2 and
Ythdf2 was not enough to disrupt preferential deadenylation of methylated mRNAs, and reveals
that the redundant functions of all three Ythdf readers are required during early development.
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Figure 4.8. Triple loss of Ythdfs disrupts zebrafish development
(A) Schematic of cross and genotyping strategy to characterize triple Ythdf mutants. Female fish
(genotype ythdf1+/-;ythdf2-/-;ythdf3+/-) were crossed to males (genotype ythdf1-/-;ythdf-+/-;ythdf3-/-) to
generate triple homozygous embryos (1 out of 8 possible genotypes). Every 3 days, 48 larvae were
genotyped, and 200 additional fish were genotyped at 30 dpf to identify triple homozygotes.
(B) Percentage of triple heterozygous (dark blue, ythdf1+/-;ythdf2+/-;ythdf3+/-) or triple homozygous (light
blue, ythdf1-/-;ythdf2-/-;ythdf3-/-) fish during development. Grey dotted line, expected percentage (12.5%)
of fish with each possible genotype produced from cross in (D).
(C) Number of fish observed with each genotype produced from the cross in (D) at 30 dpf. For each
ythdf allele: open squares, heterozygous allele (+/-); m, homozygous allele (-/-). Grey dotted line
indicates expected number of fish (25), equal for all genotypes.

4.4. Mettl3 or Mettl14 loss of function is lethal to zebrafish
To assess the role of m6A globally in embryogenesis, I generated mutants of the core
enzymes of the methyltransferase complex, mettl3 and mettl14, aiming to determine if
development can proceed in the complete absence of maternal m6A modifications. Loss of function
of Mettl3 or Mettl14 resulted in late stage larval lethality, in which no fish homozygous for the
mutant alleles could be recovered past 35 days post fertilization (Fig. 4.9.). This suggests that some
function of the methyltransferases is essential during zebrafish development, but prevents analysis
of the maternal functions of m6A during early embryogenesis
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Figure 4.9. Mettl3 or Mettl14 loss of function is larval lethal
Percentage of fish homozygous for the corresponding mutant allele surviving over time during
development. Grey dotted line, expected percentage (25%) of fish with homozygous genotype
produced from in cross of two heterozygous fish.
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CHAPTER 5: Discussion and Future Outlook
This work aimed to understand how RNA methylation and its reader proteins guide
maternal transcriptome remodeling during early embryonic development. Here, I showed that m6A
modification promotes mRNA deadenylation during the MZT, establishing it as an additional facet
of control over maternal transcript fate. Although the importance of m6A is clear, future
investigations are necessary to understand how this pathway integrates into the larger landscape
of posttranscriptional regulation during embryogenesis.
To characterize the role of the Ythdf s, oogenesis, and zebrafish viability. Given that m6A
and its readers influence global changes in gene expression across developmental transitions, this
study strengthens the model of RNA methylation as a universal mechanism to promote
reprogramming.

5.1. RNA methylation contributes to maternal mRNA clearance

5.1.1. Discussion on the unknowns of m6A-mediated maternal mRNA deadenylation
My analysis of maternal mRNA stability in zebrafish embryos revealed that RNA
methylation contributes to transcript degradation during the vertebrate MZT and promotes poly(A)
tail shortening of maternal mRNAs. This is consistent with early studies proposing m6A as a key
determinant of transcript lifetimes (Batista et al., 2014; Liu et al., 2014; Schwartz et al., 2014), and
more recent findings that show m6A promotes deadenylation in cell culture (Du et al., 2016).
Thus, methylation may serve as a universal regulator of transcript stability, especially in the
context of cell fate determination (Heck and Wilusz, 2019). Yet, the potential mechanisms
underlying this activity are not fully clear, as the impact of m6A on deadenylation and decay are

94

often intertwined. Indeed, I observed that the effects of m6A were greater on deadenylation than
decay for endogenously methylated mRNAs (Fig. 2.2.), which may be due to the combined effects
of poly(A) tail-shortening and mRNA decay driven by m6A when assaying poly(A)-selected
mRNA. Further, the rapid deadenylation and enhanced degradation of the methylated reporter
(Fig. 2.3.) may reflect its hypermethylated state, or indicate that m6A-mediated deadenylation
enables subsequent and rapid decay. Thus, it remains difficult to determine the extent to which
methylation driven deadenylation and decay are connected. Given that poly(A) tail shortening
often proceeds decapping and decay (Chen and Shyu, 2011; Zheng et al., 2008), a stepwise
pathway beginning with m6A-mediated deadenylation is likely, but this must be more thoroughly
investigated.
The enzymes on which m6A relies to control mRNA deadenylation and decay during the
zebrafish MZT also remain unclear. Methylation readers of the YTH family are associated with
both the Pan2-Pan3 and Ccr4-Not deadenylase complexes, the 5’-to-3’exoribonuclease XRN1, and
stress granule components (Du et al., 2016; Kretschmer et al., 2018; Liu et al., 2020b; Zaccara and
Jaffrey, 2020), suggesting m6A may degrade transcripts through parallel pathways. Destabilization
of m6A marked transcripts was demonstrated here to differentially depend on Dcp2 and Caf1,
although whether this is a direct or indirect dependence is yet to be tested. The modification has
also been linked to additional decay mechanisms, including endoribonucleolytic cleavage (Park et
al., 2019) and localization to P-bodies and stress granules (Fu and Zhuang, 2020; Gao et al., 2019;
Ries et al., 2019; Wang et al., 2014a). Future work should address which deadenylases control
methylation-dependent deadenylation during the MZT and whether it is uncoupled or
interconnected with the contributions of m6A to these other pathways. Further, the extent to which
m6A-based deadenylation is essential for maternal mRNA clearance is unknown, as my attempts
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to remove methylation from the maternal transcriptome were frustrated by the lethal phenotype
exhibited by mutants of the methyltransferase complex, Mettl3 and Mettl14 (see section 4.4.).
Despite this limitation, my work provides mechanistic insight that m6A fosters mRNA
destabilization via deadenylation, establishing it as an important regulator of maternal mRNA
clearance.

5.1.2. Zygotic mode dependence of m6A methylation
Analysis of m6A-modified messages upon failure of ZGA has revealed that methylated
mRNA clearance is reliant on zygotic transcription. This reliance is unlikely to be a total
dependency, as methylated reporter abundance did decrease somewhat by 2 hpf before ZGA,
reflecting some maternal contributions. Further, methylated reporter deadenylation was unaffected
by RNA PolII inhibition, suggesting that poly(A) tail modulation pre-MZT is executed by maternal
elements. This is consistent with prior reports of polyadenylated mRNA abundance fluctuating
prior to ZGA (Aanes et al., 2011; Eichhorn et al., 2016; Mathavan et al., 2005; Rabani et al., 2014;
Subtelny et al., 2014; Winata et al., 2018). Indeed, this mechanism of deadenylating transcripts
early, but delaying decay, was previously observed in embryogenesis, and may serve to carefully
control maternal protein output from key developmental genes without necessitating transcript
turnover (Despic and Neugebauer, 2018; Graindorge et al., 2008; Voeltz and Steitz, 1998).
A clearer understanding of the relative dependence of m6A-mediated decay on the maternal
and zygotic programs may be achieved through a deep investigation of m6A-interactors. For
instance, the Ythdf readers are all maternally supplied (see Section 3.1.) and thus have the capacity
to influence early adenylation. Yet, their activity may be regulated by ZGA-dependent alterations
in posttranslational modifications (Hou et al., 2021), localization, or protein partners (Vejnar et al.,
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2019), enabling them to control downstream decay. Further study is required to illuminate the
precise nature of the maternal and zygotic mode contributions to methylated mRNA clearance.

5.1.3. Interaction between m6A and other decay pathways
My dissection of the relation between m6A and miR-430 demonstrated that RNA
methylation functions independently but additively with the miR-430 pathway to target maternal
mRNAs for clearance. This is coherent with the observation that most unstable maternal mRNAs
depend on multiple decay programs (Rabani et al., 2017; Thomsen et al., 2010; Vejnar et al., 2019).
This sort of combinatorial regulation is thought to serve as a mechanism to ensure that selected
transcripts are rapidly and robustly eliminated (Vejnar et al., 2019; Yartseva and Giraldez, 2015).
Indeed, I found that those mRNAs targeted by both m6A and miR-430 were the most degraded
(Fig. 2.7.a), reflecting faster elimination due to co-regulation. Thus, by combining multiple
pathways, different transcripts are conferred different degrees of destabilization, allowing for
dynamic regulation in the timing and extent of mRNA decay.
Given the extensive catalog of posttranscriptional pathways that contribute to maternal
clearance, it will be exciting to establish possible interactions with m6A for each of them. For
instance, co-occurrence of the m6A consensus site with other RBP binding motifs (Zhang et al.,
2020c) could reflect coordinated regulation or indicate that these trans factors help specify the
functional output of m6A on its targets. Methylated maternal transcripts in zebrafish were found to
be enriched in sequence motifs similar to those bound by Dazl and Unr, two RBPs involved in
translational regulation via the poly(A) tail (Aanes et al., 2019), suggesting potential co-regulation.
Another intriguing possibility is that m6A modulates RBP binding through its function as a
structural switch, either by masking or unmasking motifs, or creating favorable conformations for
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RBP recognition, as it does for HNRNP proteins (Liu et al., 2015, 2017; Wu et al., 2018).
Similarly, codon optimality is known to modulate poly(A) length through the translation of optimal
and suboptimal codons (Bazzini et al., 2016; Buschauer et al., 2020; Mishima and Tomari, 2016;
Presnyak et al., 2015), and m6A can disrupt tRNA selection and translation elongation (Choi et al.,
2016). Whether RNA methylation enhances the effects of codon optimality by contributing to
ribosome pausing remains to be determined.
Finally, m6A-dependent regulation may also cooperate with other RNA modifications.
Ybx1, a reader of 5-methylcytosine (m5C), is linked to the regulation of mRNA stability and
translation during early embryogenesis (Sun et al., 2018; Yang et al., 2019), and the Ythdf proteins
were recently implicated as readers and destabilizers of N1-methyladenosine (m1A) marked
mRNAs (Dai et al., 2018; Seo and Kleiner, 2020; Zheng et al., 2020). Dual modification by m1A
and m6A may enhance transcript recognition by the Ythdfs, guaranteeing down-regulation.
Additionally, terminal uridylation is known to help degrade maternal transcripts with short poly(A)
tails (Chang et al., 2018) during the MZT. m6A may induce deadenylation of maternal mRNAs,
after which uridylation facilitates their degradation. Simultaneous analysis of all RNA
modifications decorating maternal transcripts will provide key insights into how m6A function is
integrated into the larger posttranscriptional regulatory landscape.

5.1.4. m6A and the regulation of mRNA translation
Ribosome profiling analysis indicated that m6A modification correlated with early
maternal mRNA translation. This raises the intriguing possibility that translational regulation by
methylation is linked to its modulation of polyadenylation, especially given that poly(A) tail length
is a major determinant of translation during embryogenesis (Eichhorn et al., 2016; Subtelny et al.,
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2014; Vastenhouw et al., 2019; Winata et al., 2018). Indeed, at 2 hpf, methylation was associated
with both greater adenylation and enhanced translation efficiency, but these relations dissolved by
6 hpf, when modified mRNAs were instead differentially deadenylated. This pattern of dynamic
regulation exhibited by methylated transcripts is consistent with the finding that the correlation
between poly(A) tail length and translation efficiency diminishes following ZGA (Subtelny et al.,
2014; Vastenhouw et al., 2019). Thus it is possible that m6A contributes to the coupling of
translation and adenylation during the MZT, although this mechanism requires further
investigation of the connection between tail length, translation, and m6A levels. Additionally, the
factors mediating the effects of methylation on translation have yet to be identified. Studies in
human cells link Ythdf1 and Ythdf3 to translational upregulation (Shi et al., 2017; Wang et al.,
2015b), although other work suggests that the Ythdf readers have no impact on translation (Zaccara
and Jaffrey, 2020), meaning the Ythdfs’ role must be further explored. Ythdc2 is also found to
promote translation, although it employs its helicase domains (not present in the DFs) to unwind
mRNA structures and facilitate ribosome translocation (Mao et al., 2019). Finally, it will be
worthwhile to assess how the fate of maternal mRNAs varies based on the location of m6A within
the transcript, as where the mark is deposited may help to determine the downstream translational
consequences (Mao et al., 2019).

5.2. Ythdf2 is not the sole driver of methylated transcript turnover
Although my study showed that m6A promotes maternal mRNA clearance, I could not
establish Ythdf2, the proposed driver of methylated transcript turnover (Lee et al., 2020; Wang et
al., 2014a; Zhao et al., 2017), as the sole mediator of these effects. Further, I found that Ythdf2 is
not obligatory for the timing or success of maternal mRNA decay or zygotic genome activation,
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in contrast to work that presents Ythdf2 as a critical regulator of mRNA fate during the zebrafish
MZT (Zhao et al., 2017). Differences in the observed MZythdf2 phenotype may arise from
differences in the genetic background of control embryos (Fig. 3.3.a). Indeed, I found that the
delay phenotype did not segregate with the ythdf2 mutation, as it was no longer observed when the
genetic background between MZythdf2 mutants and wild-type controls was matched. Comparison
of MZythdf2 mutants to unrelated wild-type embryos also accounts for the transcriptomic
phenotype; if the mutant embryos are a stage behind developmentally, their gene expression
profiles will be consistent with that earlier developmental stage, rather than arising from mRNA
dysregulation due to loss of ythdf2. Thus, my data challenges the view that Ythdf2 is required for
proper transcript clearance and ZGA, and instead indicates that Ythdf2 is not obligatory to direct
the MZT.
Additionally, I found only a minor role for Ythdf2 in the clearance of methylated
transcripts. RNA-sequencing data from both this study and Zhao et al. (2017) demonstrates that
loss of Ythdf2 stabilized only a small number of methylated transcripts, suggesting that other
factors are required for turnover of most m6A targets. Individual deletion of Ythdf1 and Ythdf3
was also unable to significantly stabilize select m6A-modified transcripts, suggesting that no single
Ythdf reader is sufficient to control methylated mRNA clearance. Notably, limitations from the
technique used to map m6A in the zebrafish embryos preclude knowledge of what fraction of a
given transcript is methylated. This means that m6A reader removal could have an appreciable
impact on a small fraction of methylated transcripts, but that these effects would be masked by the
unchanged stability for the larger, unmodified fraction of the same transcript. As m6A-mapping
techniques become more quantitative and precise (Linder and Jaffrey, 2019; McIntyre et al., 2020),
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reader specificity for methylated maternal mRNAs should be carefully assessed, to fully resolve if
the Ythdfs redundantly control m6A-modified maternal transcript turnover.

5.3. Ythdf functional redundancy during development
My analysis of double and triple Ythdf mutants demonstrated that these factors work in
concert to control mRNA fate during multiple developmental transitions (Figure 5.1.). This
finding aligns with the newly emerged model of functional redundancy between the Ythdfs, and
challenges the traditional view that each reader has a distinct regulatory role (Lasman et al., 2020a;
Patil et al., 2018; Shi et al., 2019; Zaccara and Jaffrey, 2020; Zaccara et al., 2019). Indeed, recent
evidence supports interchangeable activities for the Ythdfs. First, the Ythdfs contain the same
protein domains across vertebrates, and some invertebrates, like Drosophila, have only one YTH
homolog, reflecting a shared capacity for overlapping functions (Kan et al., 2017; Patil et al.,
2018). Second, all three proteins are known to bind the same m6A sites in multiple physiological
contexts, suggesting that co-targeting between the readers is universal (Lasman et al., 2020a; Lu
et al., 2018; Shi et al., 2017; Tirumuru et al., 2016; Zaccara and Jaffrey, 2020). Third, the
interactomes of the Ythdfs markedly coincide, with key decay and deadenylation machinery
associating with Ythdf1, Ythdf2, and Ythdf3 (Zaccara and Jaffrey, 2020). Fourth, significant
stabilization of methylated transcripts is observed only upon triple Ythdf knockdown in cell
culture, while individual knockdowns have minimal impact on m6A-modified mRNAs, mirroring
my observations in zebrafish embryos (Zaccara and Jaffrey, 2020). Together, these studies and my
work affirm a model of functional redundancy between the Ythdfs in regulation of the methylated
transcriptome.
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Figure 5.1. Single, double, and triple Ythdf zebrafish mutants reveal redundant functions in
multiple stages of development.
My study shows that in zebrafish, single Ythdf knockouts of Ythdf1, Ythdf2, or Ythdf3 do not impact
the maternal-to-zygotic transition (MZT) or embryogenesis. However, double loss of Ythdf2 and
Ythdf3 impairs oogenesis and inhibits ovary development. Triple Ythdf deletion disrupts larval
viability.
Notably, the Ythdf readers are found to target unique transcripts or exert distinctive
functions in some biological contexts (Liu et al., 2018b; Wang et al., 2014a, 2015b). While this
could arise from exclusive expression of a single paralog in a given cell or tissue type (Shi et al.,
2019), compartmentalization of readers is unlikely during the zebrafish MZT, as all three Ythdf
proteins are simultaneously expressed in the early embryo.
Indeed, redundant Ythdf activity is consistently observed in instances of cellular
reprogramming (Lasman et al., 2020a; Zaccara and Jaffrey, 2020), suggesting that this multilayered regulation is important to ensure robust changes in gene expression. For instance, a dosagedependent mechanism controls embryonic viability in mice, as determined through single, double,
and triple Ythdf knockouts (Lasman et al., 2020a). This is consistent with my results that individual
knockouts did not impede maternal mRNA decay or embryonic development, but that dual loss of
Ythdf2 and Ythdf3 impaired oogenesis, and triple Ythdf loss led to lethality. Indeed, I found that
only triple reader deletion phenocopied Mettl3 or Mettl14 knockouts, suggesting that the
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developmental impact of full reader absence is proportional to complete loss of methylation. This
has also been similarly observed in mESCs, where triple YTHDF mutagenesis impairs
differentiation to the same extent as METTL3 depletion (Lasman et al., 2020a). Together, this
evidence supports a dosage-dependent functional redundancy of the Ythdf readers during
development. Given that combinatorial decay is frequently employed to clear messages in the early
embryo (Yartseva and Giraldez, 2015), redundant regulation by the Ythdfs may guarantee specific,
timely, and orchestrated transcript turnover during key cellular transitions.
Finally, although it is clear that the Ythdfs coordinate their activity during early
development, the impact of maternal Ythdf loss of function could not be assessed due to the nonviable phenotype. Ultimately, loss of all three Ythdf readers during the MZT is required to
determine if these factors act redundantly to modulate methylated maternal mRNA fate.
Additionally, recent work has greatly expanded the list of m6A-associated factors (Arguello et al.,
2017; Edupuganti et al., 2017), whose role in cellular transitions must be explored. For instance,
the RBP IGF2BP3 was found to maintain maternal mRNA stability prior to transcript clearance
during the zebrafish MZT (Huang et al., 2018), although the extent to which this relies on m6A is
debated (Sun et al., 2019). Given that multiple readers may contribute to equilibrium between
methylated mRNA decay and stability, the specific role of each factor, especially the remaining
YTH proteins, must be fully defined to completely understand how methylation governs maternal
mRNA clearance.

5.4. The m6A pathway regulates reproductive development
The m6A modification pathway is increasingly recognized as a central regulator of stem
cell differentiation and gametogenesis (Lasman et al., 2020b). I found that simultaneous mutation

103

of Ythdf2 and Ythdf3 impaired female gonad development, demonstrating an essential function of
these proteins in zebrafish oogenesis. Intriguingly, this phenotype was restricted to female
development, as spermatogenesis and male fertility were unaffected by loss of two Ythdfs,
suggesting requirement for these readers arises after the germ cells are established. Consistent with
my study in zebrafish, this role of m6A and its effectors as regulators of gametogenesis is observed
across organisms. YTHDF2 is required for murine oocyte maturation (Ivanova et al., 2017) and
depletion of the m6A writer, Mettl3, inhibits gamete maturation in zebrafish (Xia et al., 2018).
Additionally, both YTHDC1 and YTHDC2, are found to be essential for proper spermatogenesis
and oogenesis in mice (Bailey et al., 2017; Hsu et al., 2017; Jain et al., 2018; Kasowitz et al., 2018;
Wojtas et al., 2017). It remains unclear exactly how YTHDF readers regulate mRNA stability
during oogenesis, as loss of YTHDF2 in mouse oocytes results in both up- and downregulation of
different transcripts (Ivanova et al., 2017). Alternatively, the YTHDFs may impact mRNA
translation, as modulation of m6A levels through methyltransferase mutants dysregulates
translation in mouse and Xenopus oocytes (Qi et al., 2016; Sui et al., 2020), and other male-only
phenotypes in zebrafish stem from defects in translation (Miao et al., 2017). Future work is needed
to define exactly how m6A readers govern transcriptome changes during gametogenesis.
Finally, it is notable that the dosage dependency of the Ythdfs extends to their function in
reproductive development. I observed that single Ythdf mutants did not exhibit the male-only
phenotype, and only upon double disruption was oogenesis repressed. Similarly, the severity of
defects in mouse gametes depends on the extent of m6A dysregulation. Knockout of Ythdf1 or
Ythdf3 causes no reproductive defects, loss of Ythdf2 destroys oocyte competence and decreases
sperm count, and early METTL3 mutation completely halts sperm and oocyte development
(Huang et al., 2020; Ivanova et al., 2017; Lasman et al., 2020a; Lin et al., 2017; Xu et al., 2017).
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Intriguingly, Ythdf2 appears to be the principal Ythdf controlling gametogenesis, as other readers
cannot compensate for its loss in mice (Ivanova et al., 2017; Lasman et al., 2020a). Similarly, both
of my double mutants included Ythdf2, although the combination of Ythdf1 and Ythdf3 was not
tested. Why is Ythdf2 more essential than the other readers? This is likely attributable to expression
or localization differences between Ythdfs in the developing gonads; in mice, only Ythdf2
expression persists between spermatogonia and spermatocytes, and it is the only reader with both
nuclear and cytoplasmic distribution in developing oocytes (Lasman et al., 2020a). Thus, variation
in the required dosage of the Ythdfs across various organisms and cellular contexts may reflect
expression changes, although this is yet to be confirmed in zebrafish reproductive development.

5.5. Conclusions and perspective: RNA methylation as a master
regulator of transcriptome switching
RNA modifications have become regarded as pivotal posttranscriptional regulators during
cellular transitions (Frye et al., 2018). Because chemical marks offer a unique means to tie
transcripts together for similar fates, m6A has been proposed as a universal regulator of
transcriptome switching during developmental reprogramming (Darnell et al., 2018; Frye et al.,
2018; Heck et al., 2020; Roundtree et al., 2017a; Simen Zhao et al., 2018). Indeed, as one of the
most abundant mRNA modifications, m6A is known to control gene expression changes during
stem cell differentiation, neurogenesis, cancer development, hematopoiesis, gametogenesis, and
embryogenesis (Heck and Wilusz, 2019; Lasman et al., 2020b; Zhang et al., 2020b). Across these
physiological contexts, m6A tags specific sets of transcripts for coordinated regulation, and its
effectors mediate the downstream consequences on mRNA metabolism. Thus m6A ensures the
proper genetic program is realized efficiently and correctly without requiring new transcription.
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It is possible that RNA methylation and the Ythdf readers play a similar role in
transcriptome remodeling and embryonic development in zebrafish (Zhao et al., 2017). My study
demonstrated that the m6A modification promotes maternal transcript removal, and that the Ythdf
proteins are redundantly required at multiple stages of development, including oogenesis and larval
viability. Thus methylation is another pathway woven into the landscape of posttranscriptional
regulation orchestrating the MZT, functioning alongside RBPs, microRNAs, codon optimality,
secondary structures, and other mechanisms to control maternal mRNA clearance and facilitate
early embryogenesis.
Yet, interpretation of RNA methylation as a universal mediator of development must be
considered cautiously, as it hinges on the capacity of m6A to both promote and repress mRNA
stability and translation, and to quickly switch its regulatory capacity while relying on the same
effector proteins. Indeed the dynamic nature of m6A deposition has been challenged (Darnell et
al., 2018; Mauer and Jaffrey, 2018; Simen Zhao et al., 2018), and the directionality of m6A’s
consequences on mRNA decay and translation vastly differ across physiological conditions (Patil
et al., 2018; Shi et al., 2019; Zaccara et al., 2019). Future research regarding the full profile of
mechanisms used by RNA methylation to control transcript fate across biological contexts will
clarify the role of in reprogramming. Similarly, future work on how the Ythdfs achieve specificity
yet function coherently to interpret the mark is required. Finally, understanding how methylation
is connected to other regulatory pathways will be fundamental to comprehend how the activity of
multiple posttranscriptional regulators is coordinated. Addressing these questions will provide
pivotal information regarding the function and universality of RNA modifications in shaping gene
expression changes during essential developmental transitions.
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Chapter 6: Methods
6.1. Methylated mRNA analysis and reporters
Reporter construction and injection
The methylated reporter was generated as follows: DNA fragments for the CDS and 3’UTR
were ordered as gBlocks Gene Fragments from IDT. The CDS was designed without adenine in
the sequence (with the exception of the ATG start codon, TGA stop codon, and HA tag) to limit
incorporation of m6A to the 3’UTR. The 3’UTR was designed with 12 copies of GGACT
methylation motif. DNA fragments were PCR amplified for In-Fusion cloning. The pCS2+ vector
was linearized with BamHI, and fragments were ligated with the In-Fusion HD enzyme (Takara,
639642). Adenines in the 5’UTR were converted to thymines using site directed mutagenesis with
oligos 5’- TTTCTTGCTTCTTGTTCTTTTTGCTGGTTCCATGGCCCGCCTTTGTGCTGC-3’
and 5’ GGAACCAGCAAAAAGAACAAGAAGCAAGAAATCTATAGTGTCACCTAAAT-3’
followed by DpnI digest to remove non-mutated plasmid. Plasmids were linearized with XbaI.
Capped reporter mRNA was generated by IVT using the HiScribe SP6 RNA Synthesis Kit (New
England BioLabs, E2070S) with the addition of 40 mM m7G(5')ppp(5')G RNA cap structure
analog (New England BioLabs, S1404S). For methylation containing reporters, 50 mM of N6methyladenosine 5’triphosphate (TriLink, N-1013-5) was added to the IVT in place of adenine.
m6A-IP verified the presence of m6A modifications in the reporter mRNA. mRNAs were DNase
treated following IVT. The poly(A) tail was added after IVT using the Poly(A) tailing kit
(Invitrogen, AM1350) according to the manufacturer’s instructions. Resultant mRNA was purified
using the RNeasy RNA extraction kit (Qiagen, 74104). Reverse transcription followed by Sanger
sequencing of the methylated reporter mRNA confirmed proper incorporation of m6A only as
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specified by the plasmid sequence. Zebrafish embryos were injected with 35 pg of either m6Amodified or unmodified reporter mRNA. Thirty embryos were collected for each condition at
different timepoints during the MZT for RNA extraction and subsequent Northern blot analysis.

RNA isolation
Total RNA was extracted from zebrafish embryos using the TRIzol reagent Invitrogen
(15596-018) according to the manufacturer’s protocol and eluted in RNase-free water. RNA
isolated for qRT-PCR was treated with TURBO DNase (Invitrogen, AM2238) at 37°C for 20
minutes following RNA extraction and purified using phenol chloroform extraction.

Northern blot analysis
Briefly, 3 µg of total RNA was resuspended in formamide and 2x tracking dye (1mM
EDTA, 60 mM triethanolamine, 60 mM tricine, 0.04% bromophenol blue, 2.5% formaldehyde)
and heated at 65°C for 10 minutes to denature the RNA. Samples were separated by electrophoresis
using a 1.5% agarose/1.25% formaldehyde gel in 1x Tri/Tri buffer (30 mM triethanolamine, 30
mM tricine). The gel was capillary transferred to a Nytran SPC membrane (Whatman, 10416294).
RNA was crosslinked to the membrane with 254 nm UV light at 1200 mJ. Membranes were
prehybridized with 5 mL of ExpressHyb hybridization solution (Clontech, 686831) for 1 hour at
68°C with constant rotation. RNA species were detected by either cDNA or oligonucleotide probes
hybridized at 68°C or 42°C, respectively, overnight with 5 mL of ExpressHyb solution and
5,000,000 cpm of either the reporter or the 18S control radiolabeled probes:reporter mRNA 5’GTCCTTTCTGCTGGTCCTTCCTGTGGGGGTGTCCTGTGTGGGGCCGTGCTTTGGGCTG
CCGTGCTGTCTGCTGGCCCCCTCTGCGCTGGTCCGCTTTGCGGGGGTCGCCTGTTGGC
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TGCCCGTCTCTGCGGGGGTCGTCTGTTGGGGGGCCCTCTCTGGGCTGGCGTTTCCTCT
GCTGGTCCGTCCTTGTTCGGCGTTCTCTGTT- 3’ Internal 18S maternal rRNA 5’CGTTCG
TTATCGGAATCAACCAGACAAATCGCTCCACCAACTACGAACGG- 3’ Internal 18S
somatic rRNA 5’-CCGTTCTTAGTTGGTGGAGCGATTTGTCTGGTTCATTCCGATAACGA
ACGAG- 3’.
cDNA probes were radiolabeled with ⍺-P32-dATP using the Nick Translation Kit (SigmaAldrich, 10976776001) according to the manufacturer’s protocol. Oligo probes were radiolabeled
by T4 PNK end labeling (New England BioLabs, M0201S) with g-P32-ATP. Radiolabeled probes
were purified using ProbeQuant G-50 Micro Columns (GE Healthcare, 28903408) and cDNA
probes were heated at 95°C for 5 minutes prior to hybridization. Membranes probed by cDNA
were washed three times with 2x SSC/0.05% SDS for 15 minutes and twice with 0.1x SSC/0.1%
SDS for 20 minutes at 50°C. Membranes probed with oligos were washed once with 2x SSC/0.05%
SDS for 10 minutes at room temperature and once with 0.1x SSC/0.1% SDS for 2 minutes at 42°C.
Northern blots were quantitated using a phosphorimager (Bio-Rad Personal Molecular Imager).
Levels of reporter mRNA were normalized to 18S rRNA controls.

Poly(A) tail length analysis
Datasets for poly(A) tail length were downloaded from public repositories. PALsequencing (Subtelny et al., 2014) was downloaded from GEO accession number GSE52809 and
TAIL-sequencing

data

(Chang

et

al.,

2018)

was

downloaded

from

Zenodo

doi:

10.5281/zenodo.2640028. For each dataset, the average poly(A) tail length was calculated by
averaging counts for the poly(A) tail reads for each gene at each timepoint. The same sets of
methylated and non-methylated transcripts were used to analyze each poly(A) tail dataset.
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6.2. Transcriptomic and molecular analyses of Ythdf mutants
In situ hybridization
In situ hybridization was performed as in Thisse & Thisse, 2014. To generate antisense
RNA in situ probes, transcript regions were amplified from zebrafish cDNA using the oligos listed
in Table 6.1. The reverse-orientation oligo contained a T7 promoter overhang for probe synthesis
by IVT using T7 polymerase. Probes were purified using the RNeasy RNA extraction kit (Qiagen,
74104). Each 200 µL hybridization reaction used 20 ng of DIG-labeled RNA probe. Before
imaging, embryos were cleared with 2:1 benzyl benzoate:benzyl alcohol solution. For each
condition, at least 20 embryos were analyzed and all displayed comparable levels of staining
following equal stain time. Imaging was performed using a Zeiss Discovery V12 stereo
microscope. Maternal-zygotic mutant embryos of miR-430 were collected from an incross of
homozygous miR-430 deletion fish from Y. Liu et al., 2013. Wild-type control embryos used for
in situ experiments were background-matched wild-type relatives of MZythdf2 embryos.

qRT-PCR measure of RNA abundance
Total RNA was extracted from 20 embryos per experimental condition and DNase treated.
cDNA was synthesized from 1 µg of total RNA using reverse transcription with random hexamers
and the Superscript III reverse transcriptase kit (Invitrogen, 18080093). cDNA was diluted 1:20
and 10 µl reactions for PCR reactions were prepared with 5 ml of Power SYBR Green PCR Master
Mix (Applied Biosystems, 4368706), 4.5 µl of 1:100 diluted cDNA, and 0.5 µl of 10 mM forward
and reverse primer mix. At least two biological and two technical replicates were performed for
each sample. Relative expression was measured with ViiA 7 software v1.2.2 using the DDCT
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method, with dcun15d as a reference control. Oligonucleotides used for qRT-PCR are listed in
Table 6.1.

Immunoprecipitation and western blotting
Fifty embryos were collected, flash frozen in liquid nitrogen, and resuspended in lysis
buffer (150 mM NaCl, 25 mM Tris-HCl, 1 mM EDTA, 1% Igepal CA-630, 0.1% SDS) with 1X
protease inhibitor cocktail (Roche, 11873580001). Lysates were incubated at 4°C for 10 minutes,
followed by centrifugation at 14000 rpm for 15 minutes at 4°C. Supernatants were added to
antibody-coupled Protein A Dynabeads (Invitrogen, 10008D) (10 µl of beads and 1.5 µg of
antibody, coupled according to manufacturer’s protocol). Lysates and antibodies were incubated
at 4°C for at least two hours, with rotation. Prior to washes, 20 µl of supernatant was removed for
input control. Beads were then washed three times in lysis buffer and resuspended in sample buffer
(7.5 µl of 4x NuPAGE LDS Sample Buffer (Invitrogen, NP0321PK2), 3 µl of 1 M DTT (SigmaAldrich, 43816), 19.5 µl of nuclease-free water). Samples were heated at 70°C for 10 minutes and
separated on a 1.0 mm 4-12% Bis-Tris NuPAGE mini protein gel (Invitrogen) at 180 V for 50
minutes and wet transferred onto a nitrocellulose membrane (GE LifeSciences) at 20 V for 4 hours.
Membranes were blocked in 5% milk, 1% Tween-20 in PBS for 1 hour and then incubated
overnight at 4°C with constant rotation in anti- Ythdf1, Ythdf2, or Ythdf3 antibody diluted 1:1000
or in anti-Actin diluted 1:5000 in block buffer. Secondary antibody Goat Anti-rabbit IgG antibody
(H+L) HRP conjugate (Millipore, AP307P) was diluted 1:10,000 in block buffer and the
membrane was incubated for one hour at room temperature. Membranes were washed three times
for 5-10 minutes after each antibody incubation. Membranes were developed by chemiluminescent
detection using ECL Western blotting substrate (Thermo Fisher, 34095) and imaged by and X-ray
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film (Denville Scientific, E3012). Actin was used as a loading control for input for
immunoprecipitated samples.
Antibodies against Ythdf1, Ythdf2, and Ythdf3 were custom generated by YenZyme by
raising

antibodies

in

rabbit

CKNLEPAPIQNRSRLDQERQ

for

against

amino

acid

sequences

Ythdf1,

PQQTSLPTNGQPPNQSSPQ

as

follows:

for

Ythdf2,

RNRGTMFNQNSGMDN for (amino acid sequences are listed from N to C terminus).

RNA-sequencing library preparation
For RNA-sequencing in ythdf mutants, 20 embryos per condition were collected at
indicated developmental time points and snap frozen in liquid nitrogen. Embryo collections for
mutants and background-matched wild-type were performed at the same time (time-matched),
with synchronously developing embryos. Total RNA was subjected to either poly(A)-selection by
oligo(dT) beads or to ribosomal RNA-depletion with Epicentre Ribo-Zero Gold, according to
manufacturer’s instructions. Strand-specific TruSeq Illumina RNA-sequencing libraries were then
constructed, and samples were multiplexed and sequenced on Illumina HiSeq 2500 machines to
generate 76-nucleotide single-end reads. Library preparation and mRNA sequencing was
performed by the Yale Center for Genome Analysis.

RNA-sequencing analysis
The zebrafish mRNA sequencing embryonic development time course datasets were from
previously published SRP189512 (Vejnar et al., 2019), SRP149556 (Beaudoin et al., 2018), and
SRP072296 (Bazzini et al., 2016). MZdicer fish were obtained from Giraldez et al., 2006. Re-
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analysis of published MZythdf2 RNA-sequencing data was performed on dataset from Zhao et al.,
2017, from GEO accession number GSE79213.

Mapping reads
Raw reads were mapped using STAR (Dobin et al., 2013) version 2.7.1a to the zebrafish
GRCz11 reference genome. Genomic sequence indices for STAR were built including exonjunction coordinates from Ensembl v92 (Aken et al., 2017). Gene annotations were created by
concatenating all Ensembl transcript isoforms together. To calculate read counts per gene, all reads
that mapped uniquely to the genome and overlapped at least ten nucleotides of the gene annotation
were summed. Because the miR-430 locus is internally repetitive, genome tracks for miR-430 were
generated by allowing up to 900 alignments per read. To calculate per gene RPKMs, the total
number of RNA reads mapped to each gene were summed and normalized by gene length and the
total numbers of reads mapped to the zebrafish transcriptome per million.

Differential gene expression analysis
To identify significantly differentially expressed genes between background-matched
wild-type controls and MZythdf2 mutants, read counts were compared using the R package
DESeq2 (Love et al., 2014). Genes were excluded from the analysis if the gene count was below
one for both replicates in either condition. To get DE genes, counts for all Ensembl genes were
input to the results function with the options pAdjustMethod = ‘fdr’ and independentFiltering =
FALSE. P-values reported from DESeq2 are adjusted P-values corrected for multiple testing.

Determination of maternal and zygotic genes
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Maternal, maternal-zygotic, and zygotic genes were previously defined in Lee et al., 2013.
For analyses directly comparing maternal mRNA abundance between m6A-modified and
unmodified mRNAs, only strictly maternal transcripts were included. For analyses analyzing
global abundance of maternal mRNAs, both exclusively maternally expressed and maternalzygotic mRNAs were included.

Methylated and unmethylated gene definition
Datasets for m6A-methylation in zebrafish (Zhao et al., 2017) are available from GEO
accession number GSE79213. Genes found to have transcript methylation were defined previously
from Zhao et al., 2017, and were taken directly from the provided table of processed data. Maternal
m6A-modified transcripts used for analysis here included those that were found to contain m6Amodification in both the m6A-seq and m6A-CLIP-seq from Zhao et al., 2017 at either 0 hpf or 2
hpf.

6.3. Generation of zebrafish mutants and phenotype analysis
Zebrafish maintenance and embryo production
Danio rerio (zebrafish) embryos were obtained from natural matings of adult fish of mixed
wild-type backgrounds (TU-AB and TLF strains) of mixed ages. Embryos from multiple wildtype crosses were pooled, unless performing experiments on mutant and background-matched
controls, in which case clutches from individual pairs were analyzed separately. Embryos were
grown and staged according to published standards (Kimmel et al., 1995) and all zebrafish and
embryo experiments were performed at 28°C. For experiments involving mutants and wild-type
controls, fish pairs were mated at the same time to generate synchronously growing embryos.
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Embryo collections of mutants and background-matched controls were then performed at the same
time to ensure that all embryos were time-matched for all experiments.

Treatment of juvenile fish with EE2
17 a-ethynylestradiol (EE2) (Sigma-Aldrich, E4876) was diluted with system water to
make a 100,000X stock. Approximately 40 fish were raised in a 10-liter tank with EE2 solution at
a final concentration of 10 ng/L. Fish water was renewed by dripping 40 L of EE2 solution per
day. Fish were treated from 22 to 60 days post fertilization and were sexed 30 days later.

Embryo treatments and injections
All injections into zebrafish embryos were performed on chorionated, one-cell stage
embryos with 1 nL volumes, unless otherwise stated. To inhibit RNA Polymerase II, embryos were
bathed in 5.8 mM of triptolide (Sigma-Aldrich, T3652) or injected with 0.2 ng of a-amanitin
(Sigma-Aldrich, A2263) re-suspended in nuclease-free water.
To generate rescue constructs, zebrafish ythdf1, ythdf2, and ythdf3 were PCR amplified
from cDNA from 2 hpf embryos. DNA was ligated into a pHA-SP vector containing a 3x-flag
sequence using EcoRI and XhoI restriction sites and In-Fusion cloning (Takara, 639642). Final
constructs were confirmed by Sanger sequencing. Constructs were linearized with SalI restriction
digest and purified using QIAquick PCR purification kit (Qiagen, 28104). Linearized DNA was
used as a template for in vitro transcription (IVT) using the mMessage mMachine SP6
Transcription Kit (Invitrogen, AM1340) to generate capped reporter mRNA. Resultant mRNA was
DNase treated and purified using the RNeasy RNA extraction kit (Qiagen, 74104). Zebrafish
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embryos were injected with 100 pg of mRNA and expression of the flag-tagged protein was
confirmed by Western blotting.

Gene editing and maternal-zygotic mutants
CRISPR-Cas9 gene editing in zebrafish was performed as described in Vejnar et al., 2016.
sgRNAs targeting each gene were designed using the CRISPRscan tool (crisprscan.org) (MorenoMateos et al., 2015). Guides are listed in Table 6.1. For gene editing to generate ythdf2-223/-223 and
ythdf3 mutants, 30 pg of each sgRNA was co-injected with 150 pg of Cas9 (plasmid pT3TSnCas9n, Addgene #46757, (Jao et al., 2013)) capped mRNA synthesized using mMessage
mMachine T3 Transcription kit (Thermo Fisher Scientific, AM1340). For mutagenesis of ythdf1,
20 pg of each sgRNA and 150 pg of Cas9 mRNA was co-injected with 20 pg of a single-stranded
DNA template (ythdf1 5’- gggcagccattgctagcaaaccggccaagcctcagcaactgaaggtgaagagtaagccaggga
tgcccatgtagtagtagaccaactcgcgtgacacacaggaggtgcctctggaa-3’) to facilitate large deletion and
insertion of a stop codon cassette (TAGATAGATAG) by homologous recombination. Mosaic F0
founders were identified by genotyping, using the oligos in Table 6.1. Fish were backcrossed twice
to wild-type fish before incrossing heterozygous adults to generate homozygous mutants.
Homozygous fish were then incrossed to generate maternal-zygotic mutant embryos. Homozygous
ythdf2-8/-8 zebrafish were generated by Zhao et al., 2017 and were obtained from the laboratory of
Robert Ho. Double and triple mutants were generated by crossing fish heterozygous for each gene
mutation, and then incrossing double or triple heterozygous. These fish were subject to EE2
treatment, to generate both male and female double or triple homozygous. Males and females with
double homozygous genotypes were subsequently incrossed to generate maternal-zygotic
embryos.
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To genotype zebrafish, DNA was extracted from embryos or tissue clipped from the end
of the zebrafish tail. Samples were incubated in 100 ml of 100 mM NaOH at 95°C for 20 minutes
and neutralized with 40 ml of 1 M Tris, pH 7.4 (AmericanBio, AB14044). 1 µl of crude DNA
extraction was used as a template for PCR using Taq polymerase and indicated genotyping oligos.
For the genotyping time course of triple ythdf mutants, 48 embryos were removed at random from
the pool of offspring every 3 days and subject to genotyping, without being returned to the pool.
At 30 dpf, an additional 200 fish were also genotyped.
For experiments comparing MZ mutants to wild-type embryos, wild-type controls were
generated from incrossing background-matched wild-type adults that were siblings with
homozygous mutants. This was done to homogenize the genetic background between homozygous
MZ mutants and wild-type controls. Background-matched wild-type embryos were used as wildtype controls for all experiments involving MZ mutants, unless otherwise noted. As an additional
control, some experiments included embryos generated by crossing unrelated, wild-type fish from
TU-AB stock.

Microscopy
All imaging was observed using a Zeiss Discovery V12 stereo microscope and images were
captured with an AxioCam MRc digital camera (Carl Zeiss). All imaging experiments were
performed at a monitored temperature of 28°C and were repeated with at least three biological
samples for each condition. For live imaging time course assays, live dechorionated embryos were
mounted in 0.25% low melt agarose (AmericanBio, CAS: 9012-36-6) and imaged at least every
two minutes. All image analysis was performed using ImageJ (Schneider et al., 2012).
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Histology
For juvenile fish aged either 27- or 34-days post fertilization, heads and tails were removed
and the middle body section containing the gonads were fixed in Bouin’s solution (Sigma-Aldrich,
HT10132) overnight at 4°C. Fixed tissues were embedded in paraffin and sectioned at 10 mm.
Hematoxylin and Eosin (H&E) staining was performed on the sections according to standard
protocols. Slides were mounted in Omnimount (National Diagnostics, 17997-01) and imaged
using a Zeiss Axio Imager M1 and an AxioCam MRc digital camera (Carl Zeiss).

Ythdf protein sequence alignments
Protein sequence alignment was generated using SnapGene® software (GSL Biotech,
available at snapgene.com), with Clustal Omega alignment, made relative to the consensus
sequence with a consensus threshold of > 50%. Phylogenetic tree was generated from the protein
sequence alignment described above using Clustal W2 and neighbor-joining clustering.
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Table 6.1. Oligonucleotide sequences for gene-editing, genotyping, in situs, and qRT-PCR.
CRISPR-cas9 guide RNAs
ythdf1 sgRNA 1
taatacgactcactatagggtcacgcgagttggtcacgttttagagctagaa
ythdf1 sgRNA 2
taatacgactcactataggcagggtgcctccagccatgttttagagctagaa
ythdf2 sgRNA 1
taatacgactcactatagggcatgtaggagtcggacagttttagagctagaa
ythdf2 sgRNA 2
taatacgactcactataggcttcaacttctttcccaggttttagagctagaa
ythdf3 sgRNA 1
taatacgactcactatagggcgtgttgcctaaagcacgttttagagctagaa
ythdf3 sgRNA 2
taatacgactcactataggtgcagaggagctgacagggttttagagctagaa
mettl3 sgRNA 1
taatacgactcactatagggagatgcactggggccacgttttagagctagaa
mettl14 sgRNA 1 taatacgactcactatagggtttggctgacaggtttggttttagagctagaa
mettl14 sgRNA 2 taatacgactcactatagggatcgagggggattcaggttttagagctagaa
Genotyping zebrafish mutants
ythdf1 pair 1
atgaccgacccatacctgtc
agcgatgatcttcagcacct
ythdf1 pair 2
aacagtcagctcaggcacatc
catcgaagatggaggttgtgt
ythdf2 D223
gggagcaattgtcacctg
gggagactgtccgtcaatca
ythdf2 D8
tgctgttccacctcaactctc
ttaccatgcgcagtttttct
ythdf3
ggacagatgagcaatggtga
caaaatcatgttgggcttcg
mettl3
gcttccacatggacacctg
ttctaaatcacaagattcaaatcca
mettl14 pair 1
atcggggtcgagagagaaat
attgaaccccatccctaacc
mettl14 pair 2
tattgccagcactttgtgga
ttggcacgttgcagactatc
in situ hybridization probe amplification
mtus1a
gactatttaggtgacactatagatgctgcttgtctagcgtttg gacttaatacgactcactatagggcaagcactcgtccgtttaca
zgc:162879
gactatttaggtgacactatagaatatggccacctctcctgtg gacttaatacgactcactatagggcagcaacgtcatgaggaaaa
qRT-PCR oligos
buc
caagttactggacctcaggatc
ggcagtaggtaaattcggtctc
brca2
ttgtaaagccacgagcactg
ccgcaaggttgaaaaactgt
dcun1d5
agagtggctgaagggaatga
ccaacatggattttgcagtg
mtus1a
aaggatggagcttgctgaga
tctggctttgaggtcttcgt
mylipa
gggaggctctgctctgtatg
cgccaatggtcaggtttagt
otx1b
tacatttacgcgctcacagc
gctgacgacatttagcacga
setdb1a
cttctcaacccaaaacactgc
ctatctgaagagacgggtgaaac
tdrd1
ccctgcctttaagtgtcagc
caagcaggagaaccaactcc
ticrr
tcaccagttcggcttctttt
caactgtccggtttggagtt
uspl1
ctgtgtttgcgttgcacttt
tcaagttccagccaaaatcc
vps26a
aatggaagtgggcattgaag
tgactggtgctccatccata
zgc:162879
cgaggcaagtgctaaagagg
acagcagttgctcagggtct
ythdf1
aacggtccacgacaatgact
tgatggtctccattgctgag
ythdf2
ttcgagccttacctgaatgc
taggggcataggcgtaactg
ythdf3
gaatggcaggactgaagctc
tctctaggggcacttcctga

All oligonucleotides are listed 5’-3’. The two columns for corresponding to the genotyping, in situ,
and qRT-PCR entries correspond to the forward (left) and reverse (right) oligos.
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